10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

R Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended June 30, 2013.

OR

£ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from to .

Commission file number: 001-33459

Skilled Healthcare Group, Inc.

(Exact name of registrant as specified in its charter)

Delaware	20-3934755
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)
27442 Portola Parkway, Suite 200
Foothill Ranch, California	92610
(Address of principal executive offices)	(Zip Code)

(949) 282-5800

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes  þ    No  £

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  þ    No  £

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	£		Accelerated filer	þ
Non-accelerated filer	£	(do not check if smaller reporting company)	Smaller reporting company	£

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  £    No  þ

The number of shares outstanding of each of the issuer’s classes of common stock, as of the close of business on August 2, 2013, was:

Class A common stock, $0.001 par value – 23,659,035 shares

Class B common stock, $0.001 par value –15,576,096 shares

Skilled Healthcare Group, Inc.

Form 10-Q

For the Quarterly Period Ended June 30, 2013

Index

		Page Number
Part I.	Financial Information
Item 1.	Financial Statements	3
	Condensed Consolidated Balance Sheets — June 30, 2013 (unaudited) and December 31, 2012	3
	Condensed Consolidated Statements of Operations — Three and Six months ended June 30, 2013 (unaudited) and June 30, 2012 (unaudited)	4
	Condensed Consolidated Statements of Comprehensive Income — Three and Six months ended June 30, 2013 (unaudited) and June 30, 2012 (unaudited)	5
	Condensed Consolidated Statements of Cash Flows — Three and Six months ended June 30, 2013 (unaudited) and June 30, 2012 (unaudited)	6
	Notes to Unaudited Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	45
Item 4.	Controls and Procedures	45
Part II.	Other Information
Item 1.	Legal Proceedings	47
Item 1A.	Risk Factors	47
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	62
Item 3.	Defaults Upon Senior Securities	62
Item 4.	Mine Safety Disclosures	62
Item 5.	Other Information	63
Item 6.	Exhibits	64
Signatures		65
Exhibit Index		66

PART I — FINANCIAL INFORMATION

Item 1.Financial Statements.

Skilled Healthcare Group, Inc.

Condensed Consolidated Balance Sheets

(In thousands)

	June 30, 2013			December 31, 2012
	(Unaudited)			(Audited)
ASSETS
Current assets:
Cash and cash equivalents	$	2,019		$	2,003
Accounts receivable, less allowance for doubtful accounts of $11,764 and $15,646 at June 30, 2013 and December 31, 2012, respectively	122,280			107,245
Deferred income taxes	11,430			11,696
Prepaid expenses	3,355			7,569
Other current assets	11,169			10,312
Total current assets	150,253			138,825
Property and equipment, less accumulated depreciation of $129,990 and $118,141 at June 30, 2013 and December 31, 2012, respectively	364,877			370,745
Leased facility assets, less accumulated depreciation of $4,186 and $3,935 at June 30, 2013 and December 31, 2012, respectively	9,662			9,913
Other assets:
Notes receivable	1,276			2,055
Deferred financing costs, net	6,394			6,355
Goodwill	85,609			85,609
Intangible assets, less accumulated amortization of $4,382 and $4,218 at June 30, 2013 and December 31, 2012, respectively	21,871			22,035
Deferred income taxes	3,451			7,362
Other assets	41,581			39,737
Total other assets	160,182			163,153
Total assets	$	684,974		$	682,636
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities	$	50,799		$	48,780
Employee compensation and benefits	42,393			42,185
Current portion of long-term debt	12,306			13,338
Total current liabilities	105,498			104,303
Long-term liabilities:
Insurance liability risks	26,020			27,396
Other long-term liabilities	14,259			15,477
Long-term debt, less current portion	433,207			435,629
Total liabilities	578,984			582,805
Commitments and contingencies — Note 7
Stockholders’ equity:
Class A common stock, 175,000 shares authorized, $0.001 par value per share; Issued and outstanding - 23,659 and 22,967 at June 30, 2013 and December 31, 2012, respectively	24			23
Class B common stock, 30,000 shares authorized, $0.001 par value per share; Issued and outstanding - 15,576 at June 30, 2013 and December 31, 2012	16			16
Additional paid-in-capital	377,439			376,027
Accumulated deficit	(271,515		)	(276,108		)
Accumulated other comprehensive income (loss)	26			(127		)
Total stockholders’ equity	105,990			99,831
Total liabilities and stockholders’ equity	$	684,974		$	682,636

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

Skilled Healthcare Group, Inc.

Condensed Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Revenue:
Net patient service revenue	$	212,905		$	216,607		$	431,019		$	435,266
Leased facility revenue	787			768			1,548			1,522
	213,692			217,375			432,567			436,788
Expenses:
Cost of services (exclusive of rent cost of revenue and depreciation and amortization shown below)	186,376			180,215			376,513			363,346
Rent cost of revenue	4,828			4,539			9,640			9,095
General and administrative	6,837			6,427			13,292			12,527
Change in fair value of contingent consideration	(2,244		)	499			(2,161		)	630
Depreciation and amortization	6,130			6,092			12,266			12,236
	201,927			197,772			409,550			397,834
Other (expenses) income:
Interest expense	(8,734		)	(10,521		)	(17,409		)	(20,086		)
Interest income	112			132			224			277
Other (expense) income, net	(32		)	106			(62		)	77
Equity in earnings of joint venture	472			490			961			961
Debt modification/retirement costs	(1,088		)	(3,958		)	(1,088		)	(3,958		)
Total other (expenses) income, net	(9,270		)	(13,751		)	(17,374		)	(22,729		)
Income before provision for income taxes	2,495			5,852			5,643			16,225
Provision for income taxes	972			2,355			1,050			6,391
Net income	$	1,523		$	3,497		$	4,593		$	9,834
Net income per share, basic	$	0.04		$	0.09		$	0.12		$	0.26
Net income per share, diluted	$	0.04		$	0.09		$	0.12		$	0.26
Weighted-average common shares outstanding, basic	37,646			37,400			37,602			37,343
Weighted-average common shares outstanding, diluted	38,186			37,497			38,139			37,489

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

Skilled Healthcare Group, Inc.

Condensed Consolidated Statements of Comprehensive Income

(In thousands)

(Unaudited)

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Net income	$	1,523		$	3,497		$	4,593		$	9,834
Other comprehensive income:
Unrealized (loss) on interest rate swap - net of income tax (benefit) of ($2) for the three months ended June 30, 2012; net of income tax (benefit) of ($23) for the six months ended June 30, 2012.	—			(2		)	—			(23		)
Unrealized (loss) gain on Investment available for sale - net of income tax (benefit) expense of ($9) and $3 for the three months ended June 30, 2013 and 2012, respectively; net of income tax (benefit) expense of ($10) and $27 for the six months ended June 30, 2013 and 2012, respectively.	(14		)	4			(16		)	42
Reclassification adjustments:
Interest expense on interest rate swap - net of income tax expense of $56 and $55 for the three months ended June 30, 2013 and 2012, respectively; net of income tax expense of $107 and $108 for the six months ended June 30, 2013 and 2012, respectively.	87			86			169			171
Other comprehensive income, net of tax	73			88			153			190
Comprehensive income	1,596			3,585			4,746			10,024

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

Skilled Healthcare Group, Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

	Six Months Ended June 30,
	2013			2012
Cash Flows from Operating Activities
Net income	$	4,593		$	9,834
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	12,266			12,236
Change in fair value of contingent consideration	(2,161		)	630
Provision for doubtful accounts	6,097			3,562
Non-cash stock-based compensation	1,634			2,371
Disposal of fixed assets	—			(145		)
Excess tax benefits from stock-based payment arrangements	—			242
Amortization of deferred financing costs	1,323			1,643
Debt modification/retirement costs	1,088			3,958
Deferred income taxes	4,080			(369		)
Amortization of discount on debt	475			432
Changes in operating assets and liabilities:
Accounts receivable	(21,037		)	(12,801		)
Payments on notes receivable	1,419			1,482
Other current and non-current assets	(1,642		)	(1,172		)
Accounts payable and accrued liabilities	766			(5,330		)
Employee compensation and benefits	(328		)	(1,488		)
Insurance liability risks	4,271			(3		)
Other long-term liabilities	945			(962		)
Net cash provided by operating activities	13,789			14,120
Cash Flows from Investing Activities
Additions to property and equipment	(5,981		)	(7,097		)
Acquisition of healthcare facilities and businesses, net of cash acquired	—			(1,053		)
Proceeds from divestitures	—			1,050
Net cash used in investing activities	(5,981		)	(7,100		)
Cash Flows from Financing Activities
Borrowings under line of credit	165,000			162,500
Repayments under line of credit	(161,000		)	(117,000		)
Repayments of long-term debt	(9,121		)	(157,494		)
Excess tax benefits from stock-based payment arrangements	—			(242		)
Taxes paid related to net share settlement of equity awards	(222		)	(229		)
Proceeds from issuance of long-term debt	—			98,000
Payment of financing costs	(2,449		)	(3,000		)
Net cash used in financing activities	(7,792		)	(17,465		)
Increase (decrease) in cash and cash equivalents	16			(10,445		)
Cash and cash equivalents at beginning of period	2,003			16,017
Cash and cash equivalents at end of period	$	2,019		$	5,572

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

	Six Months Ended June 30,
	2013		2012
Supplemental cash flow information
Cash paid for:
Interest expense	$	15,684	$	23,660
Income taxes, net	$	181	$	7,211
Non-cash activities:
Conversion of accounts receivable into notes receivable	$	—	$	359
Liabilities issued as purchase consideration for purchase of business	$	—	$	261
Insurance premium financed	$	1,187	$	1,107

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

7

SKILLED HEALTHCARE GROUP, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

1. Description of Business

Current Business

Skilled Healthcare Group, Inc. ("Skilled") is a holding company that owns subsidiary companies that in turn own and operate long-term care facilities and provide a wide range of post-acute care services, with a strategic emphasis on sub-acute specialty medical care. Skilled and its consolidated wholly-owned companies are collectively referred to as the "Company." As of June 30, 2013, the Company operated facilities in California, Iowa, Kansas, Missouri, Nevada, Nebraska, New Mexico and Texas, including 74 skilled nursing facilities ("SNFs"), which offer sub-acute care, rehabilitative, specialty healthcare, and skilled nursing care, and 22 assisted living facilities ("ALFs"), which provide room and board and assistance with activities of daily living. The Company leases five skilled nursing facilities in California to an unaffiliated third party operator. In addition, through its Hallmark Rehabilitation subsidiary ("Hallmark"), the Company provides a variety of rehabilitative services such as physical, occupational and speech therapy in Company-operated facilities and unaffiliated facilities. Furthermore, as of June 30, 2013, the Company provided hospice care and home health services in Arizona, California, Idaho, Montana, Nevada and New Mexico. The Company also provides private duty care services in Idaho, Montana, and Nevada. The Company has an administrative services company that provides a full complement of administrative and consultative services that allows affiliated operators and third-party operators with whom the Company contracts to better focus on delivery of healthcare services. The Company currently has one such service agreement with an unrelated skilled nursing facility operator. The Company is also a member in a joint venture located in Texas that provides institutional pharmacy services, which currently serves eight of the Company's SNFs and other facilities unaffiliated with the Company.

2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed consolidated financial statements as of June 30, 2013 and for the three and six months ended June 30, 2013 and 2012 (collectively, the "Interim Financial Statements"), are unaudited. Certain information and footnote disclosures normally included in the Company’s annual consolidated financial statements have been condensed or omitted, as permitted under applicable rules and regulations. Readers of the Interim Financial Statements should refer to the Company's audited consolidated financial statements and notes thereto, updated for Note 3, "Summary of Significant Accounting Policies", to this filing, for the year ended December 31, 2012, which are included in the Company's 2012 Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC"). Management believes that the Interim Financial Statements reflect all adjustments that are of a normal and recurring nature necessary to fairly present the Company's financial information in all material respects as of the dates and for the periods presented. The results of operations presented in the Interim Financial Statements are not necessarily indicative of operations for the entire year or any other period.

The accompanying Interim Financial Statements include the accounts of Skilled and its consolidated wholly-owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.

Estimates and Assumptions

The interim consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP"), which require the Company to consolidate company financial information and make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The most significant estimates in the Company’s consolidated financial statements relate to revenue, allowance for doubtful accounts, self-insured liability risks, income taxes, valuation of contingent consideration and impairment of long-lived assets and goodwill. Actual results could differ materially from those estimates. There was a $3.6 million increase in insurance expense in the six months ended June 30, 2013 due to an increase in the reserves on professional liability claims from prior years.

Reclassifications

Certain items previously reported in specific financial statement captions have been reclassified to conform to the current period presentation. Such reclassifications do not impact previously reported revenue, operating loss, net loss, total assets, liabilities, or stockholders' equity.

Revenue and Accounts Receivables

8

SKILLED HEALTHCARE GROUP, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Revenue and accounts receivable are recorded on an accrual basis as services are performed at their estimated net realizable value. The Company derives a majority of its revenue from funds under federal Medicare and state Medicaid assistance programs, the continuation of which are dependent upon governmental policies and are subject to audit risk and potential recoupment.

Overall payments made by Medicare for hospice services are subject to an annual cap amount on a per hospice agency basis. Total Medicare payments received for services rendered during the applicable Medicare hospice cap year by each Medicare-certified agency during this period are compared to the cap amount for the relevant period. Payments in excess of the cap are subject to recoupment by Medicare. For the three months ended June 30, 2013 and 2012, the Company recorded hospice Medicare cap reserves of $1.4 million and $1.0 million, respectively, as adjustments to revenue. Of the $1.4 million hospice cap reserves recorded in the three months ended June 30, 2013, $0.7 million was related to the 2013 cap year and $0.7 million was related to the 2012 cap year. The $1.0 million recorded in the three months ended June 30, 2012 was related to the 2012 cap year. For the six months ended June 30, 2013 and 2012, the Company recorded hospice Medicare cap adjustment of $2.9 million and $1.2 million respectively, as adjustments to revenue. Of the $2.9 million, $0.7 million was related to the 2013 cap year, $2.0 million was related to the 2012 cap year, and $0.2 million was related to the 2011 cap year. The $1.2 million recorded in the six months ended June 30, 2012 was related to the 2012 cap year.

Notes Receivable

As of June 30, 2013 and December 31, 2012, net notes receivable were approximately $3.7 million and $5.2 million, respectively, of which $2.4 million and $3.1 million was reflected as current assets as of June 30, 2013 and December 31, 2012, with the remaining balances reflected as long-term assets. Interest rates on these notes approximated market rates as of the date the notes were originated.

As of June 30, 2013, two of the Company's rehabilitation therapy services business customers were responsible for $3.7 million, or 100%, of the net notes receivable balance. These notes receivable, as well as the trade receivables from these customers, are secured by the assets of the customers as well as a personal guaranty by the principal owners of the customers. As of June 30, 2013, these two customers represented $12.7 million, or 47.7% of the net accounts receivable for the Company's rehabilitation therapy services business and approximately $22.2 million, or 41.4%, of the external revenue of the rehabilitation therapy services business for the six months ended June 30, 2013.

The Company also had a note receivable of $0.2 million which had an allowance for uncollectibility of $0.2 million and $0.1 million, as of June 30, 2013 and December 31, 2012, respectively.

Recent Accounting Pronouncements

In November 2011, the FASB issued ASU No. 2011-11, Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities, ("ASU 2011-11"). This ASU require an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. The adoption of ASU 2011-11 becomes effective for the Company's interim and annual periods beginning on or after January 1, 2013. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.

In February 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income. The amendments in this update require an entity to provide information about the amounts reclassified from accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in the notes, significant amounts reclassified from accumulated other comprehensive income by the net income line item. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.

3. Net Income Per Share of Class A Common Stock and Class B Common Stock

The Company computes net income per share of Class A common stock and Class B common stock using the two-class method. The Company's Class A common stock and Class B common stock are identical in all respects, except with respect to voting rights and except that each share of Class B common stock is convertible into one share of Class A common stock under certain circumstances. Net income is allocated on a proportionate basis to each class of common stock in the determination of income per share.

Basic net income per share was computed by dividing net income by the weighted-average number of outstanding shares for the period. Dilutive earnings per share is computed by dividing net income plus the effect of assumed conversions (if applicable) by the weighted-average number of outstanding shares after giving effect to all potential dilutive common stock, including options, warrants, common stock subject to repurchase and convertible preferred stock, if any. The following table sets forth the computation of basic and diluted net income per share of Class A common stock and Class B common stock for the three and six months ended June 30, 2013 and 2012 (amounts in thousands, except per share data):

	Three months ended June 30, 2013						Three months ended June 30, 2012
	Class A		Class B		Total		Class A		Class B		Total
Net Income per share, basic
Numerator:
Allocation of net income	$	893	$	630	$	1,523	$	1,950	$	1,547	$	3,497
Net Income per share, diluted
Numerator:
Allocation of net income	$	902	$	621	$	1,523	$	1,954	$	1,543	$	3,497
Denominator for basic and diluted net income per share:
Weighted average common shares outstanding, basic	22,070		15,576		37,646		20,852		16,548		37,400
Plus: incremental shares related to dilutive effect of stock options and restricted stock, if applicable	540		—		540		97		—		97
Adjusted weighted-average common shares outstanding, diluted	22,610		15,576		38,186		20,949		16,548		37,497
Net income per share, basic	$	0.04	$	0.04	$	0.04	$	0.09	$	0.09	$	0.09
Net income per share, diluted	$	0.04	$	0.04	$	0.04	$	0.09	$	0.09	$	0.09

	Six months ended June 30, 2013						Six months ended June 30, 2012
	Class A		Class B		Total		Class A		Class B		Total
Net Income per share, basic
Numerator:
Allocation of net income	$	2,690	$	1,903	$	4,593	$	5,425	$	4,409	$	9,834
Net Income per share, diluted
Numerator:
Allocation of net income	$	2,717	$	1,876	$	4,593	$	5,442	$	4,392	$	9,834
Denominator for basic and diluted net income per share:
Weighted average common shares outstanding, basic	22,026		15,576		37,602		20,600		16,743		37,343
Plus: incremental shares related to dilutive effect of stock options and restricted stock, if applicable	537		—		537		146		—		146
Adjusted weighted-average common shares outstanding, diluted	22,563		15,576		38,139		20,746		16,743		37,489
Net income per share, basic	$	0.12	$	0.12	$	0.12	$	0.26	$	0.26	$	0.26
Net income per share, diluted	$	0.12	$	0.12	$	0.12	$	0.26	$	0.26	$	0.26

The following were excluded from the weighted-average diluted shares computation for the three and six months ended June 30, 2013 and 2012, as their inclusion would have been anti-dilutive (shares in thousands):

	Three Months Ended June 30,		Six Months Ended June 30,
	2013	2012	2013	2012
Options to purchase common shares	585	464	585	464
Non-vested common shares	434	1,018	911	898
Total excluded	1,019	1,482	1,496	1,362

4. Business Segments

The Company has three reportable operating segments: (i) long-term care services ("LTC"), which includes the operation of SNFs and ALFs which is the most significant portion of the Company's business, the Company's administrative services provided to an unrelated SNF operator, and the facility lease revenue from a third-party operator; (ii) the Company's

9

SKILLED HEALTHCARE GROUP, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

rehabilitation therapy services business; and (iii) the Company's hospice and home health businesses. The "other" column in the table below includes general and administrative items. The Company's reporting segments are business units that offer different services, and that are managed differently due to the nature of the services provided.

At June 30, 2013, LTC services included 74 wholly-owned SNF operating companies that offer post-acute, rehabilitative custodial and specialty skilled nursing care, as well as 22 wholly-owned ALF operating companies that provide room and board and social services. Therapy services included rehabilitative services such as physical, occupational and speech therapy provided in the Company's facilities and in unaffiliated facilities. Hospice and home health services were provided by the Company's wholly-owned subsidiaries to patients.

The Company evaluates performance and allocates capital resources to each segment based on an operating model that is designed to maximize the quality of care provided and profitability. Accordingly, earnings from operations before net interest, tax, depreciation and amortization, non-core expenses ("Adjusted EBITDA") and rent cost of revenue ("Adjusted EBITDAR") is used as the primary measure of each segment’s operating results because it does not include such costs as interest expense, income taxes, depreciation, amortization and rent cost of revenue which may vary from segment to segment depending upon various factors, including the method used to finance the original purchase of assets within a segment or the tax law of the states in which a segment operates. By excluding these items, the Company is better able to evaluate operating performance of the segment by focusing on more controllable measures. Adjusted EBITDA and Adjusted EBITDAR are non‑GAAP financial measures. For a full discussion of the definitions of these terms and the reasons why the Company utilizes such measures, see Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations, of this filing. General and administrative expenses are not allocated to any segment for purposes of determining segment profit or loss, and are included in the "other" category in the selected segment financial data that follows. Intersegment sales and transfers are recorded at cost plus standard mark-up; intersegment transactions have been eliminated in consolidation.

The following table sets forth selected financial data consolidated by business segment (dollars in thousands):

	Long-Term Care Services		Therapy Services		Hospice & Home Health Services		Other			Elimination			Total
Three months ended June 30, 2013
Net patient service revenue from external customers	$	161,012	$	26,637	$	25,256	$	—		$	—		$	212,905
Leased facility revenue	787		—		—		—			—			787
Intersegment revenue	653		14,018		—		—			(14,671		)	—
Total revenue	$	162,452	$	40,655	$	25,256	$	—		$	(14,671	)	$	213,692
Operating income (loss)	$	12,176	$	2,705	$	3,879	$	(6,995	)	$	—		$	11,765
Interest expense, net of interest income													(8,622		)
Other expense													(32		)
Equity in earnings of joint venture													472
Debt modification costs													(1,088		)
Income before provision for income taxes													$	2,495
Depreciation and amortization	$	5,656	$	174	$	135	$	165		$	—		$	6,130
Segment capital expenditures	$	3,365	$	70	$	83	$	62		$	—		$	3,580
Adjusted EBITDA	$	17,801	$	2,879	$	1,792	$	(4,832	)	$	—		$	17,640
Adjusted EBITDAR	$	22,171	$	2,879	$	2,258	$	(4,840	)	$	—		$	22,468
Three months ended June 30, 2012
Net patient service revenue from external customers	$	163,287	$	26,385	$	26,935	$	—		$	—		$	216,607
Leased facility revenue	768		—		—		—			—			768
Intersegment revenue	601		15,818		—		—			(16,419		)	—
Total revenue	$	164,656	$	42,203	$	26,935	$	—		$	(16,419	)	$	217,375
Operating (loss) income	$	18,126	$	3,543	$	4,521	$	(6,587	)	$	—		$	19,603
Interest expense, net of interest income													(10,389		)

10

SKILLED HEALTHCARE GROUP, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

	Long-Term Care Services		Therapy Services		Hospice & Home Health Services		Other			Elimination			Total
Other expense													106
Equity in earnings of joint venture													490
Debt retirement costs													(3,958		)
Income before provision for income taxes													$	5,852
Depreciation and amortization	$	5,630	$	164	$	145	$	153		$	—		$	6,092
Segment capital expenditures	$	2,894	$	269	$	114	$	345		$	—		$	3,622
Adjusted EBITDA	$	23,719	$	3,850	$	5,255	$	(6,034	)	$	—		$	26,790
Adjusted EBITDAR	$	27,940	$	3,850	$	5,565	$	(6,026	)	$	—		$	31,329
Six months ended June 30, 2013
Net patient service revenue from external customers	$	325,925	$	53,744	$	51,350	$	—		$	—		$	431,019
Leased facility revenue	1,548		—		—		—			—			1,548
Intersegment revenue	1,194		29,190		—		—			(30,384		)	—
Total revenue	$	328,667	$	82,934	$	51,350	$	—		$	(30,384	)	$	432,567
Operating income (loss)	$	24,426	$	5,659	$	6,582	$	(13,650	)	$	—		$	23,017
Interest expense, net of interest income													(17,185		)
Other income													(62		)
Equity in earnings of joint venture													961
Debt modification costs													(1,088		)
Income before provision for income taxes													$	5,643
Depreciation and amortization	$	11,267	$	350	$	291	$	358		$	—		$	12,266
Segment capital expenditures	$	5,562	$	93	$	213	$	113		$	—		$	5,981
Adjusted EBITDA	$	35,632	$	6,010	$	4,784	$	(10,856	)	$	—		$	35,570
Adjusted EBITDAR	$	44,354	$	6,010	$	5,702	$	(10,856	)	$	—		$	45,210
Six months ended June 30, 2012
Net patient service revenue from external customers	$	329,625	$	52,501	53,140		$	—		$	—		$	435,266
Leased facility revenue	1,522		—		—		—			—			1,522
Intersegment revenue	1,355		31,799		—		—			(33,154		)	—
Total revenue	$	332,502	$	84,300	53,140		$	—		$	(33,154	)	$	436,788
Operating (loss) income	$	36,264	$	6,491	9,053		$	(12,854	)	$	—		$	38,954
Interest expense, net of interest income													(19,809		)
Other income													77
Equity in earnings of joint venture													961
Debt retirement costs													(3,958		)
Income before provision for income taxes													$	16,225
Depreciation and amortization	$	11,301	$	332	$	291	$	312		$	—		$	12,236
Segment capital expenditures	$	5,299	$	546	$	317	$	935		$	—		$	7,097
Adjusted EBITDA	$	47,499	$	6,966	$	10,123	$	(11,730	)	$	—		$	52,858
Adjusted EBITDAR	$	55,955	$	6,966	$	10,747	$	(11,715	)	$	—		$	61,953

11

SKILLED HEALTHCARE GROUP, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

A reconciliation of Adjusted EBITDA and Adjusted EBITDAR to net income is as follows (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Adjusted EBITDAR	$	22,468		$	31,329		$	45,210		$	61,953
Rent cost of revenue	(4,828		)	(4,539		)	(9,640		)	(9,095		)
Adjusted EBITDA	17,640			26,790			35,570			52,858
Depreciation and amortization	(6,130		)	(6,092		)	(12,266		)	(12,236		)
Interest expense	(8,734		)	(10,521		)	(17,409		)	(20,086		)
Interest income	112			132			224			277
Change in fair value of contingent consideration	2,244			(499		)	2,161			(630		)
Organization restructure costs	(1,549		)	—			(1,549		)	—
Debt retirement costs	(1,088		)	(3,958		)	(1,088		)	(3,958		)
Provision for income taxes	(972		)	(2,355		)	(1,050		)	(6,391		)
Net income	$	1,523		$	3,497		$	4,593		$	9,834

The following table presents the segment assets as of June 30, 2013 compared to December 31, 2012 (in thousands):

	Long-Term Care  Services		Therapy Services		Hospice & Home Health Services		Other		Total
June 30, 2013:
Segment total assets	$	463,370	$	57,005	$	105,157	$	59,442	$	684,974
Goodwill and intangibles included in total assets	$	1,532	$	23,693	$	82,255	$	—	$	107,480
December 31, 2012:
Segment total assets	$	471,129	$	52,559	$	103,800	$	55,148	$	682,636
Goodwill and intangibles included in total assets	$	1,670	$	23,693	$	82,281	$	—	$	107,644

5. Property and Equipment

Property and equipment consisted of the following as of June 30, 2013 and December 31, 2012 (in thousands):

	June 30, 2013			December 31, 2012
Land and land improvements	$	64,983		$	64,983
Buildings and leasehold improvements	335,118			331,316
Furniture and equipment	86,818			83,949
Construction in progress	7,948			8,638
	494,867			488,886
Less accumulated depreciation	(129,990		)	(118,141		)
	$	364,877		$	370,745

Leased facility assets consisted of the following as of June 30, 2013 and December 31, 2012 (in thousands):

	June 30, 2013			December 31, 2012
Leased facility assets	$	13,848		$	13,848
Less accumulated depreciation	(4,186		)	(3,935		)
	$	9,662		$	9,913

12

SKILLED HEALTHCARE GROUP, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

The Company began leasing five skilled nursing facilities in California to an unaffiliated third party operator in April 2011 and signed a 10-year lease with two10-year extension options exercisable by the lessee.

6. Income Taxes

For the three months ended June 30, 2013, the Company recorded an income tax expense of $1.0 million representing an effective tax rate of 39.0% compared to an income tax expense of $2.4 million for the same period in 2012. For the six months ended June 30, 2013 and 2012 the Company recorded an income tax expense of $1.1 million and $6.4 million respectively. The effective tax rate for the six months ended June 30, 2013 was less than the statutory rate primarily due to a $1.2 million benefit from the resolution and ultimate disposition of remaining funds related to the 2010 settlement of the Humboldt County Action. See Note 7, "Commitments and Contingencies - Legal Matters," for additional detail.

On July 11, 2013, legislation was enacted in California that will limit the carryover period for unused Enterprise Zone credits to 10 years beginning in 2014.  Prior to this legislation, unused Enterprise Zone credits could be carried over indefinitely.  The Company is currently evaluating the impact of this change of law.

7. Commitments and Contingencies

Legal Matters

General

Skilled and its subsidiaries are party to various legal actions and administrative proceedings and are subject to various claims arising in the ordinary course of business, including without limitation claims that their services have resulted in injury or death to patients who receive care from the Company's businesses and claims related to employment, staffing requirements and commercial matters. Although Skilled and its subsidiaries intend to vigorously defend themselves in these matters, there can be no assurance that the outcomes of these matters will not have a material adverse effect on the Company's results of operations and financial condition.

Skilled and its subsidiaries operate in a highly regulated industry. They are subject to ongoing regulatory oversight by state and federal regulatory authorities. Actual or alleged failure to comply with legal and regulatory requirements could subject Skilled and its subsidiaries to civil, administrative or criminal fines, penalties or restitutionary relief, and reimbursement authorities could seek the suspension or exclusion of the offending provider or individual from participation in government healthcare programs and could lead to recoupment claims on prior payments by government healthcare programs. Adverse determinations in legal and regulatory investigations, actions and proceedings, whether currently asserted or arising in the future, could have a material adverse effect on the Company's financial position, results of operations and cash flows.

See also Part II, Item 1A -- Risk Factors, included elsewhere in this report, including without limitation the sections therein entitled "Significant legal actions, which are commonplace in our professions, could subject us to increased operating costs and substantial uninsured liabilities, which would materially and adversely affect our results of operations, liquidity and financial condition," "Revenue we receive from Medicare and Medicaid is subject to potential retroactive reduction or repayment," "We are subject to extensive and complex laws and government regulations. If we are not operating in compliance with these laws and regulations or if these laws and regulations change, we could be required to make significant expenditures or change our operations in order to bring our facilities and operations into compliance" and "We face reviews, audits and investigations under federal and state government programs and contracts. These audits could have adverse findings that may negatively affect our business."

Humboldt County Litigation

In connection with the September 2010 settlement of the class action litigation against Skilled and certain of its subsidiaries related to, among other matters, alleged understaffing at certain California skilled nursing facilities operated by Skilled's subsidiaries (the "Humboldt County Action"), Skilled and its defendant subsidiaries (collectively, the "Defendants”) entered into settlement agreements with the plaintiffs and intervenor and agreed to an injunction. The settlement was approved by the Superior Court of California, Humboldt County on November 30, 2010. Under the terms of the settlement agreements, the defendant entities deposited a total of $50.0 million into escrow accounts to cover settlement payments to class members, notice and claims administration costs, reasonable attorneys' fees and costs and certain other payments, including $5.0 million to settle certain government agency claims and potential government claims that may arise. Of the $5.0 million provided for such government claims, $1.0 million was initially released by the court to the Humboldt County Treasurer-Tax Collector on behalf of the People of the State of California for their release of the Defendants. The remaining $4.0 million was available for

13

SKILLED HEALTHCARE GROUP, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

the settlement and releases by the California Attorney General and certain other District Attorneys. However, in the event that any of these government authorities were to instead file certain actions against the Defendants by the second anniversary of the effective date of the settlement agreement, which occurred in February 2013, the entire $4.0 million would have reverted to the Defendants upon their request to the Settlement Administrator.No such actions were filed, however, resulting in an additional $1.0 million distribution to the Humboldt County District Attorney's Office and the remaining $3.0 million being distributed to the class settlement fund, as required by the settlement agreement.

In addition to the payments to the Humboldt County Treasurer-Tax Collector on behalf of the People of the State of California, the court alsoapproved payments from the escrow of up to approximately $24.8 million for attorneys' fees and costs and $10,000 to each of the three named plaintiffs.  Pursuant to the injunction, the twenty-two Defendants that operated California nursing facilities were required to provide specified nurse staffing levels, comply with specified state and federal regulations governing staffing levels and posting requirements, and provide reports and information to a court-appointed auditor. The injunction was to remain in effect for a period of twenty-four months unless extended for additional three-month periods as to those Defendants that may be found in violation. Defendants demonstrating compliance for an eighteen-month period that ended September 30, 2012 were permitted to petition for early termination of the injunction. The Defendants were required to demonstrate over the term of the injunction that the costs of the injunction met a minimum threshold level pursuant to the settlement agreement, which level, initially $9.6 million, was reduced by the portion attributable to any Defendant in the case that no longer operated a skilled nursing facility during the injunction period.

In April 2011, five of the subsidiary Defendants transferred their operations to an unaffiliated third party skilled nursing facility operator (the “Former Humboldt County Facilities”). On November 14, 2012, the Defendants filed a motion to terminate the injunction and vacate the final judgment in the Humboldt County Action. Based upon compliance with the injunction through the requisite eighteen-month period, on December 21, 2012, the Superior Court of California, Humboldt County granted the Defendants' motion for early termination of the injunction, and the injunction has now ended with respect to the 17 California nursing facilities that the subsidiary Defendants still operate. In its order, the court determined that the injunction termination did not apply to the Former Humboldt County Facilities. However, the 2010 court-approved stipulation and order establishing the injunction provides that the injunction applies to the named defendants and any successor licensees of the applicable nursing facilities, but only if those successor licensees are affiliates of the named defendants. As noted above, the Former Humboldt County Facilities have been operated by an unaffiliated third party since April 2011. Therefore, under the terms of the injunction it does not apply to the Former Humboldt County Facilities unless an affiliate of the Defendants operates them. Pursuant to the BMFEA matter discussed below the California theories in this context were released in February 2013.

In the course of ongoing communications with the California Attorney General's Bureau of Medi-Cal Fraud & Elder Abuse ("BMFEA") related to the BMFEA matter discussed below, representatives of the California Attorney General and the U.S. Department of Justice ("DOJ") indicated an interest in pursuing an action under the False Claims Act ("FCA"). The DOJ has expressed that it believes the company has FCA and other legal liabilities based upon the jury findings in the Humboldt County Action and otherwise related to staffing considerations related thereto. While the Company continues to cooperate with the government's evaluation of the matter, the Company views the government's apparent legal theories, including the False Claims Act theories, as lacking support in the established case law. The Company intends to vigorously defend any such action if brought.

BMFEA Matter

On April 15, 2009, two of Skilled's wholly-owned companies, Eureka Healthcare and Rehabilitation Center, LLC (“EHRC”), which at the time operated Eureka Healthcare and Rehabilitation Center (the "Facility"), and Skilled Healthcare, LLC (“SHC”), the administrative services provider for the Facility, were served with a search warrant that related to an investigation of the Facility by the BMFEA. The search warrant related to, among other things, records, property and information regarding certain enumerated patients of the Facility and covered the period from January 1, 2007 through the date of the search. On October 31, 2012, the BMFEA filed a criminal complaint (the “BMFEA Action”) in California Superior Court, Humboldt County against EHRC, SHC and Skilled alleging elder endangerment in nine misdemeanor counts under Penal Code Section 368(c) and two felony counts under Penal Code Section 368(b)(1) related to the care of certain patients at the Facility in 2008. No individuals were named as defendants in the complaint. The Company disputed the BMFEA's theories of alleged criminal liability and vigorously defended the action. The charges filed by the BMFEA, if proven, would have carried fines of up to $6,000 for each of the two felony counts and $2,000 for each of the nine misdemeanor counts. Convictions could also lead to exclusion from participation in federal healthcare programs under federal laws such as the Federal False Claims Act and the Civil Monetary Penalty Law, which could be materially adverse to Skilled's business. EHRC transferred its operations in April 2011 to an unaffiliated third party skilled nursing facility operator, and has not had any ongoing operations since that time.

14

SKILLED HEALTHCARE GROUP, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

On February 15, 2013, the parties reached a mutually satisfactory settlement of the BMFEA Action. Pursuant to the settlement: (i) Skilled and SHC were dismissed from the case with prejudice; (ii) EHRC pled no contest to a single misdemeanor count of elder endangerment under Penal Code Section 368(c) and agreed to pay a statutory fine of $680, pay $145,000 to the California Attorney General for its costs of investigation, and to serve two (2) years of summary probation; and (iii) the California Attorney General granted Skilled, SHC, and twenty-five (25) of their affiliates who currently or formerly operated skilled nursing facilities in California, a release of any potential liability to the California Attorney General under certain civil statutes based upon conduct occurring through the effective date of the settlement (including the FCA theories discussed under Humboldt County Litigation above). The court accepted EHRC's misdemeanor plea and the other relevant terms of the settlement on February 15, 2013. Notwithstanding EHRC's no contest plea to the single misdemeanor charge, the Company, SHC and EHRC continue to deny any liability for the allegations in the BMFEA Action. The release granted by the California Attorney General may not apply to the DOJ should it choose to pursue action against us.

Pursuant to the settlement, Skilled, SHC and their twenty (20) affiliated current California skilled nursing facility operators also agreed to a 2-year staffing agreement (the “2013 Staffing Agreement”) with the California Attorney General that essentially continues the requirements of the staffing-related injunction that was in effect until December 2012 as a result of the September 2010 settlement of the Humboldt County Action. Similar to the former staffing-related injunction, the 2013 Staffing Agreement requires the applicable nursing facility operators to provide a minimum of 3.2 nursing hours per patient day as required by applicable California regulation and to adhere to related regulatory requirements, as well as to submit to periodic compliance audits of the same. Unlike the former staffing-related injunction, however, the 2013 Staffing Agreement does not provide for early termination based on demonstrated compliance and does not contain a minimum spend requirement. To date the 2013 Staffing Agreement has not, and the Company does not believe it will, require the Company or its affected affiliates to incur any material staffing or other costs beyond what they would otherwise incur in the ordinary course of business.

Creekside Hospice Investigation

On August 2, 2013, the United States Attorney for the District of Nevada indicated that its Civil Division is investigating the Company, as well as its subsidiary, Creekside Hospice II, LLC, for possible violations of federal and state healthcare fraud and abuse laws and regulations. These laws could include the federal False Claims Act ("FCA") and the Nevada False Claims Act ("NFCA"). The FCA provides for civil and administrative fines and penalties, including civil fines ranging from $5,500 to $11,000 per claim plus treble damages. The NFCA provides for similar fines and penalties, including treble damages. Violations of these federal or state laws could also subject the Company and/or its subsidiaries to exclusion from participation in the Medicare and Medicaid programs. Any damages, fines, penalties, other sanctions and costs that we may incur as a result of any state or federal FCA suit could be significant and could have a material and adverse effect on our results of operations and financial condition. At this time, we cannot predict what effect, if any, the investigation or any potential claims arising under the FCA, the NFCA, or other statutes or regulations, could have on the Company.

Insurance

The Company maintains insurance for workers' compensation, general and professional liability, employee benefits liability, property, casualty, directors’ and officers’ liability, inland marine, crime, boiler and machinery, automobile, employment practices liability and earthquake and flood. The Company believes that its insurance programs are adequate and appropriate, and where there has been a direct transfer of risk to the insurance carrier, the Company does not recognize a liability in the consolidated financial statements.

Workers' Compensation. The Company has maintained workers' compensation insurance as statutorily required. Most of its commercial workers' compensation insurance purchased is loss sensitive in nature, except as noted below. As a result, the Company is responsible for adverse loss development. Additionally, the Company self-insures the first unaggregated $1.0 million per workers' compensation claim for all California, New Mexico and Nevada skilled nursing and assisted living businesses. The Company has elected not to carry workers' compensation insurance in Texas and it may be liable for negligence claims that are asserted against it by its Texas-based employees. For the policy periods up to December 31, 2011, the Company has purchased guaranteed cost policies for its Kansas, Missouri, Iowa and Nebraska skilled nursing and assisted living businesses, as well as all of its hospice and home health businesses. There are no deductibles associated with these programs. Since January 1, 2013, the Company self-insures the first $0.5 million for these businesses. The Company recognizes a liability in its interim consolidated financial statements for its estimated self-insured workers' compensation risks. Historically, estimated liabilities have been sufficient to cover actual claims.

General and Professional Liability. The Company's services subject it to certain liability risks. Malpractice and similar claims may be asserted against the Company if its services are alleged to have resulted in patient injury or other adverse effects. The Company is subject to malpractice and similar claims and other litigation in the ordinary course of business.

15

SKILLED HEALTHCARE GROUP, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Effective September 1, 2008, the Company's California-based skilled nursing facility companies purchased individual general and professional liability insurance policies for claims reported through August 31, 2011, with a per occurrence and annual aggregate coverage limit of $1.0 million and $3.0 million, respectively, and an unaggregated $0.1 million per claim self-insured retention. Effective September 1, 2008, the Company also had an excess liability policy for claims reported through August 31, 2011, with a $14.0 million per loss limit and an $18.0 million annual aggregate limit for losses arising from claims in excess of $1.1 million for the California skilled nursing facilities and in excess of $1.0 million for all other businesses.

Effective September 1, 2011, the Company purchased excess liability policies with $25.0 million per loss and annual aggregate limits for claims in excess of $1.0 million per loss for all businesses. Effective September 1, 2011, the Company also self-insures professional liability claims at its California based SNF subsidiaries through its wholly-owned offshore captive insurance company, Fountain View Reinsurance, Ltd., for claims up to $1.0 million. Effective September 1, 2012, the Company self-insures professional liability claims for all of its SNF and ALF subsidiaries through its wholly-owned off shore captive company for claims up to $1.0 million.

The Company retains an unaggregated self-insured retention of $1.0 million per claim for all of its businesses other than its hospice and home health businesses, which are insured under a separate general and professional liability insurance policy with a $1.0 million per loss limit. The excess liability policy referenced above is also applicable to this policy.

Employee Medical Insurance. Medical preferred provider option programs are offered as a component of the Company's employee benefits. The Company retains a self-insured amount up to a contractual stop loss amount of $0.25 million deductible for most participants on its preferred provider organization plan. All other employee medical plans are guaranteed cost plans.

A summary of the liabilities related to insurance risks are as follows (dollars in thousands):

	As of June 30, 2013:											As of December 31, 2012
	General and Professional			Employee Medical			Workers’ Compensation			Total		General and Professional			Employee Medical			Workers’ Compensation			Total
Current	$	7,153	(1)	$	2,516	(2)	$	5,492	(2)	$	15,161	$	5,622	(1)	$	2,143	(2)	$	5,328	(2)	$	13,093
Non-current	13,053			—			12,967			26,020		15,587			—			11,809			27,396
	$	20,206		$	2,516		$	18,459		$	41,181	$	21,209		$	2,143		$	17,137		$	40,489

(1) Included in accounts payable and accrued liabilities.

(2) Included in employee compensation and benefits.

Hallmark Indemnification

Hallmark, the Company's rehabilitation services subsidiary, provides physical, occupational and speech therapy services to various unaffiliated skilled nursing facilities. These unaffiliated skilled nursing facilities are reimbursed for these services from the Medicare Program and other third-party payors. Hallmark has indemnified these unaffiliated skilled nursing facilities from a portion of certain disallowances of these services. Additionally, to the extent a Recovery Audit Contractor ("RAC") or other regulatory authority or contractor is successful in making a claim for recoupment of revenue from any of these skilled nursing facilities, Hallmark will typically be required to indemnify them against their charges associated with this loss. No material indemnification payments were required to be made in three or six months ended June 30, 2013 or 2012.

Financial Guarantees

Substantially of all Skilled's wholly-owned subsidiaries guarantee the Company's first lien senior secured credit facility. These guarantees are full and unconditional and joint and several. Other subsidiaries of Skilled that are not guarantors are considered minor. On May 12, 2012, the Company redeemed the entire $130.0 million of its then outstanding 11.0% senior subordinated notes due 2014 (the "2014 Notes"). The 2014 Notes were guaranteed by substantially all of Skilled's wholly-owned subsidiaries on terms similar to their guarantees of the Company's first lien senior secured credit facility.

8. Stockholders' Equity

Accumulated Other Comprehensive Income

Accumulated other comprehensive income refers to gains and losses that are recorded as an element of stockholders' equity but are excluded from net income. The Company's other comprehensive income consists of net deferred gains and losses on certain derivative instruments accounted for as cash flow hedges and gains and losses from investments available for sale.

16

SKILLED HEALTHCARE GROUP, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Details of other comprehensive income are included in the accompanying condensed consolidated Statement of Comprehensive Income.

2007 Incentive Award Plan

There were no new stock options granted in the three months ended June 30, 2013 and 2012. There were zero and 106,748 new stock options granted in the six months ended June 30, 2013 and 2012, respectively.

The fair value of the stock option grants for the six months ended June 30, 2012 was estimated on the dates of the grants using the Black-Scholes option pricing model with the following assumptions:

	Six Months Ended June 30,
	2013	2012
Risk-free interest rate	n/a	1.75		%
Expected Life	n/a	6.25 years
Dividend yield	n/a	—		%
Volatility	n/a	70.81		%
Weighted-average fair value	n/a	$	5.44

There were no options exercised during the three and six months ended June 30, 2013 or 2012. As of June 30, 2013, there was $0.7 million of unrecognized compensation cost related to outstanding stock options, net of estimated forfeitures. This amount is expected to be recognized over a weighted-average period of 1.43 years. To the extent the forfeiture rate is different than the Company has anticipated, stock-based compensation related to these awards will be different from the Company's expectations.

The following table summarizes stock option activity during the six months ended June 30, 2013 under the Skilled Healthcare Group, Inc. Amended and Restated 2007 Incentive Award Plan:

	Number of Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 2013	1,122,195	$	8.83
Granted	—	$	—
Exercised	—	$	—
Forfeited or cancelled	—	$	—
Outstanding at June 30, 2013	1,122,195	$	8.83	4.75	$	342
Fully vested and expected to vest at June 30, 2013	1,109,739	$	8.85	4.74	$	339
Exercisable at June 30, 2013	879,061	$	9.31	4.48	$	256

Aggregate intrinsic value represents the value of Skilled's closing stock price on the New York Stock Exchange on the last trading day of the fiscal period in excess of the exercise price, multiplied by the number of options outstanding or exercisable.

Compensation related to stock option grants and stock awards included in general and administrative expenses was $0.1 million for the three months ended June 30, 2013 and $0.8 million for the three months ended June 30, 2012. The amount of compensation included in general and administrative expenses was $0.9 million and $1.5 million for the six months ended June 30, 2013 and 2012 respectively. The amount of compensation included in cost of services was $0.2 million and $0.4 million for the three months ended June 30, 2013 and 2012, respectively. The amount of compensation included in the cost of services for the six months ended June 30, 2013 and 2012 was $0.8 million and $0.9 million respectively.

9. Fair Value Measurements

Fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other

17

SKILLED HEALTHCARE GROUP, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions. The following table summarizes the valuation of the Company’s interest rate hedge transaction, marketable securities, and contingent consideration as of June 30, 2013 (dollars in thousands):

	June 30, 2013						December 31, 2012
	Level 1		Level 2		Level 3		Level 1		Level 2			Level 3
Interest rate hedges	$	—	$	—	$	—	$	—	$	(277	)	$	—
Available for sale securities	$	—	$	1,044	$	—	$	—	$	1,070		$	—
Contingent consideration – acquisitions	$	—	$	—	$	3,777	$	—	$	—		$	6,238

In June 2010, the Company entered into an interest rate cap agreement (which expired December 31, 2011) and an interest rate swap agreement in order to manage fluctuations in cash flows resulting from interest rate risk. The interest rate swap agreement was for a notional amount of $70.0 million with a LIBOR rate not to exceed 2.3% from January 2012 to June 2013. The Company continues to assess its exposure to interest rate risk on an ongoing basis.

The interest rate swap is required to be measured at fair value on a recurring basis. The fair value of the interest rate swap contract is determined by calculating the value of the discounted cash flows of the difference between the fixed interest rate of the interest rate swap and the counterparty’s forward LIBOR curve, which is the input used in the valuation. The forward LIBOR curve is readily available in public markets or can be derived from information available in publicly quoted markets. Therefore, the Company has categorized the interest rate swap as Level 2. For periods ended prior to the expiration of the swap agreement, the Company obtained the counterparty’s calculation of the valuation of the interest rate swap as well as a forward LIBOR curve from another investment bank and independently recalculated the valuation of the interest rate swap, which agreed with the counterparty’s calculation.

The Company's wholly-owned offshore captive insurance company is required by regulatory agencies to set aside assets to comply with the laws of the jurisdiction in which it operates. These assets consist of restricted cash and available for sale securities, which are included in other assets in the Company's consolidated June 30, 2013 balance sheet. The Company's available for sale securities are U.S. government securities with an amortized cost basis and aggregate fair value of $1.0 million and $1.0 million, respectively, as of June 30, 2013 and 2012. Net unrealized loss included in other comprehensive income on the Company's available for sale securities was negligible for the six months ended June 30, 2013 and 2012.

On May 1, 2010, the Company acquired substantially all of the assets of five Medicare-certified hospice companies and four Medicare-certified home health companies located in Arizona, Idaho, Montana and Nevada (which is sometimes referred to herein as the "Hospice/Home Health Acquisition"). As part of the purchase agreement, the purchase consideration included cash, promissory notes, contingent consideration, and deferred cash payments. The contingent consideration arrangement requires the Company to pay contingent payments should the acquired operations achieve certain financial targets based on EBITDA of the acquired businesses, as defined in the acquisition agreement, which was filed as Exhibit 2.1 to the Company’s Report on Form 10-Q filed with the SEC on May 4, 2010. The contingent consideration is up to $7.0 million over a period of 5 years following the closing. The fair value of the contingent consideration was estimated using a probability-weighted discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement. The contingent consideration was recorded at the date of acquisition in the amount of $4.9 million. As of December 31, 2012 and June 30, 2013, the contingent consideration had a fair value of $3.8 million and $1.6 million, respectively. The change from December 31, 2012 represents a reduction in fair value due to a decrease in projected EBITDA for the acquired business over the remainder of the earn-out period. This is included in the Company’s other long-term liabilities on the balance sheet. The change in fair value related to the contingent consideration is included in the Company's depreciation and amortization on the statements of operations. There has been no change in the valuation technique of the contingent consideration from December 31, 2012 to June 30, 2013.

On July 1, 2011, a wholly-owned subsidiary of the Company acquired Altura Homecare & Rehab ("Altura"). The acquisition includes contingent earn-out consideration which can be earned based on the acquired business's achievement of an EBITDA threshold. The contingent consideration is up to $1.5 million over a period of 3 years following the closing. The fair value of the contingent consideration was estimated using a probability-weighted discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement. The fair value of the earn-out at the acquisition date was $1.3 million and at June 30, 2013 was $1.0 million which reflects payments of $0.5 million to the seller and mark to market adjustments of $0.2 million.

On October 24, 2011, wholly-owned subsidiaries of the Company acquired substantially all of the assets of Cornerstone Hospice, Inc. ("Cornerstone"). The acquisition includes contingent earn-out consideration which can be earned based on the

18

SKILLED HEALTHCARE GROUP, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

acquired business's achievement of an EBITDA threshold. The contingent consideration is up to $1.5 million over a period of 5 years following the closing. The fair value of the contingent consideration was estimated using a probability-weighted discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement. The fair value of the earn-out at the acquisition date was $1.2 million and at June 30, 2013 was $1.1 million which reflects a $0.3 million payments to the seller and mark to market adjustments of $0.2 million.

On May 13, 2012, a wholly-owned subsidiary of the Company acquired substantially all of the assets of A Better Care Home Health, Inc. ("ABC"). The acquisition includes contingent earn-out consideration which can be earned based on the acquired operations' achievement of an EBITDA threshold. The contingent consideration spans 3 years following the closing. The fair value of the contingent consideration was estimated using a probability-weighted discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement. The fair value of the earn-out at the acquisition date and at June 30, 2013 was $0.1 million.

As discussed above, EBITDA is the basis for calculating the contingent consideration. The unobservable inputs to the determination of the fair value of the contingent consideration include assumptions as to the ability of the acquired businesses to meet their EBITDA targets and discount rates used in the calculation. Should the actual EBITDA generated by the acquired businesses increase or decrease as compared to our assumptions, the fair value of the contingent consideration obligations would increase or decrease, up to the contracted limit, as applicable. As the timing of contingent payments go further into the future, discount rate assumptions increase due to the increased uncertainty of the EBITDA that may be generated in those periods.

The Company's assumptions range from the acquired businesses achieving none, a portion, or all of the consideration, and discount rates range from 2%- 5%.

Below is a table listing the Level 3 rollforward as of June 30, 2013 (in thousands):

Level 3 Rollforward
Value at January 1, 2013	$	6,238
Change in fair value	(2,161		)
Payout	(300		)
Value at June 30, 2013	$	3,777

Long Term Debt

At June 30, 2013 and December 31, 2012, the fair value of the Company's term loan, due in 2016 and the revolving credit facility, due in 2015, using the Level 2 inputs, was approximately $446.9 million and $447.4 million, respectively. The carrying value of the debt at June 30, 2013 and December 31, 2012 was $442.8 million and $443.6 million, respectively. Fair value was estimated based on current yield rates plus the Company's estimated credit spread available for loan products with similar terms and maturities.

10. Debt

The Company’s long-term debt is summarized as follows (dollars in thousands):

19

SKILLED HEALTHCARE GROUP, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

	As of June 30, 2013			As of December 31, 2012
Revolving Credit Facility due 2015, interest rate comprised of LIBOR plus 4.25%, or 4.50% at June 30, 2013	$	28,000		$	25,000
Revolving Credit Facility due 2015, interest rate comprised of the Prime rate of 3.25% plus 3.50%, or 6.75% at June 30, 2013	11,000			10,000
Term Loan, due 2016, interest rate based on LIBOR (subject to a 1.50% floor) plus 5.25%, or 6.75% at June 30, 2013; collateralized by substantially all assets of the Company	385,940			411,600
Term Loan due 2016, interest rate based comprised of base rate at prime plus 4.25% or 7.50% at June 30, 2013	20,417			—
Term Loan original issue discount	(2,538		)	(3,013		)
Note payable due December 2018, interest rate fixed at 6.50%, payable in monthly installments, collateralized by a first priority deed of trust	1,040			1,118
Hospice/Home Health Acquisition note, interest rate fixed at 6.00%, due November 1, 2014	—			1,483
Insurance premiums financed	1,049			2,119
Other	605			660
Total long-term debt	445,513			448,967
Less amounts due within one year	(12,306		)	(13,338		)
Long-term debt, net of current portion	$	433,207		$	435,629

Term Loan and Revolving Loan

On April 9, 2010, the Company entered into an up to $360.0 million senior secured term loan and a $100.0 million revolving credit facility (the "Prior Credit Agreement") that amended and restated the senior secured term loan and revolving credit facility that were set to mature in June 2012. On April 12, 2012, the Company entered into an Amendment and Restatement and Additional Term Loan Assumption Agreement (“Restated Credit Agreement”) that amended and restated the Prior Credit Agreement and pursuant to which, among other things, the size of the Company's existing senior secured term loan was increased by $100.0 million (hereinafter referred to as the incremental senior secured term loan). On June 6, 2013, the Company entered into an amendment to the Restated Credit Agreement that increased the maximum leverage ratio by 0.50 throughout the life of the Restated Credit Agreement. The amendment additionally permits the Company to make future offers to the lenders under the revolving loan facility to extend the maturity date of all or a portion of the revolving loans. The credit arrangements provided under the Restated Credit Agreement are collectively referred to herein as the Company's senior secured credit facility.

The Company expensed fees paid in connection with the refinancing of the Prior Credit Agreement in the amount of $2.0 million in conjunction with the amended senior secured credit facility. In connection with the June 6, 2013 modification, the Company paid fees totaling $2.5 million, of which $1.1 million were recorded as debt modification costs in the consolidated statement of operations, and $1.4 million were recorded as other assets in the consolidated balance sheet. Substantially all of the Company's assets are pledged as collateral under the senior secured credit facility. Amounts borrowed under the senior secured term loan may be prepaid at any time without penalty, except for LIBOR breakage costs. Commitments under the revolving credit facility terminate on April 9, 2015. The senior secured term loan matures on April 9, 2016.

The incremental senior secured term loan bears interest, at our option, at the London Interbank Offered Rate ("LIBOR") (subject to a floor of 1.50%) plus a margin of 5.25% or the prime rate (subject to a floor of 2.50%) plus a margin of 4.25%. As part of the refinancing, the interest rate on the existing senior secured term loan was amended to match the interest rate of the incremental senior secured term loan. The interest rate on the existing revolving credit facility was also amended to be, at the Company's option, LIBOR plus a margin of between 4.25% and 4.50% (based upon consolidated senior leverage) or the prime rate plus a margin of between 3.25% and 3.50% (based upon consolidated senior leverage). There is no longer a LIBOR or prime rate floor with respect to the revolving credit facility. Pursuant to the Restated Credit Agreement, the quarterly term loan amortization payments increased to $2.6 million beginning June 30, 2012 compared to $0.9 million under the Prior Credit Agreement. Additionally, the maximum portion of the annual Consolidated Excess Cash Flow (as defined in the Restated Credit Agreement) to be applied to term debt reductions increased to 75% from 50%, subject to stepdowns to 50% and 25% based on consolidated leverage. The Company also increased its ability to refinance a portion of its credit facility with U.S. Department of Housing and Urban Development ("HUD") insured debt up to $250 million, subject to certain credit facility covenants. The Company has received the formal portfolio conditional credit approval from HUD for up to an aggregate of $460 million in HUD insured loans secured by up to 78 facilities under HUD's Section 232 loan program, which provides loans

20

SKILLED HEALTHCARE GROUP, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

for nursing homes, assisted living and related facilities. Any HUD insured borrowings beyond $250 million would necessitate either refinancing the senior secured credit facility in full or otherwise seeking a waiver or amendment from the senior secured lenders. The Company has not yet determined the amount of borrowings it will ultimately seek under the HUD insured loan program, and all loan applications will be subject to further review and approval by HUD. Furthermore, there can be no assurance that the Company will ultimately be approved for and close any HUD insured loans, what the timing of any approvals or closings would be, or what the interest rates on any HUD insured loans would be. The HUD approval process is subject to a number of contingencies, many of which are out of the Company's control. The Restated Credit Agreement requires that all of the net proceeds from any HUD insured loans be used to pay down the term portion of the Company's senior secured credit facility.

The Company has the right to increase its borrowings under the revolving credit facility up to an aggregate amount of $150 million provided that the Company is in compliance with the Restated Credit Agreement, that the additional debt would not cause any covenant violation of the Restated Credit Agreement, and that existing or new lenders within the Restated Credit Agreement agree to increase their commitments. To reduce the risk related to interest rate fluctuations, the Prior Credit Agreement required the Company to enter into, and the Restated Credit Agreement requires us to continue to maintain, an interest rate swap, cap or similar agreement to effectively fix or cap the interest rate on 40% of its funded long-term debt within three months of the April 2010 commencement of the senior secured credit facility. The Company entered into two interest rate hedge transactions, as described in Note 9 - "Fair Value Measurements," in order to comply with this requirement.

Under the senior secured credit facility, the Company must maintain compliance with specified financial covenants measured on a quarterly basis. The senior secured credit facility also includes certain additional affirmative and negative covenants, including limitations on the incurrence of additional indebtedness, liens, investments in other businesses and capital expenditures. Also under the senior secured credit facility, subject to certain exceptions and minimum thresholds, the Company is required to apply all of the proceeds from any issuance of debt, as much as half of the proceeds from any issuance of equity, as much as 75% of the Company's annual Consolidated Excess Cash Flow (as defined in the Restated Credit Agreement), and amounts received in connection with any sale of the Company's assets to repay the outstanding amounts under the Restated Credit Agreement. The Company believes that it is in compliance with its debt covenants as of June 30, 2013. As of June 30, 2013, the fixed charge coverage ratio was 2.3, which compares to a minimum requirement of 1.75 and the leverage ratio was 4.9, as compared to an allowed maximum of 5.25.

Senior Subordinated Notes

On May 12, 2012, the Company redeemed the entire $130.0 million outstanding principal amount plus all accrued but unpaid interest, of the 2014 Notes. The proceeds from the incremental senior secured term loan (as well as a draw on the revolving portion of the senior secured credit facility) were used to fund the redemption of the outstanding 2014 Notes at par plus accrued interest. In addition, the Company expensed unamortized deferred financing fees and original issue discount ("OID") in the amount of $1.9 million in conjunction with the redemption of the 2014 Notes.

The 2014 Notes were issued in December 2005 in the aggregate principal amount of $200.0 million, with an interest rate of 11.0% and a discount of $1.3 million. Interest was payable semiannually in January and July of each year. The 2014 Notes were to mature on January 15, 2014. The 2014 Notes were unsecured senior subordinated obligations and ranked junior to all of the Company's existing and future senior indebtedness, including indebtedness under the senior secured credit facility. The 2014 Notes were guaranteed on a senior subordinated basis by certain of the Company's subsidiaries.

Other Debt

The Company issued $10.0 million of promissory notes as part of the purchase consideration for the Hospice/Home Health Acquisition. The notes bear interest at 6.0% with $2.0 million of principal due annually beginning November 1, 2010. During 2012, the notes were substantially paid down leaving a remaining balance of $1.5 million at December 31, 2012. The promissory notes are payable to the selling entities, of which the Senior Vice President, of Signature Hospice & Home Health, LLC are significant shareholders. Signature Hospice & Home Health, LLC is a consolidated subsidiary of Skilled holding 100% interests in the operating companies for the Hospice/Home Health Acquisition. The promissory notes were paid in full in April 2013.

21

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Management’s Discussion and Analysis of Financial Condition and Results of Operations is intended to assist in understanding and assessing the trends and significant changes in our results of operations and financial condition as of the dates and for the periods presented. Historical results may not indicate future performance. Our forward-looking statements, which reflect our current views about future events, are based on assumptions and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those contemplated by these statements. Factors that may cause differences between actual results and those contemplated by forward-looking statements include, but are not limited to, those discussed in our Annual Report on Form 10-K for the year ended December 31, 2012 and our subsequent reports on Form 10-Q and Form 8-K filed with the Securities and Exchange Commission (the “SEC”). As used in this Management’s Discussion and Analysis of Financial Condition and Results of Operations, the words, “we,” “our,” and “us” refer to Skilled Healthcare Group, Inc. and its wholly-owned subsidiaries. This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with our condensed consolidated financial statements and related notes included in this report.

Business Overview

Skilled Healthcare Group, Inc. ("Skilled") is a holding company that owns subsidiary companies that in turn own and operate skilled nursing facilities, assisted living facilities, hospices, home health providers and a rehabilitation therapy business. As used in this report, the terms "we," "us," "our" and the "Company," and similar terms, refer collectively to Skilled and its consolidated wholly-owned subsidiaries, unless the context requires otherwise. We have an administrative service company that provides a full complement of administrative and consultative services that allows our affiliated operators and third-party operators with whom we contract to better focus on delivery of healthcare services. We currently also have one such service agreement with an unaffiliated skilled nursing facility operator. All of our subsidiaries focus on providing high-quality care to the people we serve, and our skilled nursing facility subsidiaries, which comprise the largest portion of our consolidated business, have a strong commitment to treating patients who require a high level of skilled nursing care and extensive rehabilitation therapy, whom we refer to as high-acuity patients. As of June 30, 2013, we owned or leased 74 skilled nursing facilities and 22 assisted living facilities, together comprising 10,413 licensed beds. We also lease five skilled nursing facilities in California to an unaffiliated third party operator. Our skilled nursing and assisted living facilities are located in California, Texas, Iowa, Kansas, Missouri, Nebraska, Nevada and New Mexico, and are generally clustered in large urban or suburban markets. We owned 77% of these facilities as of June 30, 2013. As of June 30, 2013 we provided hospice and home health services in Arizona, California, Idaho, Montana, Nevada, and New Mexico. We also provided private duty care services in Idaho, Montana, and Nevada. For the six months ended June 30, 2013, we generated approximately 72% of our revenue from our skilled nursing facilities, including our integrated rehabilitation therapy services at these facilities. The remainder of our revenue is generated from our assisted living services, rehabilitation therapy services provided to third-party facilities, hospice care and home health services.

Industry Trends

Medicare and Medicaid Reimbursement

Rising healthcare costs due to a variety of factors, including an aging population and increasing life expectancies, has in recent years increased demand for post-acute healthcare services, such as skilled nursing, assisted living, home health care, hospice care and rehabilitation therapy. In an effort to mitigate the cost of providing healthcare benefits, third party payors including Medicare, Medicaid, managed care providers, insurance companies and others have increasingly encouraged the treatment of patients in lower-cost care settings. As a result, in recent years skilled nursing facilities, which typically have significantly lower cost structures than acute care hospitals and certain other post-acute care settings, have generally been serving larger populations of higher-acuity patients than in the past. Despite this growth in demand, uncertainty over Medicare and Medicaid reimbursement rates persists. Medicare and Medicaid reimbursement rates are subject to change from time to time and, because revenue derived directly or indirectly from Medicare and Medicaid reimbursement has historically comprised the most significant portion of our consolidated revenue, a reduction in rates could materially and adversely impact our revenue.

Medicare reimburses our skilled nursing facilities under a prospective payment system ("PPS") for certain inpatient covered services. Under the PPS, facilities are paid a predetermined amount per patient, per day, for certain services based on the anticipated costs of treating patients. The amount to be paid is determined by classifying each patient into a resource utilization group ("RUG") category that is based upon each patient's acuity level. In October 2010, the number of RUG categories was expanded from 53 to 66 as part of the implementation of the RUGs IV system and the introduction of a revised and substantially expanded patient assessment tool called the minimum data set (MDS) version 3.0.

On July 29, 2011, the Centers for Medicare & Medicaid Services ("CMS") issued a final rule providing for, among other things, a net 11.1% reduction in PPS payments to skilled nursing facilities for CMS's fiscal year 2012 (which began October 1, 2011) as compared to PPS payments in CMS's fiscal year 2011 (which ended September 30, 2011). The 11.1% reduction was

22

on a net basis, after the application of a 2.7% market basket increase, and reduced by a 1.0% multi-factor productivity adjustment required by the Patient Protection and Affordable Care Act of 2010 ("PPACA"). The final CMS rule also adjusted the method by which group therapy is counted for reimbursement purposes, and changed the timing in which patients who are receiving therapy must be reassessed for purposes of determining their RUG category.

The Budget Control Act of 2011, enacted on August 2, 2011, increased the United States debt ceiling in connection with deficit reductions over the next ten years. Under the Budget Control Act of 2011, $1.2 trillion in domestic and defense spending reductions were automatically set to begin February 1, 2013, split evenly between domestic and defense spending. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. As discussed below, the American Taxpayer Relief Act of 2012 (the “Taxpayer Relief Act”) subsequently delayed by two months the automatic budget sequestration cuts established by the Budget Control Act of 2011. The automatic 2% reduction on each claim submitted to Medicare began on April 1, 2013. Reductions to Medicare and Medicaid reimbursement resulting from the Budget Control Act of 2011 could have a material adverse effect on the Company's business, financial position, results of operations and liquidity.

The Middle Class Tax Relief and Job Creation Act of 2012 was signed into law on February 22, 2012, extending the Medicare Part B outpatient therapy cap exceptions process through December 31, 2012. As noted below, the exceptions process has been further extended for an additional year. The statutory Medicare Part B outpatient therapy cap for occupational therapy (OT) was $1,880 for 2012, and the combined cap for physical therapy (PT) and speech-language pathology services (SLP) was also $1,880 for 2012.  This is the annual per beneficiary therapy cap amount determined for each calendar year. Similar to the therapy cap, Congress established a threshold of $3,700 for PT and SLP services combined and another threshold of $3,700 for OT services. All therapy services rendered above the $3,700 are subject to manual medical review ("MMR") and may be denied unless pre-approved by the provider's Medicare Administrative Contractor (or "MAC"). The law requires an exceptions process to the therapy cap that allows providers to receive payment from Medicare for medically necessary therapy services above the therapy cap amount.  Beginning October 1, 2012 some therapy providers may submit requests for exceptions (pre-approval for up to 20 therapy treatment days for beneficiaries at or above the $3,700 threshold) to avoid denial of claims for services above the threshold amount. The $3,700 figure is the defined threshold that triggers the provision for an exception request. Prior to October 1, 2012 there was no provision for an exception request when the threshold was exceeded.

July 27, 2012, CMS issued a final rule providing for, among other things, a net 1.8% increase in PPS payments to skilled nursing facilities for CMS's fiscal year 2013 (which began October 1, 2012 and runs through September 30, 2013) as compared to PPS payments in CMS's fiscal year 2012 (which ended September 30, 2012). The 1.8% increase was on a net basis, after the application of a 2.5% market basket increase, and reduced by a 0.7% multi-factor productivity adjustment required by PPACA. After our wage index adjustment, our net increase was 1.7%.

In July 2012, CMS issued its final rule for hospice services for its 2013 fiscal year. The rule includes a market basket increase of 2.6% less a 0.3% reduction in the market basket as a result of the PPACA and a 0.7% reduction due to productivity adjustment. After our wage index adjustment, our net increase was 0.9%.

On July 31, 2013, CMS issued its final rule providing for, among other things, a net increase of 1.3% in PPS payments to skilled nursing facilities for CMS's fiscal year 2014 (which begins October 1, 2013) as compared to the PPS payments in CMS's fiscal year 2013 (which ends September 30, 2013). The 1.3% increase is on a net basis, after the application of a 2.3% market basket increase reduced by a 0.5% forecast error correction and further reduced by 0.5% multi-factor productivity adjustment required by the Patient Protection and Affordable Care Act of 2010 ("PPACA").

On June 27, 2013, CMS proposed a decrease of 1.5% in PPS payments to home health agencies for CMS's fiscal year 2014 as compared to the PPS payments in CMS's fiscal year 2013. The proposed 1.5% decrease is on a net basis, after the application of a 3.5% rebasing decrease and other reductions, partially offset by a 2.4% market basket increase.

The American Taxpayer Relief Act of 2012 (the “ATRA”) was enacted on January 2, 2013. As noted above, the ATRA delayed by two months the automatic budget sequestration cuts established by the Budget Control Act of 2011. The ATRA also extended the therapy cap exception process for one year. The ATRA also made additional changes to the Multiple Procedure Payment Reduction ("MPPR") previously implemented in 2010. The existing discount to multiple therapy procedures performed in an outpatient environment during a single day was 25%. Effective April 1, 2013, ATRA increased the discount by an additional 25% to 50%. We believe that the new rules related to MPPR will reduce our revenue by $0.8 million for the eight month period from April 1, 2013 through December 31, 2013.

Should future changes in PPS include further reduced rates or increased standards for reaching certain reimbursement levels (including as a result of automatic cuts tied to federal deficit cut efforts or otherwise), our Medicare revenues derived from our skilled nursing facilities (including rehabilitation therapy services provided at our skilled nursing facilities) could be reduced, with a corresponding adverse impact on our financial condition and results of operation. Our rehabilitation therapy, hospice and home health care businesses are also to a large degree directly or indirectly dependent on (and therefore affected by changes in) Medicare and Medicaid reimbursement rates. For example, our rehabilitation therapy business may have difficulty increasing or maintaining the rates it has negotiated with third party nursing facilities in light of the reduced PPS reimbursement rates that took effect on October 1, 2011 as discussed above or future reductions in reimbursement rates.

23

We also derive a substantial portion of our consolidated revenue from Medicaid reimbursement, primarily through our skilled nursing business. Medicaid programs are administered by the applicable states and financed by both state and federal funds. Medicaid spending nationally has increased substantially in recent years, becoming an increasingly significant component of state budgets. This, combined with slower state revenue growth and other state budget demands, has led both the federal government and many states, including California and other states in which we operate, to institute measures aimed at controlling the growth of Medicaid spending (and in some instances reducing it).

Historically, adjustments to reimbursement under Medicare and Medicaid have had a significant effect on our revenue and results of operations. Recently enacted, pending and proposed legislation and administrative rulemaking at the federal and state levels could have similar effects on our business. Efforts to impose reduced reimbursement rates, greater discounts and more stringent cost controls by government and other payors are expected to continue for the foreseeable future and could adversely affect our business, financial condition and results of operations. Additionally, any delay or default by the federal or state governments in making Medicare and/or Medicaid reimbursement payments could materially and adversely affect our business, financial condition and results of operations.

Federal Health Care Reform

In addition to the matters described above affecting Medicare and Medicaid participating providers, PPACA enacted several reforms with respect to skilled nursing facilities, home health agencies and hospices, including payment measures to realize significant savings of federal and state funds by deterring and prosecuting fraud and abuse in both the Medicare and Medicaid programs. While many of the provisions of PPACA will not take effect for several years or are subject to further refinement through the promulgation of regulations, some key provisions of PPACA are presently effective.

• Enhanced CMPs and Escrow Provisions. PPACA includes expanded civil monetary penalty ("CMP") and related provisions applicable to all Medicare and Medicaid providers. CMS rules adopted to implement applicable provisions of PPACA also provide that assessed CMPs may be collected and placed in whole or in part into an escrow pending final disposition of the applicable administrative and judicial appeals processes. To the extent our businesses are assessed large CMPs that are collected and placed into an escrow account pending lengthy appeals, such actions could adversely affect our liquidity and results of operations.

• Nursing Home Transparency Requirements. In addition to expanded CMP provisions, PPACA imposes new transparency requirements for Medicare-participating nursing facilities. In addition to previously required disclosures regarding a facility's owners, management and secured creditors, PPACA expanded the required disclosures to include information regarding the facility's organizational structure, additional information on officers, directors, trustees and "managing employees" of the facility (including their names, titles, and start dates of services), and information regarding certain parties affiliated with the facility. The transparency provisions could result in the potential for greater government scrutiny and oversight of the ownership and investment structure for skilled nursing facilities, as well as more extensive disclosure of entities and individuals that comprise part of skilled nursing facilities' ownership and management structure.

• Face-to-Face Encounter Requirements. PPACA imposes new patient face-to-face encounter requirements on home health agencies and hospices to establish a patient's ongoing eligibility for Medicare home health services or hospice services, as applicable. A certifying physician or other designated health care professional must conduct the face-to-face encounters within specified timeframes, and failure of the face-to-face encounter to occur and be properly documented during the applicable timeframes could render the patient's care ineligible for reimbursement under Medicare.

• Suspension of Payments During Pending Fraud Investigations. PPACA provides the federal government with expanded authority to suspend Medicare and Medicaid payments if a provider is investigated for allegations or issues of fraud. This suspension authority creates a new mechanism for the federal government to suspend both Medicare and Medicaid payments for allegations of fraud, independent of whether a state exercises its authority to suspend Medicaid payments pending a fraud investigation. To the extent the suspension of payments provision is applied to one of our businesses for allegations of fraud, such a suspension could adversely affect our liquidity and results of operations.

• Overpayment Reporting and Repayment; Expanded False Claims Act Liability. PPACA enacted several important changes that expand potential liability under the federal False Claims Act. Overpayments related to services provided to both Medicare and Medicaid beneficiaries must be reported and returned to the applicable payor within specified deadlines, or else they are considered obligations of the provider for purposes of the federal False Claims Act. This new provision substantially tightens the repayment and reporting requirements generally associated with operations of health care providers to avoid False Claims Act exposure.

24

• Home and Community Based Services. PPACA provides that states can provide home and community-based attendant services and supports through the Community First Choice State plan option. States choosing to provide home and community based services under this option must make them available to assist with activities of daily living, instrumental activities of daily living and health related tasks under a plan of care agreed upon by the individual and his/her representative. For states that elect to make coverage of home and community-based services available through the Community First Choice State plan option, the percentage of the state's Medicaid expenses paid by the federal government will increase by 6 percentage points. PPACA also includes additional measures related to the expansion of community and home based services and authorizes states to expand coverage of community and home-based services to individuals who would not otherwise be eligible for them. The expansion of home-and-community based services could reduce the demand for the facility based services that we provide.

• Health Care-Acquired Conditions. PPACA provides that the Secretary of Health and Human Services must prohibit payments to states for any amounts expended for providing medical assistance for certain medical conditions acquired during the patient's receipt of health care services. The CMS regulation implementing this provision of PPACA prohibits states from making payments to providers under the Medicaid program for conditions that are deemed to be reasonably preventable. It uses Medicare's list of preventable conditions in inpatient hospital settings as the base (adjusted for the differences in the Medicare and Medicaid populations) and provides states the flexibility to identify additional preventable conditions and settings for which Medicaid payment will be denied.

• Value-Based Purchasing. PPACA requires the Secretary of Health and Human Services to develop a plan to implement a value-based purchasing (“VBP”) program for payments under the Medicare program for skilled nursing facilities and to submit a report containing the plan to Congress. The intent of the provision is to potentially reconfigure how Medicare pays for health care services, moving the program towards rewarding better value, outcomes, and innovations, instead of volume. According to the plan submitted to Congress in June 2012, the funding for the VBP program could come from payment withholds from poor-performing skilled nursing facilities or by holding back a portion of the base payment rate or the annual update for all skilled nursing facilities. If a VBP program is ultimately implemented, it is uncertain what effect it would have upon skilled nursing facilities, but its funding or other provisions could negatively affect skilled nursing facilities.

• Anti-Kickback Statute Amendments. PPACA amended the Anti-Kickback Statute so that (i) a claim that includes items or services violating the Anti-Kickback Statute also would constitute a false or fraudulent claim under the federal False Claims Act and (ii) the intent required to violate the Anti-Kickback Statute is lowered such that a person need not have actual knowledge or specific intent to violate the Anti-Kickback Statute in order for a violation to be deemed to have occurred. These modifications of the Anti-Kickback Statute could expose us to greater risk of inadvertent violations of the statute and to related liability under the federal False Claims Act.

The provisions of PPACA discussed above are examples of recently enacted federal health reform provisions that we believe may have a material impact on the long-term care profession generally and on our business. However, the foregoing discussion is not intended to constitute, nor does it constitute, an exhaustive review and discussion of PPACA. It is possible that other provisions of PPACA may be interpreted, clarified, or applied to our businesses in a way that could have a material adverse impact on our business, financial condition and results of operations. Similar federal and/or state legislation that may be adopted in the future could have similar effects.

Revenue

Revenue by Service Offering

We operate our business in three reportable operating segments: (i) long-term care services, which includes the operation of skilled nursing and assisted living facilities and is the most significant portion of our business; (ii) our rehabilitation therapy services business; and (iii) our hospice and home health businesses. Our reporting segments are business units that offer different services, and that are managed separately due to the nature of services provided.

In our long-term care services segment, we derive the majority of our revenue by providing skilled nursing care and integrated rehabilitation therapy services to residents in our affiliated skilled nursing facilities. The remainder of our long-term care segment revenue is generated by our assisted living facilities, by our administration of an unaffiliated third party skilled nursing facility, and from our leasing of five skilled nursing facilities to an unaffiliated third party operator. In our therapy services segment, we derive revenue by providing rehabilitation therapy services to third-party facilities. In our hospice and home health services segment, we provide hospice and home health services.

25

The following table shows the revenue and percentage of our total revenue generated by each of these segments for the periods presented (dollars in thousands):

	Three Months Ended June 30,
	2013				2012
	Revenue Dollars		Revenue Percentage		Revenue Dollars		Revenue Percentage		Increase/(Decrease)
									Dollars			Percentage
Long-term care services:
Skilled nursing facilities	$	153,877	72.0	%	$	156,267	71.9	%	$	(2,390	)	(1.5	)%
Assisted living facilities	6,982		3.3		6,895		3.2		87			1.3
Administration of third party facility	153		0.1		125		0.1		28			22.4
Facility lease revenue	787		0.3		768		0.4		19			2.5
Total long-term care services	161,799		75.7		164,055		75.5		(2,256		)	(1.4	)
Therapy services:
Third-party rehabilitation therapy services	26,637		12.5		26,385		12.1		252			1.0
Total therapy services	26,637		12.5		26,385		12.1		252			1.0
Hospice & home health services:
Hospice	18,386		8.6		20,576		9.5		(2,190		)	(10.6	)
Home health	6,870		3.2		6,359		2.9		511			8.0
Total hospice & home health services	25,256		11.8		26,935		12.4		(1,679		)	(6.2	)
Total	$	213,692	100.0	%	$	217,375	100.0	%	$	(3,683	)	(1.7	)%

	Six Months Ended June 30,
	2013				2012
	Revenue Dollars		Revenue Percentage		Revenue Dollars		Revenue Percentage		Increase/(Decrease)
									Dollars			Percentage
Long-term care services:
Skilled nursing facilities	$	311,504	72.0	%	$	315,251	72.2	%	$	(3,747	)	(1.2	)%
Assisted living facilities	14,109		3.3		13,809		3.2		300			2.2
Administration of third party facility	312		0.1		565		0.1		(253		)	(44.8	)
Facility lease revenue	1,548		0.3		1,522		0.3		26			1.7
Total long-term care services	327,473		75.7		331,147		75.8		(3,674		)	(1.1	)
Therapy services:
Third-party rehabilitation therapy services	53,744		12.5		52,501		12.1		1,243			2.4
Total therapy services	53,744		12.5		52,501		12.1		1,243			2.4
Hospice & home health services:
Hospice	37,369		8.6		40,330		9.2		(2,961		)	(7.3	)
Home health	13,981		3.2		12,810		2.9		1,171			9.1
Total hospice & home health services	51,350		11.8		53,140		12.1		(1,790		)	(3.4	)
Total	$	432,567	100.0	%	$	436,788	100.0	%	$	(4,221	)	(1.0	)%

Sources of Revenue

The following table sets forth revenue consolidated by state in dollars and as a percentage of total revenue for the periods presented (dollars in thousands):

26

	Three Months Ended June 30,
	2013				2012
	Revenue Dollars		Percentage of Revenue		Revenue Dollars		Percentage of Revenue
California	$	87,899	41.1	%	$	88,694	40.8	%
Texas	42,959		20.1		44,134		20.3
New Mexico	24,199		11.3		24,299		11.2
Kansas	14,937		7.0		15,690		7.2
Nevada	14,914		7.0		16,209		7.5
Missouri	14,520		6.8		14,286		6.6
Arizona	3,793		1.8		3,044		1.4
Montana	3,535		1.7		3,996		1.8
Idaho	2,792		1.3		2,474		1.1
Iowa	2,213		1.0		2,739		1.3
Nebraska	1,461		0.7		1,083		0.5
Indiana	470		0.2		727		0.3
Total	$	213,692	100.0	%	$	217,375	100.0	%

	Six months ended June 30,
	2013				2012
	Revenue Dollars		Percentage of Revenue		Revenue Dollars		Percentage of Revenue
California	$	176,872	40.9	%	$	176,922	40.5	%
Texas	87,971		20.3		89,794		20.6
New Mexico	48,473		11.2		48,900		11.2
Kansas	30,343		7.0		31,393		7.2
Nevada	29,827		6.9		31,557		7.2
Missouri	29,602		6.8		29,406		6.7
Arizona	8,181		1.9		7,042		1.6
Montana	7,087		1.6		7,637		1.8
Idaho	5,524		1.3		4,897		1.1
Iowa	4,766		1.1		5,666		1.3
Nebraska	2,942		0.7		1,942		0.4
Indiana	979		0.3		1,632		0.4
Total	$	432,567	100.0	%	$	436,788	100.0	%

Long-Term Care Services Segment

Skilled Nursing Facilities. Within our skilled nursing facilities, we generate our revenue from Medicare, Medicaid, managed care providers, insurers, private pay and other sources. We believe that our skilled mix, which we define as the number of Medicare and non-Medicaid managed care patient days at our skilled nursing facilities divided by the total number of patient days at our skilled nursing facilities for any given period, is an important indicator of our success in attracting high-acuity patients because it represents the percentage of our patients who are reimbursed by Medicare and managed care payors, for whom we receive higher reimbursement rates. Most of our skilled nursing facilities include our Express Recovery^TM program. This program uses a dedicated unit within a skilled nursing facility to deliver a comprehensive rehabilitation and recovery regimen in accommodations specifically designed to serve high-acuity patients.

Assisted Living Facilities. Within our assisted living facilities, which are mostly in Kansas, we generate our revenue primarily from private pay sources, with a small portion earned from Medicaid or other state-specific programs.

Leased Facility Revenue. We lease five skilled nursing facilities in California to an unaffiliated third party operator. For additional information on the lease arrangement, see Note 5 - "Property and Equipment" to the interim financial statements.

Therapy Services Segment

27

As of June 30, 2013, we provided rehabilitation therapy services to a total of 194 healthcare facilities, including 64 of our facilities, as compared to 186 facilities, including 64 of our facilities, as of June 30, 2012. In addition, we have contracts to manage the rehabilitation therapy services for our 10 healthcare facilities in New Mexico. The net increase of 8 facilities serviced was comprised of 20 new facilities serviced, net of 12 cancellations. Rehabilitation therapy revenue derived from servicing our own facilities is included in our revenue from skilled nursing facilities. Our rehabilitation therapy business receives payment for services from the third-party facilities that it serves based on negotiated patient per diem rates or a negotiated fee schedule based on the type of service rendered. As of June 30, 2013, we provided rehabilitation therapy services to facilities in California, Nevada, New Mexico, Texas, Missouri, Nebraska, Iowa, and Indiana.

Hospice and Home Health Services Segment

Hospice. As of June 30, 2013, we provided hospice care in Arizona, California, Idaho, Montana, Nevada and New Mexico. We derive substantially all of the revenue from our hospice business from Medicare and managed care reimbursement.

Federal law imposes a Medicare payment cap on hospice service programs. We monitor the impact of the Medicare cap on our hospice business by attempting to address our average length-of-stay on an agency-by-agency basis. A key component of this strategy is to analyze each hospice agency's mix of patients and referral sources to achieve a desirable mix of the types of patients and referral sources that we serve in each of our agencies. To the extent that actual lengths of stay exceed our estimates, our recorded reserves could prove insufficient.

Home Health. We provided home health care in Arizona, California, Idaho, Montana, Nevada and New Mexico as of June 30, 2013. We derive the majority of the revenue from our home health business from Medicare. Net service revenue is recorded under the Medicare payment program based on a 60-day episodic payment rate that is subject to downward adjustment based on certain variables.

Regulatory and Other Governmental Actions Affecting Revenue

We derive a substantial portion of our revenue from government Medicare and Medicaid programs. In addition, our rehabilitation therapy services, for which we receive payment from private payors, is significantly dependent on Medicare and Medicaid funding, as those private payors are primarily funded or reimbursed by these programs. The following table summarizes the amount of revenue that we received from each of our payor classes by segment in the periods presented (dollars in thousands):

	Three Months Ended June 30,
	2013										2012
	Long-Term Care Services		Therapy Services		Hospice & Home Health Services		Total Revenue		Revenue Percentage		Long-Term Care Services		Therapy Services		Hospice & Home Health Services		Total Revenue		Revenue Percentage
Medicare Part A	$	41,089	$	—	$	21,657	$	62,746	29.4	%	$	45,476	$	—	$	23,299	$	68,775	31.6	%
Medicare Part B	3,396		—		—		3,396		1.6		4,806		—		—		4,806		2.2
Medicaid	65,804		—		726		66,530		31.1		64,159		—		639		64,798		29.8
Subtotal Medicare and Medicaid	110,289		—		22,383		132,672		62.1		114,441		—		23,938		138,379		63.6
Managed Care Part A	25,297		—		1,418		26,715		12.5		23,302		—		1,153		24,455		11.4
Managed Care Part B	587		—		—		587		0.3		542		—		—		542		0.2
Private pay and other	25,626		26,637		1,455		53,718		25.1		25,770		26,385		1,844		53,999		24.8
Total	$	161,799	$	26,637	$	25,256	$	213,692	100.0	%	$	164,055	$	26,385	$	26,935	$	217,375	100.0	%

28

	Six Months Ended June 30,
	2013										2012
	Long-Term Care Services		Therapy Services		Hospice & Home Health Services		Total Revenue		Revenue Percentage		Long-Term Care Services		Therapy Services		Hospice & Home Health Services		Total Revenue		Revenue Percentage
Medicare Part A	$	85,484	$	—	$	44,322	$	129,806	30.0	%	$	94,663	$	—	$	46,541	$	141,204	32.3	%
Medicare Part B	7,762		—		—		7,762		1.8		9,076		—		—		9,076		2.1
Medicaid	131,036		—		1,383		132,419		30.6		129,003		—		1,058		130,061		29.8
Subtotal Medicare and Medicaid	224,282		—		45,705		269,987		62.4		232,742		—		47,599		280,341		64.2
Managed Care Part A	50,920		—		2,780		53,700		12.4		46,216		—		2,258		48,474		11.1
Managed Care Part B	1,155		—		—		1,155		0.3		1,001		—		—		1,001		0.2
Private pay and other	51,116		53,744		2,865		107,725		24.9		51,188		52,501		3,283		106,972		24.5
Total	$	327,473	$	53,744	$	51,350	$	432,567	100.0	%	$	331,147	$	52,501	$	53,140	$	436,788	100.0	%

Medicare. Medicare is a federal program that provides certain healthcare benefits to beneficiaries who are 65 years of age or older, blind, disabled or qualify for Medicare’s End Stage Renal Disease program. Medicare provides health insurance benefits in two primary parts for services that we provide:

• Part A. Medicare Part A is hospital insurance, which provides reimbursement for inpatient services for hospitals, skilled nursing facilities, hospices, home health and certain other healthcare providers and patients requiring daily professional skilled nursing and other rehabilitative care. Coverage in a skilled nursing facility is limited for a period of up to 100 days, if medically necessary, after the individual has qualified for Medicare coverage as a result of a three-day or longer hospital stay. Medicare pays for the first 20 days of stay in a skilled nursing facility in full and the next 80 days, to the extent above a daily coinsurance amount. Covered services include supervised nursing care, room and board, social services, pharmaceuticals and supplies as well as physical, speech and occupational therapies and other necessary services provided by nursing facilities. Medicare Part A also covers hospice care and some home health care. Skilled nursing facilities are paid under Medicare Part A on the basis of a prospective payment system, or PPS. The PPS payment rates are adjusted for case mix and geographic variation in wages and cover all costs of furnishing covered skilled nursing facilities services (routine, ancillary, and capital-related costs). The amount to be paid is determined by classifying each patient into a resource utilization group ("RUG"), category, which is based upon the patient's acuity level. CMS generally evaluates and adjusts payment rates on an annual basis.

• Part B. Medicare Part B is supplemental medical insurance, which requires the beneficiary to pay monthly premiums, covers physician services, limited drug coverage and other outpatient services, such as physical, occupational and speech therapy services, enteral nutrition, certain medical items and X-ray services received outside of a Part A covered inpatient stay.

Medicaid. Medicaid is a state-administered medical assistance program for the indigent, operated by the individual states with the financial participation of the federal government. Each state has relatively broad discretion in establishing its Medicaid reimbursement formulas and coverage of service, which must be approved by the federal government in accordance with federal guidelines. All states in which we operate cover long-term care services for individuals who are Medicaid eligible and qualify for institutional care. Providers must accept the Medicaid reimbursement level as payment in full for services rendered. Medicaid programs generally make payments directly to providers, except in cases where the state has implemented a Medicaid managed care program, under which providers receive Medicaid payments from managed care organizations ("MCOs") that have subcontracted with the Medicaid program. PPACA provides for increased financial participation by the federal government in a state's Medicaid program if the state chooses to expand its Medicaid program as contemplated by PPACA. However, states are not required to expand their Medicaid programs and it is uncertain as to which states, including states in which we operate, will ultimately expand their programs.

Managed Care. Our managed care patients consist of individuals who are insured by a third-party entity, typically called a senior Health Maintenance Organization, ("HMO") plan, or are Medicare beneficiaries who assign their Medicare benefits to a senior HMO plan.

29

Private Pay and Other. Private pay and other sources consist primarily of individuals or parties who directly pay for their services or are beneficiaries of the Department of Veterans Affairs. In addition, the revenue related to the five leased properties is also included as part of the other payor sources.

Critical Accounting Estimates

There has been no change in our critical accounting policies and estimates as included under "Management's Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies and Estimates" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012, which we filed with the SEC on February 11, 2013.

30

Results of Operations

The following table summarizes some of our key performance indicators, along with other statistics, for each of the periods indicated:

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Occupancy statistics (skilled nursing facilities):
Available beds in service at end of period	8,801			8,805			8,801			8,805
Available patient days	801,625			801,743			1,594,857			1,603,269
Actual patient days	657,281			665,486			1,315,927			1,333,679
Occupancy percentage	82.0		%	83.0		%	82.5		%	83.2		%
Average daily number of patients	7,223			7,313			7,270			7,328
Hospice average daily census	1,324			1,402			1,330			1,389
Home health episodic-based admissions	2,091			2,099			4,333			4,084
Home health episodic-based recertifications	476			360			966			693
Revenue per patient day (skilled nursing facilities prior to intercompany eliminations)
LTC only Medicare (Part A)	$	519		$	513		$	520		$	511
Medicare blended rate (Part A & B)	562			567			567			571
Managed care (Part A)	389			385			385			384
Managed care blended rate (Part A & B)	398			394			394			392
Medicaid	162			157			162			157
Private and other	170			173			173			173
Weighted-average for all	$	235		$	236		$	238		$	237
Patient days by payor (skilled nursing facilities):
Medicare	79,135			88,690			164,363			181,724
Managed care	65,074			60,464			132,280			120,486
Total skilled mix days	144,209			149,154			296,643			302,210
Private pay and other	107,719			107,242			210,270			211,442
Medicaid	405,353			409,090			809,014			820,027
Total days	657,281			665,486			1,315,927			1,333,679
Patient days as a percentage of total patient days (skilled nursing facilities):
Medicare	12.0		%	13.3		%	12.5		%	13.6		%
Managed care	9.9			9.1			10.1			9.0
Skilled Mix	21.9			22.4			22.6			22.6
Private pay and other	16.4			16.1			16.0			15.9
Medicaid	61.7			61.5			61.4			61.5
Total	100.0		%	100.0		%	100.0		%	100.0		%
Revenue for total company:
Medicare	31.0		%	33.8		%	31.8		%	34.4		%
Managed care, private pay, and other	37.9			36.4			37.6			35.8
Quality mix	68.9			70.2			69.4			70.2
Medicaid	31.1			29.8			30.6			29.8
Total	100.0		%	100.0		%	100.0		%	100.0		%

31

The following table sets forth details of our revenue, expenses, and net income and other items as a percentage of total revenue for the periods indicated:

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Revenue	100.0		%	100.0		%	100.0		%	100.0		%
Expenses:
Cost of services (exclusive of rent cost of revenue and depreciation and amortization shown below)	87.2			82.9			87.0			83.2
Rent cost of revenue	2.3			2.1			2.2			2.1
General and administrative	3.2			3.0			3.1			2.9
Change in fair value of contingent consideration	(1.1		)	0.2			(0.4		)	0.1
Depreciation and amortization	2.9			2.8			2.8			2.8
	94.5			91.0			94.7			91.1
Other income (expenses):
Interest expense	(4.1		)	(4.8		)	(4.0		)	(4.6		)
Interest income	0.1			0.1			0.1			0.1
Other income (expense)	—			—			—			—
Equity in earnings of joint venture	0.2			0.2			0.2			0.2
Loss on disposal of asset	—			—			—			—
Debt modification/retirement costs	(0.5		)	(1.8		)	(0.3		)	(0.9		)
Total other (expenses) income, net	(4.3		)	(6.3		)	(4.0		)	(5.2		)
Income before provision for income taxes	1.2			2.7			1.3			3.7
Provision for income taxes	0.5			1.1			0.2			1.5
Net income	0.7		%	1.6		%	1.1		%	2.2		%
Adjusted EBITDA(1)	8.3		%	12.3		%	8.2		%	12.1		%
Adjusted EBITDAR(2)	10.5		%	14.4		%	10.5		%	14.2		%
	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Reconciliation from net income to EBITDA, EBITDAR, Adjusted EBITDA and Adjusted EBITDAR (in thousands):
Net income	$	1,523		$	3,497		$	4,593		$	9,834
Interest expense, net of interest income	8,622			10,389			17,185			19,809
Provision for income taxes	972			2,355			1,050			6,391
Depreciation and amortization expense	6,130			6,092			12,266			12,236
EBITDA(1)	17,247			22,333			35,094			48,270
Rent cost of revenue	4,828			4,539			9,640			9,095
EBITDAR(2)	22,075			26,872			44,734			57,365
EBITDA(1)	17,247			22,333			35,094			48,270
Change in fair value of contingent consideration	(2,244		)	499			(2,161		)	630
Organization restructure costs	1,549			—			1,549			—
Debt modification/retirement costs	1,088			3,958			1,088			3,958
Adjusted EBITDA(1)	17,640			26,790			35,570			52,858
Rent cost of revenue	4,828			4,539			9,640			9,095
Adjusted EBITDAR(2)	$	22,468		$	31,329		$	45,210		$	61,953

(1) We define EBITDA as net income before depreciation, amortization and interest expense (net of interest income) and the provision for income taxes. Adjusted EBITDA is EBITDA adjusted for non-core business items, such as change in

32

fair value of contingent consideration, organization restructuring costs, gains or losses on debt modification/retirement costs, or the disposal of property and equipment.

(2) We define EBITDAR as net income before depreciation, amortization, interest expense (net of interest income), the provision for income taxes and rent cost of revenue. Adjusted EBITDAR is EBITDAR adjusted for the non-core business items listed above for the definition of Adjusted EBITDA (each to the extent applicable in the appropriate period.)

We believe that the presentation of EBITDA, EBITDAR, Adjusted EBITDA and Adjusted EBITDAR provides useful information regarding our operational performance because they enhance the overall understanding of the financial performance and prospects for the future of our core business activities.

Specifically, we believe that a report of EBITDA, EBITDAR, Adjusted EBITDA and Adjusted EBITDAR provides consistency in our financial reporting and provides a basis for the comparison of results of core business operations between our current, past and future periods. EBITDA, EBITDAR, Adjusted EBITDA and Adjusted EBITDAR are primary indicators management uses for planning and forecasting in future periods, including trending and analyzing the core operating performance of our business from period-to-period without the effect of expenses, revenues and gains (losses) that we believe are unrelated to the day-to-day performance of our business but are required to be reported in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). We also use EBITDA, EBITDAR, Adjusted EBITDA and Adjusted EBITDAR to benchmark the performance of our business against expected results, analyzing year-over-year trends as described below and to compare our operating performance to that of our competitors.

Management, including operating company based management, uses EBITDA, EBITDAR, Adjusted EBITDA and Adjusted EBITDAR to assess the performance of our core business operations, to prepare operating budgets and to measure our performance against those budgets on a consolidated and segment level. Segment management uses these metrics to measure performance on a business unit by business unit basis. We typically use Adjusted EBITDA and Adjusted EBITDAR for these purposes on a consolidated basis as the adjustments to EBITDA and EBITDAR are not generally allocable to any individual business unit and we typically use EBITDA and EBITDAR to compare the operating performance of each skilled nursing facility, assisted living facility, or other business unit as well as to assess the performance of our operating segments. EBITDA, EBITDAR, Adjusted EBITDA and Adjusted EBITDAR are useful in this regard because they do not include such costs as interest expense (net of interest income), income taxes, depreciation and amortization expense, rent cost of revenue (in the case of EBITDAR and Adjusted EBITDAR) and special charges, which may vary from business unit to business unit and period-to-period depending upon various factors, including the method used to finance the business, the amount of debt that we have determined to incur, whether a facility is owned or leased, the date of acquisition of a facility or business, the original purchase price of a facility or business unit or the tax law of the state in which a business unit operates. We believe these types of charges are dependent on factors unrelated to the underlying business unit performance. As a result, we believe that the use of EBITDA, EBITDAR, Adjusted EBITDA and Adjusted EBITDAR provides a meaningful and consistent comparison of our underlying business units between periods by eliminating certain items required by U.S. GAAP which have little or no significance to their day-to-day operations.

Finally, we use Adjusted EBITDA to determine compliance with our debt covenants and assess our ability to borrow additional funds and to finance or expand operations. Our senior secured credit facility uses a measure substantially similar to Adjusted EBITDA as the basis for determining compliance with our financial covenants, specifically our minimum interest coverage ratio and our maximum total leverage ratio, and for determining the interest rate of our first lien term loan. For example, the senior secured credit facility includes adjustments to EBITDA for (i) gain or losses on sale of assets, (ii) the write-off of deferred financing costs of extinguished debt, (iii) pro forma adjustments for acquisitions to show a full year of EBITDA and interest expense, (iv) sponsorship fees paid to Onex which totals $0.5 million annually, (v) non-cash stock compensation and (vi) impairment of long-lived assets. Our noncompliance with these financial covenants could lead to acceleration of amounts due under our senior secured credit facility.

Despite the importance of these measures in analyzing our underlying business, maintaining our financial requirements, designing incentive compensation and for our goal setting both on an aggregate and individual business level basis, EBITDA, EBITDAR, Adjusted EBITDA and Adjusted EBITDAR are non-GAAP financial measures that have no standardized meaning defined by U.S. GAAP. Therefore, our EBITDA, EBITDAR, Adjusted EBITDA and Adjusted EBITDAR measures have limitations as analytical tools, and they should not be considered in isolation, or as a substitute for analysis of our results as reported under U.S. GAAP. Some of these limitations are:

• they do not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;

• they do not reflect changes in, or cash requirements for, our working capital needs;

• they do not reflect the interest expense, or the cash requirements necessary to service interest or principal payments, on our debt;

• they do not reflect any income tax payments we may be required to make;

33

• although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements;

• they are not adjusted for all non-cash income or expense items that are reflected in our consolidated statements of cash flows;

• they do not reflect the impact on earnings of charges resulting from certain matters we consider not to be indicative of our ongoing operations; and

• other companies in our industry may calculate these measures differently than we do, which may limit their usefulness as comparative measures.

We compensate for these limitations by using EBITDA, EBITDAR, Adjusted EBITDA and Adjusted EBITDAR only to supplement net income on a basis prepared in conformance with U.S. GAAP in order to provide a more complete understanding of the factors and trends affecting our business. Furthermore, the non-GAAP financial measures that we present may be different from the presentation of similar measures by other companies, so the comparability of the measures among companies may be limited. We strongly encourage investors to consider net income determined under U.S. GAAP as compared to EBITDA, EBITDAR, Adjusted EBITDA and Adjusted EBITDAR, and to perform their own analysis, as appropriate.

Three Months Ended June 30, 2013 Compared to Three Months Ended June 30, 2012

Revenue. Revenue decreased by $3.7 million, or 1.7%, to $213.7 million in the three months ended June 30, 2013 from $217.4 million in the three months ended June 30, 2012.

Long term care services

	Three Months Ended June 30,
	2013				2012				Increase/(Decrease)
	Revenue Dollars		Revenue Percentage		Revenue Dollars		Revenue Percentage		Dollars			Percentage
	(dollars in millions)
Skilled nursing facilities	$	153.9	72.0	%	$	156.3	71.9	%	$	(2.4	)	(1.5	)%
Assisted living facilities	7.0		3.3		6.9		3.2		0.1			1.4
Administration of third party facility	0.1		0.1		0.1		0.1		—			—
Leased facility revenue	0.8		0.4		0.7		0.3		0.1			14.3
Total long-term care services	$	161.8	75.7	%	$	164.0	75.5	%	$	(2.2	)	(1.3	)%

The $2.4 million decrease in skilled nursing facilities revenue in the second quarter of 2013 as compared to the second quarter of 2012 was primarily due to a shift in payor mix from traditional Medicare to Managed Medicare (Medicare Advantage) and a reduction in Medicare Part B revenue. The shift in payor mix resulted in a net reduction of revenue by $2.4 million. Medicare Part B revenue decreased by $1.4 million due to the impact of the MMR process that was implemented October 1, 2012. The MAC's are still not able to process the volume of MMR's submitted and providers have decreased Part B treatments of patients due to the risk of not being paid. These reductions were offset by $1.7 million increase in Medicaid revenue and a $0.2 million decrease in other revenue. In addition, we experienced a slight decrease in our average daily census ("ADC") in our skilled nursing facilities in the second quarter of 2013 as compared to the second quarter of 2012. Our average patient per day ("PPD") rate decreased by $0.59 for the second quarter of 2013 as compared to the second quarter of 2012 primarily due to the shift in payor mix and the impact of the 2.0% sequestration.

The increase of $0.1 million at our assisted living facilities in the second quarter of 2013 as compared to the second quarter of 2012 was due primarily to the increase in the private PPD rate by $2.00.

Therapy services

34

	Three Months Ended June 30,
	2013					2012					Increase/(Decrease)
	Revenue Dollars			Revenue Percentage		Revenue Dollars			Revenue Percentage		Dollars			Percentage
	(dollars in millions)
Rehabilitation therapy services	$	40.6		19.0	%	$	42.2		19.4	%	$	(1.6	)	(3.8	)%
Intersegment elimination of services related to affiliated entities	(14.0		)	(6.5	)	(15.8		)	(7.3	)	1.8			(11.4	)
Third party therapy services	$	26.6		12.5	%	$	26.4		12.1	%	$	0.2		0.8	%

Hallmark revenue for third party therapy services increased by $0.2 million. This increase was related to a $0.4 million increase in revenue for new third party therapy contracts added since the second quarter of 2012 offset by a $0.2 million decrease in revenue for facilities that operated for full three months ended June 30, 2013 and 2012. The Medicare Part B MMR process that went into effect on October 1, 2012 reduced revenue from third party therapy customers for the three months ended June 30, 2013 by $1.0 million as compared to the same period a year ago as many of our customers are hesitant to provide therapy treatment to their patients in excess of the $3,700 Medicare Part B threshold. We expect the MMR process to continue to negatively impact our therapy revenue in the future. This was offset by an increase in revenue of $1.0 million due to an increase in treatment of managed care patients and an increase in revenue of $0.2 million due to an increase in treatment of Medicare Part A patients at the third party facilities. The MPPR for outpatient therapy included in the ATRA went into effect April 1, 2013 negatively impacted revenue by $0.3 million.

Hospice & Home Health services

	Three Months Ended June 30,
	2013				2012				Increase/(Decrease)
	Revenue Dollars		Revenue Percentage		Revenue Dollars		Revenue Percentage		Dollars			Percentage
	(dollars in millions)
Hospice	$	18.4	8.6	%	$	20.6	9.5	%	$	(2.2	)	(10.7	)%
Home Health	6.9		3.2		6.3		2.9		(0.6		)	(9.5	)
Total hospice & home health services	$	25.3	11.8	%	$	26.9	12.4	%	$	(1.6	)	(5.9	)%

The $2.2 million decrease in hospice revenue was a result of a reduction in ADC for the second quarter of 2013 as compared to the second quarter of 2012 as well as increased hospice Medicare cap reserves recorded in the second quarter of 2013. For the quarters ended June 30, 2013 and 2012, we recorded hospice cap adjustments of $1.4 million and $1.0 million, respectively, as adjustments to revenue, which negatively affected the weighted average PPD rates for both periods. Of the $1.4 million hospice cap reserves recorded in the three months ended June 30, 2013 $0.7 was related to the 2012 cap year and $0.7 was related to the 2013 cap year. The entire $1.0 million recorded in the three months ended June 30, 2012 was for the 2012 cap year.

Of the $0.6 million increase in our home health revenue in the second quarter of 2013 as compared to the second quarter of 2012, $0.3 million was from home health agencies operated for all of both periods, with a $0.2 million increase from an increase in episodes and a $0.1 million increase in rate per episode. The increase in rate per episode was primarily due to a 3.7% decrease in Medicare reimbursement rates offset by a 6.8% increase in managed care reimbursement rates and a 12.8% increase in private reimbursement rates. The remaining $0.2 million increase in home health revenue was due to acquisitions completed in the second quarter of 2012.

Cost of Services Expenses. Cost of services expenses increased $6.2 million, or 3.4%, to $186.4 million, or 87.2% of revenue, in the three months ended June 30, 2013, from $180.2 million, or 82.9% of revenue, in the three months ended June 30, 2012.

Long term care services

35

	Three Months Ended June 30,
	2013				2012				Increase/(Decrease)
	Cost of Service Dollars (prior to intersegment eliminations)		Percentage of Revenue		Cost of Service Dollars (prior to intersegment eliminations)		Percentage of Revenue
									Dollars		Percentage
	(dollars in millions)
Skilled nursing facilities	$	130.1	84.5	%	$	126.9	81.2	%	$	3.2	2.5	%
Assisted living facilities	5.1		72.7		4.7		68.8		0.4		8.5
Regional operations support	5.0		n/a		5.0		n/a		—		—
Total long-term care services	$	140.2	86.7	%	$	136.6	83.3	%	$	3.6	2.6	%

Cost of services expenses at our skilled nursing facilities increased $3.2 million in the second quarter of 2013 as compared to the second quarter of 2012. The $3.2 million increase was primarily the result of a $1.5 million increase in benefits in the second quarter of 2013 as compared to the second quarter of 2012 due to an increase in self insured employee medical expense and self insured workers compensation expense. There was a $1.2 million increase in the bad debt expense in the second quarter of 2013 as compared to the second quarter of 2012 due to aging accounts receivables for private co-pay and managed care patients. The increase was also attributable to an increase in general and professional liability insurance of $0.6 million in the second quarter of 2013 as compared to the second quarter of 2012 due to a change in the estimated reserves on the professional liability claims from prior years. Taxes and licenses expense increased by $1.0 million in the second quarter of 2013 as compared to the second quarter of 2012 due to an increase in California quality assurance ("QA") fees. These increases were offset by a decrease in rehab and ancillaries expense of $1.5 million due to the reduction in Medicare Part B revenue.

Cost of services at our assisted living facilities increased $0.4 million in the second quarter of 2013 as compared to the second quarter of 2012. Approximately $0.2 million of this increase was due to an increase in labor and benefits expense in the second quarter of 2013 as compared to the second quarter of 2012.

Therapy services

	Three Months Ended June 30,
	2013						2012						Increase/(Decrease)
	Revenue (prior to intersegment eliminations)		Cost of Service Dollars (prior to intersegment eliminations)		Percentage of Revenue		Revenue (prior to intersegment eliminations)		Cost of Service Dollars (prior to intersegment eliminations)		Percentage of Revenue
													Dollars			Percentage
	(dollars in millions)
Rehabilitation therapy services	$	40.6	$	37.8	93.1	%	$	42.2	$	38.5	91.2	%	$	(0.7	)	(1.8	)%
Total therapy services	$	40.6	$	37.8	93.1	%	$	42.2	$	38.5	91.2	%	$	(0.7	)	(1.8	)%

Rehabilitation therapy costs of services as a percentage of revenue increased by 1.9% for the three months ended June 30, 2013, as compared to the same period in 2012. The increase in the cost of services as a percentage of revenue is due to an increase in the treatment of managed care patients for which we receive a lower revenue rate per minute, the MPPR which went into effect April 1, 2013, and from an increase in administrative work due to the compliance with the review process on the MMRs and training involved in G-Code (reporting of the functional status of therapy patients by the therapist) implementation.

Hospice and home health services

36

	Three Months Ended June 30,
	2013				2012				Increase/(Decrease)
	Cost of Service Dollars		Percentage of Revenue		Cost of Service Dollars		Percentage of Revenue
									Dollars		Percentage
	(dollars in millions)
Hospice	$	16.4	89.0	%	$	15.8	76.6	%	$	0.6	3.8	%
Home Health	6.7		96.9		5.7		89.5		1.0		17.5
Total hospice & home health services	$	23.1	91.2	%	$	21.5	79.7	%	$	1.6	7.4	%

Cost of services expenses related to our hospice business increased $0.6 million in the second quarter of 2013 as compared to the second quarter of 2012. The $0.6 million increase resulted from an increase in operating costs of $12.26 PPD, or 9.9%, to $135.86 PPD in the three months ended June 30, 2013 from $123.60 PPD for the three months ended June 30, 2012. This was partially the result of the July 2012 opening of the general inpatient (GIP) unit at our Las Vegas, Nevada hospice. GIP units require a higher level of patient care and result in increased PPD costs.In addition, salaries and wages increased on a PPD basis as the agencies were overstaffed for their census levels.

Cost of services related to our home health business increased $1.0 million in the second quarter of 2013 as compared to the second quarter of 2012. The increase was primarily due to an increase of $0.7 million of additional expenses at our existing home health agencies, due to an increase in salaries and benefits for employees. The remaining balance of the increase in home health cost of services expense was due to acquisitions.

Rent Cost of Revenue. Rent cost of revenue increased $0.3 million, or 6.4%, to $4.8 million, or 2.3% of revenue, in the three months ended June 30, 2013 from $4.5 million, or 2.1% of revenue, in the three months ended June 30, 2012. The increase was primarily related to a new lease that went into effect in the fourth quarter of 2012 at one of our California facilities.

General and Administrative Services Expenses. Our general and administrative services expenses increased $0.4 million, or 6.4%, to $6.8 million, or 3.2% of revenue, in the three months ended June 30, 2013 from $6.4 million, or 3.0% of revenue, in the three months ended June 30, 2012. The increase is primarily due to $1.5 million in severance costs accrued related to the elimination of positions not related to patient care and an increase of $0.2 million in purchased services-related expense in the second quarter of 2013 as compared to the second quarter of 2012. These increases were offset by a $0.7 million reduction in stock compensation expense related to performance shares awarded in 2013 which are not expected to vest and $0.5 million less of incentive accruals in the second quarter of 2013 compared to 2012.

Depreciation and Amortization. Depreciation and amortization remained consistent at $6.1 million, or 2.9% of revenue, in the three months ended June 30, 2013 and June 30, 2012.

Change in fair value of contingent consideration. The change in fair value of contingent consideration decreased by $2.7 million, to negative $2.2 million, or 1.1% of revenue, in the three months ended June 30, 2013 from positive $0.5 million, or 0.2% of revenue, in the three months ended June 30, 2012. The decrease is related to the change in fair value of the contingent consideration related to the 2010 hospice and home health acquisition due to reductions in forecasted EBITDA, which reduces the likelihood of the businesses achieving their EBITDA target necessary for the earn-out to be paid in future periods.

Interest Expense. Interest expense decreased by $1.8 million, or 17.0%, to $8.7 million , or 4.1% of revenue, in the three months ended June 30, 2013 from $10.5 million, or 4.8% of revenue, in the three months ended June 30, 2012. The decrease is related to the replacement of subordinated debt with term debt as well as $1.1 million in double interest expense on our 2014 Notes in the second quarter of 2012. The subordinated debt had a higher interest rate than our term debt.

Interest Income. Interest income remained consistent at approximately $0.1 million for the three months ended June 30, 2013 and June 30, 2012.

Debt modification/retirement costs. Debt modification/retirement costs decreased by $2.9 million to $1.1 million or 0.5% of revenue, in the three months ended June 30, 2013 from $4.0 million or 1.8% of revenue in the three months ended June 30, 2012. The $1.1 million expensed in 2013 related to the June 2013 credit facility amendment, which increased the maximum leverage ratio by 0.5. Of the $4.0 million expensed in 2012, $1.9 million in costs related unamortized subordinated debt deferred financing fees expensed when the bonds were defeased and $2.1 million related to the June 2012 credit facility amendment.

37

Equity in Earnings of Joint Venture. Equity earnings of our pharmacy joint venture remained consistent at $0.5 million in the three months ended June 30, 2013 and June 30, 2012.

Income Before Provision for Income Taxes. Income before provision for incomes taxes decreased by $3.4 million to $2.5 million in the three months ended June 30, 2013 from $5.9 million in the three months ended June 30, 2012 as a result of the decrease in revenue and increased operating expenses for the three months ended June 30, 2013 as compared to the three months ended June 30, 2012.

Provision for Income Taxes. We recorded a tax expense of $1.0 million, or 39.0% of pre-tax earnings, for the three months ended June 30, 2013, as compared to $2.4 million, or 40.2% of pre-tax earnings, for the three months ended June 30, 2012. The decrease in the tax expense was a result of the decrease in pre-tax earnings for the three months ended in June 30, 2013 as compared to the same period in 2012.

Six Months Ended June 30, 2013 Compared to Six Months Ended June 30, 2012

Revenue. Revenue decreased by $4.2 million, or 1.0%, to $432.6 million in the six months ended June 30, 2013 from $436.8 million in the six months ended June 30, 2012.

Long term care services

	Six Months Ended June 30,
	2013				2012				Increase/(Decrease)
	Revenue Dollars		Revenue Percentage		Revenue Dollars		Revenue Percentage		Dollars			Percentage
	(dollars in millions)
Skilled nursing facilities	$	311.5	72.0	%	$	315.2	72.2	%	$	(3.7	)	(1.2	)%
Assisted living facilities	14.1		3.3		13.8		3.2		0.3			2.2
Administration of third party facility	0.4		0.1		0.6		0.1		(0.2		)	(33.3	)
Leased facility revenue	1.5		0.3		1.5		0.3		—			—
Total long-term care services	$	327.5	75.7	%	$	331.1	75.8	%	$	(3.6	)	(1.1	)%

The $3.7 million decrease in the skilled nursing facilities revenue in the first six months of 2013 as compared to the first six months of 2012 was primarily due a shift in payor types from traditional Medicare to Managed Medicare (Medicare Advantage) and due to one less business day in the six months ended June 30, 2013 as compared to the six months ended June 30, 2012. The payor shift resulted in a net decrease in revenue of $5.8 million, which was offset by a $2.0 million increase in Medicaid revenue due to increased Medicaid PPD rates. In addition, we experienced a decrease in ADC for the six months ended in June 30, 2013 as compared to the six months ended in June 30, 2012.

The increase of $0.3 million at our assisted living facilities in the six months ended June 30, 2013 as compared to the same period in 2012 was due primarily to the increase in PPD rate by 3.0% to $97 for the six months ended June 30, 2013 as compared to $94 for the six months ended June 30, 2012.

Therapy services

	Six Months Ended June 30,
	2013					2012					Increase/(Decrease)
	Revenue Dollars			Revenue Percentage		Revenue Dollars			Revenue Percentage		Dollars			Percentage
	(dollars in millions)
Rehabilitation therapy services	$	82.9		19.2	%	$	84.3		19.2	%	$	(1.4	)	(1.7	)%
Intersegment elimination of services related to affiliated entities	(29.2		)	(6.8	)	(31.8		)	7.3		2.6			(8.2	)
Third party therapy services	$	53.7		12.4	%	$	52.5		12.1	%	$	1.2		2.3	%

The $1.2 million increase in our Hallmark third party therapy services revenue was related to an increase in revenue for facilities that operated for the full six months ended June 30, 2013 and 2012. The intersegment revenue from affiliated facilities decreased by $2.8 million for the six months ended June 30, 2013 as compared to the same period a year ago. The Medicare Part B MMR process that went into effect on October 1, 2012 reduced revenue from our third party customers for the six months ended June 30, 2013 by $1.6 million as compared to the same period a year ago as many of our customers are hesitant

38

to provide therapy treatment to their patients in excess of the $3,700 Medicare Part B threshold. We expect the MMR process to continue to negatively impact our therapy revenue in the future. This was offset by a $1.9 million increase in revenue due an increase in the treatment of managed care residents at the third party facilities and a $1.0 million increase in revenue due an increase in the treatment of Medicare Part A residents at the third party facilities for the six months ended June 30, 2013 as compared to the same period a year ago. The MPPR for outpatient therapy included in the ATRA went into effect April 1, 2013 negatively impacted our revenue by $0.3 million.

Hospice & Home Health services

	Six Months Ended June 30,
	2013				2012				Increase/(Decrease)
	Revenue Dollars		Revenue Percentage		Revenue Dollars		Revenue Percentage		Dollars			Percentage
	(dollars in millions)
Hospice	$	37.4	8.6	%	$	40.3	9.2	%	$	(2.9	)	(7.2	)%
Home Health	14.0		3.2		12.8		2.9		1.2			9.4
Total hospice & home health services	$	51.4	11.8	%	$	53.1	12.1	%	$	(1.7	)	(3.2	)%

Of the $2.9 million decrease in hospice revenue for the first six months of 2013 as compared to the first six months of 2012, $1.9 million was due to a decrease in ADC. For the six months ended June 30, 2013 and 2012, we recorded hospice Medicare cap adjustments of $2.9 million and $1.2 million, respectively, as adjustments to revenue, which negatively affected the weighted average PPD rates for both periods and accounted for the remaining decrease in revenue. Of the $2.9 million hospice cap reserves recorded in the six months ended June 30, 2013, $0.7 million was related to the 2013 cap year, $2.0 million was related to the 2012 cap year and $0.2 million was related to the 2011 cap year. The $1.2 million in cap adjustment recorded in the six months ended June 30, 2012 was related to the 2012 cap year.

Of the $1.2 million increase in our home health revenue in the first six months of 2013 as compared to the first six months of 2012, $0.6 million was from home health agencies operated for all of both periods, with a $1.1 million increase from an increase in episodes, offset by a $0.5 million decrease in rate per episode. The decrease in rate per episode was primarily due to the decrease in Medicare reimbursement rates and additional decreases in private and other payer sources. The remaining $0.6 million increase in home health revenue was due to acquisitions.

Cost of Services Expenses. Cost of services expenses increased $13.2 million, or 3.6%, to $376.5 million, or 86.9% of revenue, in the six months ended June 30, 2013, from $363.3 million, or 83.2% of revenue, in the six months ended June 30, 2012.

Long term care services

	Six Months Ended June 30,
	2013				2012				Increase/(Decrease)
	Cost of Service Dollars (prior to intersegment eliminations)		Percentage of Revenue		Cost of Service Dollars (prior to intersegment eliminations)		Percentage of Revenue
									Dollars		Percentage
	(dollars in millions)
Skilled nursing facilities	$	262.8	84.4	%	$	256.0	81.2	%	$	6.8	2.7	%
Assisted living facilities	10.2		72.0		9.9		71.4		0.3		3.0
Regional operations support	11.2		n/a		10.6		n/a		0.6		5.7
Total long-term care services	$	284.2	86.8	%	$	276.5	83.5	%	$	7.7	2.8	%

Cost of services expenses at our skilled nursing facilities increased $6.8 million in the first six months of 2013 as compared to the first six months of 2012. The $6.8 million increase was primarily the result of a $3.6 million increase in self insured general and professional liability expense in the first six months of 2013 as compared to the first six months of 2012 due to a change in the estimated reserves on the professional liability claims from prior years. There was a $2.9 million increase in labor and benefit costs for the six months ended June 30, 2013 as compared to the six months ended June 30, 2012, primarily

39

due to increases in self insured medical and workers compensation expense. Bad debt expense increased $1.9 million in the six months ended June 30, 2013 as compared to the year ago period due to the payor mix shift and an increase in the aging of private co-pay receivables. Taxes and licenses expense increased by $1.1 million in the six months ended June 30, 2013 as compared to the six months ended June 30, 2012 due to an increase in the California QA fees. These increases were offset by a decrease in rehab and ancillaries expense of $2.6 million due to the reduction in Medicare Part B revenue.

Cost of services expenses at our assisted living facilities increased $0.3 million in the first six months of 2013 as compared to the first six months of 2012 due to an increase of $0.5 million in our facilities that operated for the full six months in both periods attributable to an $0.2 million increase in labor costs resulting from increases in self insured medical and self insured workers compensation expense. In addition, there was a $0.2 million increase in professional liability reserves on existing claims in the first six month of 2013 as compared to the first six months of 2012. These increases were offset by a $0.2 million decrease in expenses due to the closure of an assisted living facility in Southern California in April, 2012.

Cost of services at our regional operations support increased by $0.6 million in the first six months of 2013 as compared to the first six months of 2012. The primary reason for the increase was an increase in non-routine legal costs of $1.1 million. These were offset by a decrease of $0.3 million in benefits.

Therapy services

	Six Months Ended June 30,
	2013						2012						Increase/(Decrease)
	Revenue (prior to intersegment eliminations)		Cost of Service Dollars (prior to intersegment eliminations)		Percentage of Revenue		Revenue (prior to intersegment eliminations)		Cost of Service Dollars (prior to intersegment eliminations)		Percentage of Revenue
													Dollars			Percentage
	(dollars in millions)
Rehabilitation therapy services	$	82.9	$	76.9	92.8	%	$	84.3	$	77.5	91.9	%	$	(0.6	)	(0.7	)%
Total therapy services	$	82.9	$	76.9	92.8	%	$	84.3	$	77.5	91.9	%	$	(0.6	)	(0.7	)%

Rehabilitation therapy costs of services as a percentage of revenue increased 0.9% for the six months ended June 30, 2013, as compared to the same period in 2012. The increase in the cost of services as a percentage of revenue is due to an increase in the treatment of managed care patients foe which we receive a lower revenue rate per minute, the MPPR which went into effect April 1, 2013, and from an increase in administrative work due to compliance with the MMR process and training involved in G-Code implementation.

Hospice and home health services

	Six Months Ended June 30,
	2013				2012				Increase/(Decrease)
	Cost of Service Dollars		Percentage of Revenue		Cost of Service Dollars		Percentage of Revenue
									Dollars		Percentage
	(dollars in millions)
Hospice	$	32.5	87.0	%	$	31.4	77.8	%	$	1.1	3.5	%
Home Health	13.2		94.8		11.1		87.1		2.1		18.6
Total hospice & home health services	$	45.7	89.0	%	$	42.5	80.1	%	$	3.2	7.5	%

Cost of services expenses related to our hospice business increased $1.1 million in the first six months of 2013 as compared to the first six months of 2012. The $1.1 million increase resulted from an increase in operating costs of $10.81 PPD, or 8.7%, to $135.02 PPD in the six months ended June 30, 2013 from $124.20 PPD for the six months ended June 30, 2012. This was partially the result of the opening of the GIP unit at our Las Vegas, Nevada hospice. GIP units require a higher level of patient care and result in increased PPD costs.In addition, salaries and wages increased on a PPD basis as the agencies were overstaffed for their census levels.

Cost of services related to our home health business increased $2.1 million in the first six months of 2013 as compared to the first six months of 2012. The increase was primarily due to an increase of $1.3 million of additional expenses at our existing home health agencies, commensurate with the increase in episodes. Of the $1.3 million, salaries, contract, and benefits

40

related expense increased by $1.0 million for these facilities. The remaining balance of $0.8 million in home health cost of services expense was due to acquisitions.

Rent Cost of Revenue. Rent cost of revenue increased $0.5 million, or 6.0%, to $9.6 million, or 2.2% of revenue, in the six months ended June 30, 2013 from $9.1 million, or 2.1% of revenue, in the six months ended June 30, 2012. The increase was primarily related to a new lease that went into effect in the fourth quarter of 2012 at one of our leased California facilities.

General and Administrative Services Expenses. Our general and administrative services expenses increased $0.8 million, or 6.4%, to $13.3 million, or 3.1% of revenue, in the six months ended June 30, 2013 from $12.5 million, or 2.9% of revenue, in the six months ended June 30, 2012. The increase is primarily due to $1.5 million in severance costs accrued related to the elimination of positions not related to patient care. There was also an increase of $0.2 million in purchased services related expense in 2013 as compared to 2012. These increases were offset by the $0.2 million reversal of stock compensation related to performance shares awarded in 2013 which are not expected to vest and $0.8 million less of incentive accruals in the second quarter of 2013 compared to 2012.

Depreciation and Amortization. Depreciation and amortization remained consistent at $12.3 million, or 2.8% of revenue, in the six months ended June 30, 2013 and June 30, 2012.

Change in fair value of contingent consideration. The change in fair value of contingent consideration decreased by $2.8 million, to negative $2.2 million, or 0.5% of revenue, in the six months ended June 30, 2013 from positive $0.6 million, or 0.1% of revenue, in the six months ended June 30, 2012. The decrease is related to the change in fair value of the contingent consideration related to the 2010 hospice and home health acquisition due to reductions in forecasted EBITDA, which reduces the likelihood of the businesses achieving their EBITDA target necessary for the earn-out to be paid in future periods.

Interest Expense. Interest expense decreased by $2.7 million, or 13.3%, to $17.4 million, or 4.0% of revenue, in the six months ended June 30, 2013 from $20.1 million, or 4.6% of revenue, in the six months ended June 30, 2012. The decrease is related to the replacement of higher cost subordinated debt with term debt in the second quarter of 2012.

Interest Income. Interest income decreased by $0.1 million to $0.2 million or 0.1% of revenue, in the six months ended June 30, 2013 as compared to $0.3 million or 0.1% of revenue, in the six months ended June 30, 2012.

Equity in Earnings of Joint Venture. Equity earnings of our pharmacy joint venture remained consistent at $1.0 million in the six months ended June 30, 2013 and June 30, 2012.

Debt modification/retirement costs. The debt modification/retirement costs decreased by $2.9 million to $1.1 million or 0.3% of revenue, in the three months ended June 30, 2013 from $4.0 million or 0.9% of revenue in the six months ended June 30, 2012. The $1.1 million expensed in 2013 related to the June 2013 credit facility, which increased the maximum leverage ratio by 0.5. Of the $4.0 million expensed in 2012, $1.9 million in costs related unamortized subordinated debt deferred financing fees expensed when the bonds were defeased and $2.1 million related to the June 2012 credit facility amendment.

Income Before Provision for Income Taxes. Income before provision for incomes taxes decreased by $10.6 million to $5.6 million in the six months ended June 30, 2013 from $16.2 million in the six months ended June 30, 2012 as a result of the decrease in revenue and increased operating expenses for the six months ended June 30, 2013 as compared to the six months ended June 30, 2012.

Provision for Income Taxes. We recorded a tax expense of $1.1 million, or 18.6% of pre-tax earnings, for the six months ended June 30, 2013, as compared to $6.4 million, or 39.5% of pre-tax earnings, for the six months ended June 30, 2012. The lower tax expense for the six months ended June 30, 2013 was due primarily to the resolution and ultimate disposition of remaining funds related to the 2010 settlement of the Humboldt County Action. See Note 7, "Commitments and Contingencies - Legal Matters," for additional detail. In addition, the lower pre-tax earnings resulted in a lower tax expense.

Liquidity and Capital Resources

The following table presents selected data from our condensed consolidated statements of cash flows (in thousands):

41

	Six Months Ended June 30,
	2013			2012
Cash Flows from Continuing Operations
Net cash provided by operating activities	$	13,789		$	14,120
Net cash (used in) investing activities	(5,981		)	(7,100		)
Net cash (used in) financing activities	(7,792		)	(17,465		)
Net increase (decrease) in cash and cash equivalents	16			(10,445		)
Cash and cash equivalents at beginning of period	2,003			16,017
Cash and cash equivalents at end of period	$	2,019		$	5,572

Based upon our current level of operations, we believe that cash generated from operations, cash on hand and borrowings available to us will be adequate to meet our anticipated debt service requirements, capital expenditures and working capital needs for at least the next twelve months. One element of our business strategy is to selectively pursue acquisitions and strategic alliances. Any acquisitions or strategic alliances may result in our incurrence or assumption of additional indebtedness. We assess our capital needs on an ongoing basis and may from time to time seek additional financing through a variety of methods, including through an extension of our senior secured credit facility, or by accessing available debt and equity markets, and participation in U.S. Department of Housing and Urban Development ("HUD") or other government insured loan programs, as considered necessary to fund capital expenditures and potential acquisitions, refinance existing debt, or for other purposes. Our future operating performance will be subject to future economic conditions and to financial, business, regulatory and other factors, many of which are beyond our control. For additional discussion, see "Other Factors Affecting Liquidity and Capital Resources" below.

Six Months Ended June 30, 2013 Compared to Six Months Ended June 30, 2012

At June 30, 2013, we had cash and cash equivalents of $2.0 million. Our available cash is held in accounts at third-party financial institutions. We have periodically invested in AAA-rated money market funds. To date, we have experienced no loss or lack of access to our invested cash or cash equivalents; however, we can provide no assurances that access to our invested cash or cash equivalents will not be impacted by adverse conditions in the financial markets.

Net cash provided by operating activities in the six months ended June 30, 2013 was $13.8 million, compared to the $14.1 million in the six months ended June 30, 2012.  The change was primarily the result of a $5.2 million decrease in net income partially offset by a $4.9 million improvement in operating cash flows from operating activities and changes in operating assets and liabilities for the six months ended June 30, 2013 as compared to the six months ended June 30, 2012. The $4.9 million improvement was due to $6.1 million increase in accounts payable and accrued liabilities due to the timing of payments, $4.4 million in deferred taxes and $4.2 million in increases in insurance liability reserves offset by an increase in accounts receivable as days sales outstanding (DSO) was 51.2 at June 30, 2013 as compared to 45.0 at June 30, 2012.  DSO increased by 6.7 days from December 31, 2012 to June 30, 2013 and by 2.6 days from December 31, 2011 to June 30, 2012. The increase in DSO as of June 30, 2013 was caused primarily by three factors. California's Medi-Cal program once again withheld payments from providers for the last three weeks of June, which impacted our skilled nursing facilities and our third party therapy customers located in California. Additionally, an administrative issue delayed certain of our hospice cash receipts from June into July. The combined impact of the Medi-Cal and hospice cash receipts was $11.9 million, all of which was received in the beginning of July 2013. Additionally, our DSO continues to increase as a higher percentage of our receivables is due from managed care payors, which have longer payment terms.

Net cash used in investing activities in the six months ended June 30, 2013 was $6.0 million, compared to $7.1 million in the six months ended June 30, 2012 as the result of capital expenditures in both periods.

Net cash used in financing activities in the six months ended June 30, 2013 was $7.8 million, compared to the $17.5 million used in the six months ended June 30, 2012. 

Principal Debt Obligations

Our primary sources of liquidity are our cash on hand, our cash flows from operations and borrowing under our senior secured credit facility, which is subject to the satisfaction of certain financial covenants therein. Our primary liquidity requirements are for debt service on our first lien senior secured term loan, capital expenditures and working capital.

We are significantly leveraged. As of June 30, 2013, we had $445.5 million in aggregate indebtedness outstanding, consisting of $403.8 million first lien senior secured term loan (net of the unamortized portion of the original issue discount ("OID") of $2.5 million), $39.0 million principal amount outstanding under our $100.0 million revolving credit facility, and other debt of approximately $2.7 million. Furthermore, we had $4.4 million in outstanding letters of credit against our $100.0 million revolving credit facility, leaving approximately $56.6 million of additional borrowing capacity under our senior secured

42

credit facility as of June 30, 2013. Substantially all of our subsidiaries guarantee the first lien senior secured term loan and our revolving credit facility.

If our remaining ability to borrow under our revolving credit facility is insufficient for our capital requirements, we will be required to seek additional sources of financing, including issuing equity, which may be dilutive to our current stockholders, or incurring additional debt. Our ability to incur additional debt is subject to the restrictions in our senior secured credit facility. We cannot assure you that the restrictions contained in the senior secure credit facility will permit us to borrow the funds that we need to finance our operations, or that additional debt will be available to us on commercially reasonable terms or at all. If we are unable to obtain funds sufficient to finance our capital requirements, we may have to forego opportunities to expand our business, including the acquisition of additional facilities.

Term Loan and Revolving Loan

On April 9, 2010, we entered into an up to $360.0 million senior secured term loan and a $100.0 million revolving credit facility ("Prior Credit Agreement") that amended and restated the senior secured term loan and revolving credit facility that were set to mature in June 2012. On April 12, 2012, we entered into an Amendment and Restatement and Additional Term Loan Assumption Agreement (“Restated Credit Agreement”) that amended and restated the Prior Credit Agreement and pursuant to which, among other things, the size of our existing senior secured term loan was increased by $100.0 million (hereinafter referred to as the incremental senior secured term loan). On June 6, 2013, we entered into an amendment to the Restated Credit Agreement that increased the maximum leverage ratio by 0.50 throughout the life of the Restated Credit Agreement. The amendment additionally permits us to make future offers to the lenders under the revolving loan facility to extend the maturity date of all or a portion of the revolving loans. The credit arrangements provided under the Restated Credit Agreement are collectively referred to herein as the senior secured credit facility.

We expensed fees paid in connection with the refinancing of the Prior Credit Agreement in the amount of $2.0 million in conjunction with the amended senior secured credit facility. In connection with the June 6, 2013 modification, we paid fees totaling $2.5 million, of which $1.1 million were recorded as debt modification costs in the consolidated statement of operations, and $1.4 million were recorded as other assets in the consolidated balance sheet. Substantially all of our assets are pledged as collateral under the senior secured credit facility. Amounts borrowed under the senior secured term loan may be prepaid at any time without penalty, except for LIBOR breakage costs. Commitments under the revolving credit facility terminate on April 9, 2015. The senior secured term loan matures on April 9, 2016.

  The incremental senior secured term loan bears interest, at our option, at the London Interbank Offered Rate ("LIBOR") (subject to a floor of 1.50%) plus a margin of 5.25% or the prime rate (subject to a floor of 2.50%) plus a margin of 4.25%. As part of the refinancing, the interest rate on the existing senior secured term loan was amended to match the interest rate of the incremental senior secured term loan. The interest rate on the existing revolving credit facility was also amended to be, at our option, LIBOR plus a margin of between 4.25% and 4.50% (based upon consolidated senior leverage) or the prime rate plus a margin of between 3.25% and 3.50% (based upon consolidated senior leverage). There is no longer a LIBOR or prime rate floor with respect to the revolving credit facility. Pursuant to the Restated Credit Agreement, the quarterly term loan amortization payments increased to $2.6 million beginning June 30, 2012, compared to $0.9 million previously under the Prior Credit Agreement. Additionally, the maximum portion of the annual Consolidated Excess Cash Flow (as defined in the Restated Credit Agreement) to be applied to term debt reductions increased to 75% from 50%, subject to stepdowns to 50% and 25% based on consolidated leverage. We also increased our ability to refinance a portion of our credit facility with U.S. Department of Housing and Urban Development ("HUD") insured debt up to $250 million, subject to certain credit facility covenants.  We have received conditional portfolio credit approval from HUD for up to an aggregate of $460 million in HUD insured loans secured by up to 78 facilities under HUD's Section 232 loan program, which provides loans for nursing homes, assisted living and related facilities. Any HUD insured borrowings beyond $250 million would necessitate either refinancing the senior secured credit facility in full or otherwise seeking a waiver or amendment from the senior secured lenders. We have not yet determined the amount of borrowings we will ultimately seek under the HUD insured loan program, and all loan applications will be subject to further review and approval by HUD. The HUD approval process is subject to a number of contingencies and uncertainties, many of which are beyond our control. Furthermore, there can be no assurance that we will ultimately be approved for and close any HUD insured loans, what the timing of any approvals or closings would be, or what the interest rates on any HUD insured loans would be. The Restated Credit Agreement requires that all of the net proceeds from any HUD-insured loans be used to pay down the term portion of our senior secured credit facility. 

Substantially all of our assets are pledged as collateral under the senior secured credit facility. Amounts borrowed under the senior secured term loan may be prepaid at any time without penalty, except for LIBOR breakage costs. Commitments under the revolving credit facility terminate on April 9, 2015. The senior secured term loan matures on April 9, 2016.

We have the right to increase our borrowings under the revolving credit facility up to an aggregate amount of $150 million provided that the we are in compliance with the Restated Credit Agreement, that the additional debt would not cause any covenant violation of the Restated Credit Agreement, and that existing or new lenders within the Restated Credit Agreement agree to increase their commitments. To reduce the risk related to interest rate fluctuations, the Prior Credit

43

Agreement required us to enter into, and the Restated Credit Agreement requires us to continue to maintain, an interest rate swap, cap or similar agreement to effectively fix or cap the interest rate on 40% of our funded long-term debt within three months of the April 2010 commencement of the senior secured credit facility. See Item 3, Quantitative and Qualitative Disclosures About Market Risk, for information about our interest rate swap agreement.

Under the senior secured credit facility, we must maintain compliance with specified financial covenants measured on a quarterly basis. The senior secured credit facility also includes certain additional affirmative and negative covenants, including limitations on the incurrence of additional indebtedness, liens, investments in other businesses and capital expenditures. Also under the senior secured credit facility, subject to certain exceptions and minimum thresholds, we are required to apply all of the proceeds from any issuance of debt, as much as half of the proceeds from any issuance of equity, as much as 75% of our annual Consolidated Excess Cash Flow (as defined in the Restated Credit Agreement), and amounts received in connection with any sale of our assets to repay the outstanding amounts under the Restated Credit Agreement. We believe that we were in compliance with our debt covenants as of June 30, 2013. As of June 30, 2013, our fixed charge coverage ratio was 2.3, which compares to a minimum requirement of 1.75 and our leverage ratio was 4.9, as compared to an allowed maximum of 5.25.

Senior Subordinated Notes

On May 12, 2012, we redeemed the entire $130.0 million outstanding principal amount plus all accrued but unpaid interest, of the 2014 Notes. The proceeds from the incremental senior secured term loan (as well as a draw on the revolving portion of the senior secured credit facility) were used to fund the redemption of the outstanding 2014 Notes at par plus accrued interest. In addition, we expensed unamortized deferred financing fees and OID in the amount of $1.9 million in conjunction with the redemption.

The 2014 Notes were issued in December 2005 in the aggregate principal amount of $200.0 million, with an interest rate of 11.0% and a discount of $1.3 million. Interest was payable semiannually in January and July of each year. The 2014 Notes were to mature on January 15, 2014. The 2014 Notes were unsecured senior subordinated obligations and ranked junior to all of our existing and future senior indebtedness, including indebtedness under the senior secured credit facility. The 2014 Notes were guaranteed on a senior subordinated basis by certain of our subsidiaries.

Capital Expenditures

We intend to invest in the maintenance and general upkeep of our facilities on an ongoing basis. We also expect to perform renovations of our existing facilities every five to ten years to remain competitive. Combined, we expect that these activities will amount to approximately $1,500 per bed.

We anticipate that we will have capital expenditures in 2013 of approximately $15.0 million to $18.0 million. We will continue to assess our capital spending plans on an ongoing basis.

Other Factors Affecting Liquidity and Capital Resources

Medical and Professional Malpractice and Workers' Compensation Insurance. Our skilled nursing facilities and other businesses, like physicians, hospitals and other healthcare providers, are subject to a significant number of legal actions alleging malpractice, negligence or related legal theories. Many of these actions involve large claims and significant defense costs. To protect ourselves from the cost of these claims, we maintain professional liability and general liability as well as workers' compensation insurance in amounts and with deductibles that we believe to be sufficient for our operations. Historically, unfavorable pricing and availability trends emerged in the professional liability and workers' compensation insurance market and the insurance market in general that caused the cost of these liability coverages to generally increase dramatically. Many insurance underwriters became more selective in the insurance limits and types of coverage they would provide as a result of rising settlement costs and the significant failures of some nationally known insurance underwriters. As a result, we experienced substantial changes in our professional liability insurance program beginning in 2001. Specifically, we were required to assume substantial self-insured retentions for our professional liability claims. A self-insured retention is a minimum amount of damages and expenses (including legal fees) that we must pay for each claim. We use actuarial methods to estimate the value of the losses that may occur within this self-insured retention level and we are required under our workers' compensation insurance agreements to post a letter of credit or set aside cash in trust funds to securitize the estimated losses that we may incur. Because of the high retention levels, we cannot predict with certainty the actual amount of the losses we will assume and pay.

We estimate our self-insured general and professional liability reserves on a quarterly basis and our self-insured workers' compensation reserve on a semiannual basis, based upon actuarial analyses using the most recent trends of claims, settlements and other relevant data from our own and our industry's loss history. Based upon these analyses, at June 30, 2013, we had reserved $20.2 million net of $1.3 million in insurance recoveries for known or unknown or potential self-insured general and professional liability claims and $18.5 million for self-insured workers' compensation claims. Of these reserves, we estimate that a total of $12.7 million, consisting of approximately $7.2 million for self-insured general and professional liability claims based on historical experience and current claims activity and $5.5 million for self-insured workers' compensation claims, will

44

be payable within 12 months; however, there are no set payment schedules and there can be no assurance that the payment amount in the next 12 months will not be significantly larger or smaller. To the extent that subsequent claims information varies from loss estimates, the liabilities will be adjusted to reflect current loss data. There can be no assurance that in the future general and professional liability or workers' compensation insurance will be available at a reasonable price and that we will not have to further increase our levels of self-insurance. For additional information on our general and professional liability and workers’ compensation reserve, see "Business — Insurance" in Part 1, Item 1 in our Annual Report on Form 10-K filed with the SEC on February 11, 2013.

Inflation. We derive a substantial portion of our revenue from the Medicare program. We also derive revenue from state Medicaid and similar reimbursement programs. Payments under these programs generally provide for reimbursement levels that are adjusted for inflation annually based upon the state's fiscal year for the Medicaid programs and in each October for the Medicare program. However, there can be no assurance that these adjustments will continue in the future and, if received, will reflect the actual increase in our costs for providing healthcare services.

Labor and supply expenses make up a substantial portion of our operating expenses. Those expenses can be subject to increase in periods of rising inflation and when labor shortages occur in the marketplace. To date, we have generally been able to implement cost control measures or obtain increases in reimbursement sufficient to offset increases in these expenses. We cannot assure you that we will be successful in offsetting future cost increases.

Recent Accounting Standards

The information required by this item is incorporated herein by reference to Note 2, "Summary of Significant Accounting Policies," to the unaudited consolidated financial statements included under Part I, Item 1 of this report.

Off-Balance Sheet Arrangements

We had outstanding letters of credit of $4.4 million under our $100.0 million revolving credit facility as of June 30, 2013.

Item 3.Quantitative and Qualitative Disclosures About Market Risk

In the normal course of business, our operations are exposed to risks associated with fluctuations in interest rates. To the extent these interest rates increase, our interest expense will increase, which will make our interest payments and funding our other fixed costs more expensive, and our available cash flow may be adversely affected. We routinely monitor our risks associated with fluctuations in interest rates and consider the use of derivative financial instruments to hedge these exposures. We do not enter into derivative financial instruments for trading or speculative purposes nor do we enter into energy or commodity contracts.

Interest Rate Exposure—Interest Rate Risk Management

Our first lien credit agreement exposes us to variability in interest payments due to changes in interest rates. We entered into an interest rate swap agreement on June 30, 2010 in order to manage fluctuations in cash flows resulting from interest rate risk. The interest rate swap agreement matured on June 30, 2013 and was for a notional amount of $70.0 million with a LIBOR rate of 2.3% from January 2012 to June 2013.

The table below presents the principal amounts, weighted-average interest rates and fair values by year of expected maturity to evaluate our expected cash flows and sensitivity to interest rate changes (dollars in thousands):

	Twelve Months Ending June 30, (1)
	2014			2015			2016			2017			2018			Thereafter			Total		Fair Value
Fixed-rate debt	$	1,794		$	200		$	185		$	197		$	209		$	109		$	2,694	$	2,694
Average interest rate	3.9		%	5.9		%	6.0		%	6.0		%	6.0		%	6.0		%
Variable-rate debt (2)	$	10,487		$	49,487		$	385,384		$	—		$	—		$	—		$	445,358	$	449,421
Average interest rate(1)	6.8		%	5.4		%	6.8		%

(1) Based on implied forward three-month LIBOR rates in the yield curve as of June 30, 2013.

(2) Excludes unamortized original issue discount of $2.5 million on our first lien senior secured term loan debt.

Item 4.Controls and Procedures

Disclosure Controls and Procedures

As required by Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), management has evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report.

45

Disclosure controls and procedures refer to controls and other procedures designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the Securities and Exchange Commission. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in our reports that we file or submit under the Exchange Act is accumulated and communicated to management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding our required disclosure. In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management was required to apply its judgment in evaluating and implementing possible controls and procedures.

We conducted an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based upon their evaluation and subject to the foregoing, the Chief Executive Officer and Chief Financial Officer have concluded that, as of end of the period covered by this report, the disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in the reports we file and submit under the Exchange Act is recorded, processed, summarized and reported as and when required.

Changes in Internal Control Over Financial Reporting

Management determined that there were no changes in our internal control over financial reporting that occurred during the quarter covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

46

Part II. Other Information

Item 1.Legal Proceedings

For information regarding certain pending legal proceedings to which we are a party or our property is subject, see Note 7, "Commitments and Contingencies—Legal Matters," to our consolidated financial statements included elsewhere in this report, which is incorporated herein by reference.

Item 1A. Risk Factors

Statements made by us in this report and in other reports and statements released by us that are not historical facts constitute "forward-looking statements" within the meaning of Section 21 of the Exchange Act. Statements that use words such as "believe," "anticipate," "estimate," "intend," "could," "plan," "expect," "project" or the negative of these, as well as similar expressions, are intended to identify forward-looking statements. These forward-looking statements are necessarily estimates and expectations reflecting the best judgment of our senior management based on our current estimates, expectations, forecasts and projections, and include comments that express our current opinions about trends and factors that may impact future operating results. Such statements rely on a number of assumptions concerning future events, many of which are outside of our control, and involve known and unknown risks and uncertainties that could cause our actual results, performance or achievements, or industry results, to differ materially from any future results, performance or achievements, expressed or implied by such forward-looking statements. Any such forward-looking statements, whether made in this report or elsewhere, should be considered in the context of the various disclosures made by us about our business and other matters including, without limitation, the risk factors discussed below. We expressly disclaim any duty to update the forward-looking statements and other information contained in this report, except as required by law.

We operate in a rapidly changing and highly regulated environment that involves a number of risks and uncertainties, some of which are highlighted below and others are discussed elsewhere in this report. These risks and uncertainties could materially and adversely affect our business, financial condition, prospects, operating results or cash flows. The following risk factors are not the only ones facing us. Our business is also subject to the risks that affect many other companies, such as employment relations, natural disasters, general economic conditions and geopolitical events. Further, additional risks not currently known to us or that we currently believe are immaterial may in the future materially and adversely affect our business, operations, liquidity and stock price.

Risks Related to Our Business

Reductions in Medicare reimbursement rates, or changes in the rules governing the Medicare program could have a material adverse effect on our revenue, financial condition and results of operations.

Medicare is our largest source of revenue, accounting for 31.0% of our consolidated revenue during the three months period ended June 30, 2013 and 33.8% in the same period for 2012. For the six months ended June 30, 2013 and 2012 the Medicare revenue accounted for 31.8% and 34.4% of our consolidated revenue respectively. In addition, many private payors base their reimbursement rates on the published Medicare rates or, in the case of our rehabilitation therapy services customers, are themselves reimbursed by Medicare for the services we provide. Accordingly, if Medicare reimbursement rates are reduced or fail to increase as quickly as our costs, or if there are changes in the rules governing the Medicare program that are disadvantageous to our business or industry, our business and results of operations will be adversely affected.

The Medicare program and its reimbursement rates and rules are subject to frequent change. These include statutory and regulatory changes, rate adjustments (including retroactive adjustments), administrative or executive orders and government funding restrictions, all of which may materially adversely affect the rates at which Medicare reimburses us for our services. For example, CMS implemented a net 11.1% reduction in its reimbursement rates to skilled nursing facilities effective October 1, 2011. Furthermore, due to the federal sequestration, an automatic 2% reduction in Medicare spending took effect beginning in April 2013 and will remain in effect unless Congress takes action to terminate the automatic reduction or authorize spending increases. Budget pressures often lead the federal government to reduce or place limits on reimbursement rates under Medicare. Implementation of these and other types of measures has in the past and could in the future result in substantial reductions in our revenue and operating margins. Prior reductions in governmental reimbursement rates partially contributed to our predecessor's bankruptcy filing under Chapter 11 of the United States Bankruptcy Code in October 2001.

In addition, the federal government often changes the rules governing the Medicare program, including those governing reimbursement. Changes that could adversely affect our business include:

• administrative or legislative changes to base rates or the bases of payment;

• limits on the services or types of providers for which Medicare will provide reimbursement;

• changes in methodology for patient assessment and/or determination of payment levels;

47

• the reduction or elimination of annual rate increases; or

• an increase in co-payments or deductibles payable by beneficiaries.

Given the history of frequent revisions to the Medicare program and its reimbursement rates and rules, we may not continue to receive reimbursement rates from Medicare that sufficiently compensate us for our services or, in some instances, cover our operating costs. Limits on reimbursement rates or the scope of services being reimbursed could have a material adverse effect on our revenue, financial condition and results of operations. Additionally, any delay or default by the federal or state governments in making Medicare and/or Medicaid reimbursement payments could materially and adversely affect our business, financial condition and results of operations.

We expect the federal and state governments to continue their efforts to contain growth in Medicaid expenditures, which could adversely affect our revenue and profitability.

We receive a significant portion of our revenue from Medicaid, which accounted for 31.1% and 29.8% of our consolidated revenue for the three months ended June 30, 2013 and 2012 respectively. For the first six months ended June 30, 2013 and 2012 Medicaid accounted for 30.6% and 29.8% of our consolidated revenue respectively. Medicaid is a state-administered program financed by both state funds and matching federal funds. Medicaid spending has increased rapidly in recent years, becoming a significant component of state budgets. This, combined with slower state revenue growth, has led both the federal government and many states (including California and Texas, where significant portions of our Medicaid-related business is located) to institute measures aimed at controlling the growth of Medicaid spending, and in some instances reducing aggregate Medicaid spending. We expect these state and federal efforts to continue for the foreseeable future. Furthermore, not all of the states in which we operate, most notably Texas, have elected to expand Medicaid as part of federal healthcare reform legislation. If Medicaid reimbursement rates are reduced or fail to increase as quickly as our costs, or if there are changes in the rules governing the Medicaid program that are disadvantageous to our businesses, our business and results of operations could be materially and adversely affected.

Recent federal government proposals could limit the states' use of provider tax programs to generate revenue for their Medicaid expenditures, which could result in a reduction in our reimbursement rates under Medicaid.

To generate funds to pay for the increasing costs of the Medicaid program, many states utilize financial arrangements commonly referred to as "provider taxes." Under provider tax arrangements, states collect taxes from healthcare providers and then use the revenue to pay the providers as a Medicaid expenditure, which allows the states to then claim additional federal matching funds on the additional reimbursements. Current federal law provides for a cap on the maximum allowable provider tax as a percentage of the provider's total revenue. There can be no assurance that federal law will continue to provide matching federal funds on state Medicaid expenditures funded through provider taxes, or that the current caps on provider taxes will not be reduced. Any discontinuance or reduction in federal matching of provider tax-related Medicaid expenditures could have a significant and adverse effect on states' Medicaid expenditures, and as a result could have a material and adverse effect on our financial condition and results of operations.

Revenue we receive from Medicare and Medicaid is subject to potential retroactive reduction or repayment.

Payments we receive from Medicare and Medicaid can be retroactively adjusted after examination during the claims settlement process or as a result of post-payment audits. Payors may disallow our requests for reimbursement, or recoup amounts previously reimbursed, based on determinations by the payors or their third-party audit contractors that certain costs are not reimbursable because either adequate or additional documentation was not provided or because certain services were not covered or deemed to not be medically necessary. Significant adjustments, recoupments or repayments of our Medicare or Medicaid revenue, and the costs associated with complying with investigative audits by regulatory and governmental authorities, could adversely affect our financial condition and results of operations.

Additionally, from time to time we become aware, either based on information provided by third parties and/or the results of internal audits, of payments from payor sources that were either wholly or partially in excess of the amount that we should have been paid for the service provided. Overpayments may result from a variety of factors, including insufficient documentation supporting the services rendered or medical necessity of the services, other failures to document the satisfaction of the necessary conditions of payment, or in some cases for providing services that are deemed to be worthless. We are required by law in most instances to refund the full amount of the overpayment after becoming aware of it, and failure to do so within requisite time limits imposed by the law could lead to significant fines and penalties being imposed on us. Furthermore, our initial billing of and payments for services that are unsupported by the requisite documentation and satisfaction of any other conditions of payment, regardless of our awareness of the failure at the time of the billing or payment, could expose us to significant fines and penalties, including pursuant to the Federal False Claims Act ("FFCA") and the Federal Civil Monetary Penalties Law ("FCMPL"). Violations of the FFCA could lead to any combination of a variety of criminal, civil and administrative fines and penalties. The FFCA provides for civil fines ranging from $5,500 to $11,000 per claim plus treble damages. The Civil Monetary Penalties Law similarly provides for civil monetary penalties of up to $10,000 per claim plus up

48

to treble damages. We and/or certain of our operating companies could also be subject to exclusion from participation in the Medicare or Medicaid programs in some circumstances as well, in addition to any monetary or other fines, penalties or sanctions that we may incur under applicable federal and/or state law. Our repayment of any such amounts, as well as any fines, penalties or other sanctions that we may incur, could be significant and could have a material and adverse effect on our results of operations and financial condition.

From time to time we are also involved in various external governmental investigations, audits and reviews. Reviews, audits and investigations of this sort can lead to government actions, which can result in the assessment of damages, civil or criminal fines or penalties, or other sanctions, including restrictions or changes in the way we conduct business, loss of licensure or exclusion from participation in government programs. For example, the Office of the Inspector General (“OIG”) conducts a variety of routine, regular and special investigations, audits and reviews across our industry. Failure to comply with applicable laws, regulations and rules could have a material and adverse effect on our results of operations and financial condition. Furthermore, becoming subject to these governmental investigations, audits and reviews can also require us to incur significant legal and document production expenses as we cooperate with the government authorities, regardless of whether the particular investigation, audit or review leads to the identification of underlying issues.

Health reform legislation could adversely affect our revenue and financial condition.

In recent years, there have been numerous initiatives on the federal and state levels for comprehensive reforms affecting the payment for, the availability of and reimbursement for, healthcare services in the United States. These initiatives have ranged from proposals to fundamentally change federal and state healthcare reimbursement programs, including the provision of comprehensive healthcare coverage to the public under governmental funded programs, to minor modifications to existing programs. The PPACA was enacted in 2010 and is among the most comprehensive and notable of these legislative efforts. The impact of PPACA remains uncertain to a large degree due to various implementation, timing, cost and regulatory requirements imposed by the legislation. The content or timing of any future health reform legislation, and its impact on us is impossible to predict. However, it is likely that certain provisions in PPACA will impose significant costs on us or that will otherwise negatively affect our operations. For instance, the requirement to offer full time employees “affordable” healthcare insurance that meets specified coverage minimums (or alternatively pay a per-employee penalty to the federal government) will likely significantly increase our annual healthcare costs or could damage employee morale and/or cause other employee-related issues that are harmful to our operations. If significant reforms are made to the U.S. healthcare system, those reforms may have an adverse effect on our financial condition and results of operations.

In addition, we incur considerable administrative costs in monitoring the changes made within the various reimbursement programs in which we participate, determining the appropriate actions to be taken in response to those changes, and implementing the required actions to meet the new requirements and minimize the repercussions of the changes to our organization, reimbursement rates and costs

Annual caps that limit the amounts that can be paid for outpatient therapy services rendered to any Medicare beneficiary may negatively affect our results of operations.

Some of our rehabilitation therapy revenue is paid by the Medicare Part B program under a fee schedule. There are annual caps that limit, subject to certain exceptions, the amounts that can be paid (including deductible and coinsurance amounts) for rehabilitation therapy services rendered to any Medicare beneficiary under Medicare Part B. There is a combined cap for physical therapy and speech-language pathology and a separate cap for occupational therapy that apply subject to certain exceptions. The discontinuation or change in the current cap exception process or future modifications of the Medicare Part B cap structure could have an adverse effect on the revenue that we generate through our rehabilitation therapy business.  This could in turn have a negative effect on our financial condition and results of operations. For example, the Medicare Part B therapy pre-approval provisions (MMR) and multiple procedure payment reduction ("MPPR") rate reductions that took effect October 1, 2012, have continued to negatively impact our therapy business through the end of 2013.

The MMR requirement generally provides that, on a per beneficiary basis and subject to limited exceptions, services above $3,700 for physical therapy and speech-language pathology services combined and/or $3,700 for occupational therapy services are subject to manual medical review (typically on a pre-payment basis) by the applicable Medicare contractors.  Challenges in obtaining a timely response from the applicable contractors and other difficulties with the MMR system have added significant uncertainty as to whether beneficiary will have access to the applicable therapy services that are over the cap amount, and whether the provider will be reimbursed for those services.  Under the MPPR policy, when physical therapy, occupational therapy and speech-language pathology services are performed on the same day for the same patient and paid under Medicare Part B, then Medicare effectively makes a full reimbursement payment for only one of the procedures and the reimbursements for the other procedures are at a reduced rate.  The application of the MPPR policy has negatively affected our therapy business and will continue to do so as long as the policy is in effect.

49

We are subject to a Medicare cap amount for our hospice business. Our net patient service revenue and profitability could be adversely affected by limitations on Medicare payments.

Overall payments made by Medicare to us on a per hospice basis are subject to an annual cap amount. Total Medicare payments received for services rendered during the applicable Medicare hospice cap year by each of our Medicare-certified hospice programs during this period are compared to the cap amount for the relevant period. Payments in excess of the cap are subject to recoupment by Medicare.

We monitor the Medicare cap amount and seek to implement corrective measures as necessary. We maintain what we believe are adequate allowances in the event that our individual hospice agencies exceed the Medicare hospice cap in any given fiscal year. However, many of the variables involved in estimating the Medicare hospice cap contractual adjustment are beyond our control, and we cannot assure you that we will not increase or decrease our estimated contractual allowance in the future, or that we will not be required to surrender amounts we received from Medicare that were in excess of the Medicare hospice cap for any particular period(s).

For the six months ended June 30, 2013, we recorded hospice Medicare cap expense of $2.9 million, as an adjustment to revenue as compared to $1.0 million for the six months ended June 30, 2012. Of the $2.9 million, $0.7 million is related to the 2013 cap year and $2.0 million is related to the 2012 cap year and $0.2 million is related to the 2011 cap year. This adjustment related primarily to patients staying on service longer than estimated which results in the patients' cap allowances being stretched over multiple cap years. Our ability to comply with the cap limitation depends on a number of factors relating to a given hospice program, including number of admissions, average length of stay, mix in level of care and Medicare patients that transfer into and out of our hospice programs. Our revenue and profitability may be materially reduced if we are unable to comply with this and other Medicare payment limitations. We cannot assure you that our hospice programs will not exceed the cap amount in the future or that our estimate of the Medicare cap contractual adjustment will not differ materially from the actual Medicare cap amount.

We are subject to extensive and complex laws and government regulations. If we are not operating in compliance with these laws and regulations or if these laws and regulations change, we could be required to make significant expenditures or change our operations in order to bring our facilities and operations into compliance.

We, along with other companies in the healthcare industry, are required to comply with extensive and complex laws and regulations at the federal, state and local government levels relating to, among other things:

• licensure and certification;

• adequacy and quality of healthcare services;

• qualifications of healthcare and support personnel;

• quality of medical equipment;

• confidentiality, maintenance and security issues associated with medical records and claims processing;

• relationships with physicians and other referral sources and recipients;

• constraints on protective contractual provisions with patients and third-party payors;

• operating policies and procedures;

• addition of facilities and services; and

• billing for services.

Many of these laws and regulations are expansive, and we do not always have the benefit of significant regulatory or judicial interpretation of these laws and regulations. In addition, many of these laws and regulations evolve to include additional obligations and restrictions, and sometimes with retroactive effect. Certain other regulatory developments, such as revisions in the building code requirements for assisted living and skilled nursing facilities, mandatory increases in scope and quality of care to be offered to residents, revisions in licensing and certification standards, mandatory staffing levels, regulations regarding conditions for payment and regulations restricting those we can hire, could also have a material adverse effect on us. In the future, different interpretations or enforcement of these laws and regulations could subject our current or past practices to allegations of impropriety or illegality or could require us to make changes in our facilities, equipment, personnel, services, capital expenditure programs and operating expenses.

One development potentially restricting those we may hire was a decision on November 3, 2010 by the Physical Therapy Board of California ("PT Board") to rescind a 1990 PT Board resolution which determined that the offering of physical therapy services by a corporation, not organized as a professional corporation, was permitted by the Physical Therapy Practice Act, which is the California statute governing the provision of physical therapy within the state. This rescission purports to prohibit employment of a physical therapist to provide physical therapy services by any professional corporation except those owned by physical therapists and Naturopaths. Lay corporations that hold themselves out as physical therapy corporations would be similarly prohibited. We have a subsidiary that employs physical therapists in California, but is not owned by physical therapists. Our subsidiary contracts with nursing facilities to provide the facilities with personnel who are licensed to provide rehabilitation therapy services, including physical therapy, occupational therapy and/or speech language pathology services.

50

Our therapists then provide rehabilitation therapy services to the nursing facilities' patients under the skilled nursing facilities' licenses that authorize the provision of physical therapy (and other rehabilitation therapy services, if applicable). In this relationship, the nursing facilities retain the patient relationship, remain professionally responsible for the healthcare services including therapy, and bill the patient and/or third party payors for the services rendered to their patients. We are unaware of any enforcement actions by the PT Board to date and it is not clear whether the applicable law would ultimately be interpreted to mean that our rehabilitation therapy subsidiary cannot employ and provide physical therapists to nursing facilities in California as it currently does.   Nevertheless, the PT Board could seek an enforcement action against our rehabilitation therapy subsidiary and its physical therapist employees and we may have to significantly restructure our California rehabilitation therapy operations to conform to the PT Board's revised interpretation of the law. 

In addition, federal and state government agencies have increased and coordinated civil and criminal enforcement efforts as part of numerous ongoing investigations of healthcare companies, including skilled nursing facilities, home health agencies and hospice agencies. This includes investigations of:

• fraud and abuse;

• quality of care;

• financial relationships with referral sources; and

• the medical necessity of services provided.

We are unable to predict the future course of federal, state and local regulation or legislation, including Medicare and Medicaid statutes and regulations, the intensity of federal and state enforcement actions or the extent and size of any potential sanctions, fines or penalties. Changes in the regulatory framework, our failure to obtain or renew required regulatory approvals or licenses or to comply with applicable regulatory requirements, the suspension or revocation of our licenses or our disqualification from participation in federal and state reimbursement programs, or the imposition of other enforcement sanctions, fines or penalties could have a material adverse effect upon our results of operations, financial condition and liquidity. Furthermore, should we lose licenses or certifications for a number of our facilities or other businesses as a result of regulatory action, legal proceedings such as those described in Note 7, "Commitments and Contingencies-Legal Matters," or otherwise, we could be deemed to be in default under some of our agreements, including agreements governing outstanding indebtedness and the report of such issues at one of our facilities could harm our reputation for quality care and lead to a reduction in our patient referrals and ultimately our revenue and operating income.

We face reviews, audits and investigations under federal and state government programs and contracts. These audits could have adverse findings that may negatively affect our business.

As a result of our participation in the Medicare and Medicaid programs, we are subject to various governmental inspections, reviews, audits and investigations to verify our compliance with these programs and applicable laws and regulations. Managed care payors may also reserve the right to conduct audits. We also periodically conduct internal audits and reviews of our regulatory compliance. An adverse inspection, review, audit or investigation could result in:

• refunding amounts we have been paid pursuant to the Medicare or Medicaid programs or from managed care payors;

• state or federal agencies imposing fines, penalties and other sanctions on us;

• temporary suspension of payment for new patients to the facility or agency;

• decertification or exclusion from participation in the Medicare or Medicaid programs or one or more managed care payor networks;

• self-disclosure of violations to applicable regulatory authorities;

• damage to our reputation;

• the revocation of a facility's or agency's license; and

• loss of certain rights under, or termination of, our contracts with managed care payors.

We have in the past and will likely in the future be required to refund amounts we have been paid and/or pay fines and penalties, as a result of these inspections, reviews, audits and investigations. If adverse inspections, reviews, audits or investigations occur and any of the results noted above occur, it could have a material adverse effect on our business and operating results. Furthermore, the legal, document production and other costs associated with complying with these inspections, reviews, audits or investigations could be significant.

Significant legal actions, which are commonplace in our professions, could subject us to increased operating costs and substantial uninsured liabilities, which would materially and adversely affect our results of operations, liquidity and financial condition.

The long-term care profession has experienced an increasing trend in the number and severity of litigation claims involving punitive damages and settlements. We believe that this trend is endemic to the industry and is a result of a variety of

51

factors, including the number of large judgments, including large punitive damage awards, against long-term care providers in recent years resulting in an increased awareness by plaintiffs' lawyers of potentially large recoveries. While some states have enacted tort reform legislation that limits plaintiffs' recoveries in some respects, should our professional liability and general liability increase significantly in the future, we may not be able to increase our revenue sufficiently to cover the cost increases, our operating income could suffer, and we may not be able to meet our obligations to repay our liabilities. For a discussion of recent litigation claims against us, including the Humboldt County Action, see Note 7, "Commitments and Contingencies-Legal Matters" in the notes to the consolidated financial statements included elsewhere in this report.

We also may be subject to lawsuits under the FFCA and comparable state laws for submitting allegedly fraudulent or otherwise inappropriate bills for services to the Medicare and Medicaid programs. These lawsuits, which may be initiated by regulatory authorities as well as private party whistleblowers, can involve significant monetary damages, fines, attorney fees and the award of bounties to private plaintiffs who successfully bring these suits, as well as to the government programs. In recent years, government oversight and law enforcement have become increasingly active and aggressive in investigating and taking legal action against potential fraud and abuse.

We may incur significant liabilities in conjunction with legal actions against us, including as a result of damages, fines and penalties that may be assessed against us, as well as a result of the sometimes significant commitments of financial and management resources that are often required to defend against such legal actions. The incurrence of such liabilities and related commitments of resources could materially and adversely affect our business, financial condition and results of operations.

We could face significant financial difficulties as a result of one or more of the risks discussed in this report, which could cause us to significantly alter our business and/or seek protection under bankruptcy laws or could cause our creditors or government authorities to have a receiver appointed on our behalf.

We could face significant financial difficulties if Medicare or Medicaid reimbursement rates are reduced, patient demand for our services is reduced or we incur unexpected liabilities or expenses, including in connection with legal actions, sanctions, penalties or fines or the other risks discussed in this report. This financial difficulty could cause us to significantly alter our business and/or seek protection under bankruptcy laws or could cause our creditors or government authorities to have a receiver appointed on our behalf.

A significant portion of our business is concentrated in certain geographical markets, and an economic downturn or changes in the laws affecting our business in those markets could have a material adverse effect on our operating results.

For the six months ended June 30, 2013, we received approximately 40.9% of our consolidated revenue from operations in California and 20.3% from Texas. We expect to continue to receive significant portions of our consolidated revenue from those states in the future as well. Accordingly, economic conditions and changes in state healthcare spending prevailing in either of these markets or other markets in which we have significant concentrations could affect the ability of our patients and third-party payors to reimburse us for our services, either through a reduction of the tax base used to generate state funding of Medicaid programs, an increase in the number of indigent patients eligible for Medicaid benefits, changes in state funding levels or healthcare programs or other factors. A continued or prolonged economic downturn, significant changes in state healthcare spending, or changes in the laws affecting our business in these markets could have a material adverse effect on our financial position, results of operations and cash flows.

Failure to maintain effective internal control over our financial reporting could have an adverse effect on our ability to report our financial results on a timely and accurate basis.

We produce our consolidated financial statements in accordance with the requirements of accounting principles generally accepted in the United States of America ("U.S. GAAP"). Effective internal control over financial reporting is necessary for us to provide reliable financial reports, to help mitigate the risk of fraud and to operate successfully. We are required by federal securities laws to document and test our internal control procedures in order to satisfy the requirements of the Sarbanes-Oxley Act of 2002, which requires annual management assessments of the effectiveness of our internal control over financial reporting.

Testing and maintaining our internal control over financial reporting can be expensive and divert our management's attention from other matters that are important to our business. We may not be able to conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with applicable law, or our independent registered public accounting firm may not be able or willing to issue an unqualified attestation report if we conclude that our internal control over financial reporting is not effective. If we fail to maintain effective internal control over financial reporting, or our independent registered public accounting firm is unable to provide us with an unqualified attestation report on our internal control, we could be required to take costly and time-consuming corrective measures, be required to restate the affected historical financial statements, be subjected to investigations and/or sanctions by federal and state securities regulators, and be subjected to civil lawsuits by security holders. Any of the foregoing could also cause investors to lose confidence in our

52

reported financial information and in our company and would likely result in a decline in the market price of our stock and in our ability to raise additional financing if needed in the future.

Changes in the acuity mix of patients as well as payor mix and payment methodologies may significantly reduce our profitability or cause us to incur losses.

Our revenue is affected by our ability to attract a favorable patient acuity mix, and by our mix of payment sources. Changes in the type of patients we attract, as well as our payor mix among private payors, managed care companies, Medicare (both traditional Medicare and "managed" Medicare/Medicare Advantage) and Medicaid, significantly affect our profitability because not all payors reimburse us at the same rates. Particularly, if we fail to maintain our proportion of high-acuity patients or if there is any significant increase in the percentage of our population for which we receive Medicaid reimbursement, our financial position, results of operations and cash flow may be adversely affected. Furthermore, in recent periods we have continued to see a shift from “traditional” fee-for-service Medicare patients to “managed” Medicare (Medicare Advantage) patients.  Reimbursement rates are generally lower for services provided to Medicare Advantage patients than they are for the same services provided traditional fee-for-service Medicare patients.  This trend may continue in future periods.  Our financial results have been negatively affected by this shift to date.  Our financial results will continue to be negatively affected if the trend towards Medicare Advantage continues, and particularly if it accelerates.

It can be difficult to attract and retain qualified nurses, therapists, healthcare professionals and other key personnel, which can increase our costs related to these employees

Our employees are our most important asset. We rely on our ability to attract and retain qualified nurses, therapists and other healthcare professionals. The market for these key personnel is highly competitive, and we could experience significant increases in our operating costs due to shortages in their availability. Like other healthcare providers, we have at times experienced difficulties in attracting and retaining qualified personnel, especially facility administrators, nurses, therapists, certified nurses' aides and other important healthcare personnel. We may continue to experience increases in our labor costs, primarily due to higher wages and greater benefits required to attract and retain qualified healthcare personnel, and such increases may adversely affect our profitability. Furthermore, while we attempt to manage overall labor costs in the most efficient way, our efforts to them through wage freezes and similar means may have limited effectiveness and may lead to increased turnover and other challenges

Tight labor markets and high demand for such employees can contribute to high turnover among clinical professional staff. A shortage of qualified personnel at a facility could result in significant increases in labor costs and increased reliance on overtime and expensive temporary staffing agencies, and could otherwise adversely affect operations at the affected facilities. If we are unable to attract and retain qualified professionals, our ability to adequately provide services to our residents and patients may decline and our ability to grow may be constrained.

If we are unable to comply with state minimum staffing requirements at one or more of our facilities, we could be subject to fines or other sanctions.

Increased attention to the quality of care provided in skilled nursing facilities has caused several states to mandate, and other states to consider mandating, staffing laws that require minimum nursing hours of direct care per resident per day. These minimum staffing requirements further increase the gap between demand for and supply of qualified professionals, and lead to higher labor costs.

We operate a number of facilities in California, which enacted legislation aimed at establishing minimum staffing requirements for facilities operating in that state. This legislation required that the California Department of Public Health ("DPH"), promulgate regulations requiring each skilled nursing facility to provide a minimum of 3.2 nursing hours per patient day. The DPH finalized regulations in 2009 that required three 8-hour shifts for nurse-to-patient staffing, described documentation and notice requirements, and specified procedures for obtaining a waiver from per-shift staffing requirements at skilled nursing facilities. Although DPH finalized the regulations, initial implementation of the statute authorizing the regulations is contingent on an appropriation in the state's annual budged legislation or another statute. Because no appropriation was made and no additional statutes were enacted, the regulations did not become operational. Therefore, DPH will continue its practice of determining a facility's compliance with the 3.2 hour of nursing services per patient day measure in accordance with its internal policy and through on-site reviews conducted during periodic licensing and certification surveys and in response to complaints. If the DPH determines that a facility is out of compliance with this staffing measure, the DPH may issue a notice of deficiency, or a citation, depending on the impact on patient care. A citation carries with it the imposition of significant monetary fines. DPH has issued guidelines, implementing the provisions of newly enacted California laws, for state audits that verify compliance with the 3.2 nursing hours per patient day staffing requirements. If DPH determines under an audit that a facility has failed to meet the minimum staffing requirement for between 5% and 49% of the audited days, a significant administrative monetary penalty will be assessed. If DPH determines that a facility has failed to meet the minimum

53

staffing requirement for more than 49% of the audited days, then a larger administrative monetary penalty will be assessed. The issuance of either a notice of deficiency or a citation requires the facility to prepare and implement an acceptable plan of correction. The Humboldt County Action included allegations that certain of our California skilled nursing facilities failed to meet state-mandated minimum staffing requirements. The Humboldt County Action resulted in a jury verdict against us and certain of our affiliated skilled nursing companies that awarded $677 million in damages. The case was ultimately settled in September 2010, pursuant to which we were required to deposit into escrow a total of $50 million to cover certain settlement costs. For more information regarding the Humboldt County Action and the settlement, as well as a description of our February 2013 settlement with the BMFEA which included a new staffing agreement and an ongoing investigation by the DOJ regarding related staffing considerations, see Note 7, "Commitments and Contingencies-Legal Matters" in the notes to the consolidated financial statements included elsewhere in this report.

Our ability to satisfy any minimum staffing requirements depends upon our ability to attract and retain qualified healthcare professionals, including nurses, certified nurse's assistants and other personnel. Attracting and retaining this personnel is difficult, given a tight labor market for these professionals in many of the markets in which we operate. Furthermore, if states do not appropriate additional funds (through Medicaid program appropriations or otherwise) sufficient to pay for any additional operating costs resulting from minimum staffing requirements, our profitability may be materially adversely affected.

If we fail to attract patients and residents and to compete effectively with other healthcare providers, our revenue and profitability may decline and we may incur losses.

The healthcare services industry is highly competitive. Our skilled nursing facilities compete primarily on a local and regional basis with many long-term care providers, from national and regional chains to smaller providers owning as few as a single nursing center. We also compete under certain circumstances with inpatient rehabilitation facilities and long-term acute care hospitals. Our hospices and home health agencies also compete with local, regional and national companies. We anticipate additional competition in the future from accountable care organizations, as well as HMO's and similar healthcare systems that seek to provide a wider variety of healthcare services to their patients/members. Increased competition could limit our ability to attract and retain patients, maintain or increase rates and occupancy, or to expand our business. Our ability to compete successfully varies from location to location and depends on a number of factors, including the number of competitors in the local market, the types of services available, our local reputation for quality care of patients, achieve or maintain desired census levels, the commitment and expertise of our staff and physicians, our local service offerings and treatment programs, the cost of care in each locality, and the physical appearance, location, age and condition of our facilities. If we are unable to attract patients to our facilities and agencies, particularly high-acuity patients, then our revenue and profitability will be adversely affected. Some of our competitors may have greater recognition and be more established in their respective communities than we are, and may have greater financial and other resources than we have. Competing long-term care companies may also offer newer facilities or different programs or services than we do, which, combined with the foregoing factors, may result in our competitors being more attractive to our current patients, to potential patients and to referral sources. Furthermore, while we budget for routine capital expenditures at our facilities to keep them competitive in their respective markets, to the extent that competitive forces cause those expenditures to increase in the future our financial condition may be negatively affected.

Some of our competitors may accept lower profit margins than we do, which could present significant price competition, particularly for managed care and private pay patients. We believe we utilize a conservative approach in complying with laws prohibiting kickbacks and referral payments to referral sources. However, some of our competitors may use more aggressive methods than we do with this respect to obtaining patient referrals, and as a result competitors may from time to time obtain patient referrals that are not otherwise available to us.

The primary competitive factors for our assisted living, rehabilitation therapy, hospice and home health care services are similar to those for our skilled nursing businesses and include reputation, the cost of services, the quality of services, responsiveness to patient/resident needs and the ability to provide support in other areas such as third-party reimbursement, information management and patient recordkeeping. Furthermore, given the relatively low barriers to entry and continuing healthcare cost containment pressures, we expect that the markets we service will become increasingly competitive in the future. Increased competition in the future could limit our ability to attract and retain patients and residents, maintain or increase our fees, or expand our business.

Insurance coverage may become increasingly expensive and difficult to obtain for health care companies, and our self-insurance may expose us to significant losses.

It may become more difficult and costly for us to obtain coverage for patient care liabilities and certain other risks, including property and casualty insurance. Insurance carriers may require health care companies to significantly increase their self-insured retention levels and/or pay substantially higher premiums for reduced coverage for most insurance coverages, including workers' compensation, employee healthcare and patient care liability.

54

We self-insure a significant portion of our potential liabilities for several risks, including certain types of professional and general liability, workers' compensation and employee healthcare benefits. Due to our self-insured retentions under many of our professional and general liability, workers' compensation and employee healthcare benefits programs, including our election to self-insure against workers' compensation claims in Texas, there is no limit on the maximum number of claims or amount for which we can be liable in any policy period. We base our loss estimates and related accruals on actuarial analyses, which determine expected liabilities on an undiscounted basis, including incurred but not reported losses, based upon the available information on a given date. It is possible, however, for the ultimate amount of losses to exceed our estimates and related accruals, as well as our insurance limits as applicable. In the event our actual liability exceeds our estimates for any given period, our results of operations and financial condition could be materially adversely impacted. Additionally, we may from time to time need to increase our accruals as a result of future actuarial reviews and claims that may develop. Such increases could have an adverse impact on our business and results of operations. An adverse determination in legal proceedings, whether currently asserted or arising in the future, could have a material adverse effect on our business and results of operations.

If our referral sources fail to view us as an attractive health care provider, our patient base would likely decrease.

We rely significantly on appropriate referrals from physicians, hospitals and other healthcare providers in the communities in which we deliver our services to attract the kinds of patients we target. Our referral sources are not obligated to refer business to us and generally also refer business to other healthcare providers. We believe many of our referral sources refer business to us as a result of the quality of our patient service and our efforts to establish and build a relationship with them. If we lose, or fail to maintain, existing relationships with our referral resources, fail to develop new relationships or if we are perceived by our referral sources for any reason as not providing high quality patient care, our volume of referrals would likely decrease, the quality of our patient mix could suffer and our revenue and results of operations could be adversely affected.

If we do not achieve or maintain a reputation for providing high quality of care, our business may be negatively affected.

Our ability to achieve and maintain a reputation for providing high quality of care to our patients at each of our skilled nursing and assisted living facilities, or through our rehabilitation therapy, hospice and home health businesses, is important to our ability to attract and retain patients, particularly high-acuity patients. In some instances, our referral sources are affiliated with health care systems that may have affiliated businesses that offer services that compete with ours, and the frequency of this occurring may increase in the future as accountable care organizations are formed in the markets we serve. We believe that the perception of our quality of care by a potential patient or potential patient's family seeking to contract for our services is influenced by a variety of factors, including doctor and other healthcare professional referrals, community information and referral services, newspapers and other print and electronic media, results of patient surveys, recommendations from family and friends, and quality care statistics or rating systems compiled and published by CMS or other industry data. Through our focus on retaining high quality staffing, reviewing feedback and surveys from our patients and referral sources to highlight areas of improvement and integrating our service offerings at each of our facilities, we seek to maintain and improve on the outcomes from each of the factors listed above in order to build and maintain a strong reputation at our facilities. If any of our companies fail to achieve or maintain a reputation for providing high-quality care, or is perceived to provide a lower quality of care than competitors within the same geographic area, our ability to attract and retain patients would be adversely affected. If our businesses fail to maintain a strong reputation in the areas in which we operate, our business, revenue and profitability could be adversely affected.

We may be unable to reduce costs to offset decreases in our patient census levels or other expenses completely.

We depend on implementing adequate cost management initiatives in response to fluctuations in levels of patient census in our businesses in order to maintain our current cash flow and earnings levels. Fluctuation in our patient census levels may become more common as we continue our emphasis in our skilled nursing facilities on patients with shorter stays but higher acuities. A decline in patient census levels would likely result in decreased revenue. If we are unable to put in place corresponding reductions in costs in response to decreases in our patient census or other revenue shortfalls, our financial condition and operating results could be adversely affected.

We may not be fully reimbursed for all services that our skilled nursing facilities are able to bill through Medicare's consolidated billing requirements.

Skilled nursing facilities are required to bill Medicare on a consolidated basis for certain items and services that they furnish to patients and residents, regardless of the amount or costs of services that the patients and residents actually receive. The consolidated billing requirement essentially confers on the skilled nursing facility itself the Medicare billing responsibility for the entire package of care that its residents receive in these situations. Federal law also requires that post-hospitalization skilled nursing services be “bundled” into the hospital's Diagnostic Related Group ("DRG") payment in certain circumstances. Where this rule applies, the hospital and the skilled nursing facility must, in effect, divide the payment which otherwise would have been paid to the hospital alone for the patient's treatment, and no additional funds are paid by Medicare for skilled nursing

55

care of the patient. This requirement may, in instances where it is applicable, have a negative effect on skilled nursing facility utilization/census and payments, either because hospitals may find it difficult to place patients in skilled nursing facilities which will not be paid as they previously were, or because hospitals are reluctant to discharge patients to skilled nursing facilities and lose a portion of the payment that the hospital would otherwise receive. This bundling requirement could be extended to more DRGs in the future, which could exacerbate the potentially negative impact on skilled nursing facility utilization/census and payments. As a result of the bundling requirements we may not be fully reimbursed for all services that a facility bills through consolidated billing, which could adversely affect our results of operations and financial condition.

Consolidation of managed care organizations and other third-party payors or reductions in reimbursement from these payors may adversely affect our revenue and income or cause us to incur losses.

Managed care organizations and other third-party payors have in many instances consolidated in order to enhance their ability to influence the delivery of healthcare services. Consequently, the healthcare needs of a large percentage of the United States population are increasingly served by a small number of managed care organizations. These organizations generally enter into service agreements with a limited number of providers for needed services. These organizations have become an increasingly important source of revenue and referrals for us. To the extent that such organizations terminate us as a preferred provider or engage our competitors as a preferred or exclusive provider, our business could be materially adversely affected.

In addition, private third-party payors, including managed care payors, are continuing their efforts to control healthcare costs through direct contracts with healthcare providers, increased utilization reviews, or reviews of the propriety of, and charges for, services provided, and greater enrollment in managed care programs and preferred provider organizations. As these private payors increase their purchasing power, they are demanding discounted fee structures and the assumption by healthcare providers of all or a portion of the financial risk associated with the provision of care. Significant reductions in reimbursement from these sources could materially adversely affect our business and financial condition.

Delays in reimbursement may cause liquidity problems.

If we have information systems problems or payment or other issues arise with Medicare, Medicaid or other payors that affect the amount or timeliness of reimbursements, we may encounter delays in our payment cycle. Any significant payment timing delay could cause us to experience working capital shortages. As a result, working capital management, including prompt and diligent billing and collection, is an important factor in our consolidated results of operations and liquidity. Our working capital management procedures may not successfully mitigate the effects of any delays in our receipt of payments or reimbursements. Accordingly, such delays could have an adverse effect on our liquidity and financial condition.

Our rehabilitation and other related healthcare services are also subject to delays in reimbursement, as we act as vendors to other providers who in turn must wait for reimbursement from other third-party payors. Each of these customers is therefore subject to the same potential delays to which our nursing homes are subject, meaning any such delays would further delay the date we would receive payment for the provision of our related healthcare services. To the extent we grow and expand the rehabilitation and other complementary services that we offer to third parties, we may incur increasing delays in payment for these services, and these payment delays could have an adverse effect on our liquidity and financial condition. We may also experience delays in reimbursement related to change of ownership applications for our acquired facilities, as well as changes in fiscal intermediaries.

Our success is dependent upon retaining key personnel.

Our senior management team has extensive experience in the healthcare industry. We believe that they have been instrumental in guiding our businesses, instituting valuable performance and quality monitoring, and driving innovation. Accordingly, our future performance is substantially dependent upon the continued services of our senior management team. The loss of the services of any of these persons could have a material adverse effect upon us.

As previously disclosed, Boyd W. Hendrickson, our Chairman of the Board and Chief Executive Officer, has informed the Board of Directors of his desire to retire from his role as Chief Executive Officer around the end of 2013. If we are unable to find a suitable successor to Mr. Hendrickson, we may not be able to successfully manage our business. During the second quarter of 2013, we also eliminated/consolidated certain management positions in an effort to streamline our leadership and reduce labor costs. We incurred approximately $1.5 million in severance costs as a result of these actions, which we do not anticipate will continue in future periods. However, any additional restructuring efforts could result in significant severance-related costs, and lead to difficulty in retaining and attracting talented management.

Future acquisitions may use significant resources, may be unsuccessful and could expose us to unforeseen liabilities.

We intend to selectively pursue acquisitions of skilled nursing facilities, assisted living facilities, home health companies, hospice agencies and other related healthcare operations. Acquisitions may involve significant cash expenditures, debt incurrence, operating losses and additional expenses that could have a material adverse effect on our financial position, results of operations and liquidity. Acquisitions involve numerous risks, including:

56

• difficulties integrating acquired operations, personnel and accounting and information systems, or in realizing projected efficiencies and cost savings;

• diversion of management's attention from other business concerns;

• potential loss of key employees or customers of acquired companies;

• entry into markets in which we may have limited or no experience;

• increasing our indebtedness and limiting our ability to access additional capital when needed;

• assumption of unknown liabilities or regulatory issues of acquired companies, including failure to comply with healthcare regulations or to establish internal financial controls; and

• straining of our resources, including internal controls relating to information and accounting systems, regulatory compliance, logistics and others.

 Furthermore, certain of the foregoing risks could be exacerbated when combined with other growth measures that we may pursue.

Global economic conditions may impact our ability to obtain additional financing on commercially reasonable terms or at all and our ability to expand our business may be harmed.

Recent global market and economic conditions have been very challenging with tight credit conditions and slow or negative economic growth in most major economies generally expected to continue in 2013 and possibly beyond. Ongoing concerns about the systemic impact of potential long-term and widespread economic recession or stagnation, energy costs, geopolitical issues, sovereign debt issues, the availability and cost of credit, and the global real estate and mortgage markets have contributed to increased market volatility, uncertainty and liquidity issues for both borrowers and investors. These conditions, combined with volatile prices for energy, food and other commodities, unstable business and consumer confidence, and significant unemployment, have contributed to pronounced economic volatility.

As a result of these market conditions, the cost and availability of credit has been and may continue to be adversely affected by illiquid credit markets, interest rate fluctuations and wider credit spreads. Concern about the stability of the markets generally and the strength of counterparties specifically has led many lenders and institutional investors to reduce, and in some cases, cease to provide credit to businesses and consumers. These factors have led to a decrease in spending by businesses and consumers alike, and a corresponding decrease in global infrastructure spending. Continued turbulence in the U.S. and international markets and economies and prolonged declines or stagnation in business and consumer spending may adversely affect our liquidity and financial condition, and the liquidity and financial condition of our customers, including our ability to refinance maturing liabilities and access the capital markets to meet liquidity needs. If we are not able to timely retire or refinance our senior secured credit facility on acceptable terms at or before its stated maturity in April 2015 (for the revolving portion) and April 2016 (for the term portion), due to market conditions or otherwise, our liquidity, financial condition, business and operating results could be materially and adversely affected.

If our ability to borrow under our senior secured credit facility is insufficient for our capital requirements, we will be required to seek additional sources of financing, including issuing equity, which may be dilutive to our current stockholders or incurring additional debt. Our ability to incur additional debt is subject to the restrictions in our senior secured credit facility. There can be no assurance that the restrictions contained in our senior secured credit facility will permit us to borrow the funds that we need to finance our operations, or that additional debt will be available to us on commercially reasonable terms or at all. Furthermore, market conditions may impede our ability to secure additional sources of financing, whether through the extension of our existing senior secured credit facility or by accessing the debt and/or equity markets. If we are unable to obtain funds sufficient to finance our capital requirements, we may have to forego opportunities to expand our business, including the acquisition or development of additional or expanded facilities.

Our substantial indebtedness could adversely affect our financial health and prevent us from fulfilling our financial obligations.

We have now and will for the foreseeable future continue to have a significant amount of indebtedness. At June 30, 2013, our total indebtedness was approximately $445.5 million. Our substantial indebtedness could have important consequences. For example, it could:

• increase our vulnerability to adverse economic and industry conditions;

• require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, thereby reducing the availability of our cash flow to fund working capital, capital expenditures and other general corporate purposes;

• limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;

• place us at a competitive disadvantage compared to our competitors that have less debt;

• increase the cost or limit the availability of additional financing, if needed or desired, to fund future working capital, capital expenditures and other general corporate requirements, or to carry out other aspects of our business plan;

• require us to maintain debt coverage and financial ratios at specified levels, reducing our financial flexibility; and

57

• limit our ability to make strategic acquisitions and develop new or expanded facilities.

In addition, if we are unable to generate sufficient cash flow or otherwise obtain funds necessary to make required debt payments, or if we fail to comply with the various covenants and requirements of our senior secured credit facility or other existing or future indebtedness, we would be in default, which could permit the holders of our indebtedness, including our senior secured credit facility, to accelerate the maturity of indebtedness, as the case may be. Any default under our senior secured credit facility, or our other existing or future indebtedness, as well as any of the above-listed factors, could have a material adverse effect on our business, operating results, liquidity and financial condition.

58

Despite our substantial indebtedness, we may still be able to incur more debt. This could intensify the risks associated with this indebtedness.

The terms of our senior secured credit facility contain restrictions on our ability to incur additional indebtedness. These restrictions are subject to a number of important qualifications and exceptions, and the indebtedness incurred in compliance with these exceptions could be substantial. Accordingly, we could incur significant additional indebtedness in the future. The more we become leveraged, the more we become exposed to the risks described above under “Our substantial indebtedness could adversely affect our financial health and prevent us from fulfilling our financial obligations.”

Floating rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase.

Borrowings under our senior secured credit facility are subject to floating rates of interest over an interest rate floor of 1.5%. If interest rates increase over the floor, our debt service obligations on our variable rate indebtedness would increase even though the amount borrowed remained the same, and our net income and cash flows would correspondingly decrease. As of April 12, 2012, we increased the size of the term loan by $100.0 million. The incremental term loan bears interest at LIBOR (subject to a floor of 1.50%) plus a margin of 5.25%. As part of the refinancing, the interest rate on the existing term loan was amended to match the interest rate of the incremental term loan. The interest rate on the existing revolving credit facility was also amended to LIBOR plus a margin of 4.50%. There is no longer a LIBOR floor on the revolving credit facility.

Our operations are subject to environmental and occupational health and safety regulations, which could subject us to fines, penalties and increased operational costs.

We are subject to a wide variety of federal, state and local environmental and occupational health and safety laws and regulations. Regulatory requirements faced by healthcare providers such as us include those relating to air emissions, wastewater discharges, air and water quality control, occupational health and safety (such as standards regarding blood-borne pathogens and ergonomics), management and disposal of low-level radioactive medical waste, biohazards and other wastes, management of explosive or combustible gases, such as oxygen, specific regulatory requirements applicable to asbestos, lead-based paints, polychlorinated biphenyls and mold, other occupational hazards associated with our workplaces, and providing notice to employees and members of the public about our use and storage of regulated or hazardous materials and wastes. Failure to comply with these requirements could subject us to fines, penalties and increased operational costs. Moreover, changes in existing requirements or more stringent enforcement of them, as well as discovery of currently unknown conditions at our owned or leased facilities, could result in additional cost and potential liabilities, including liability for conducting cleanup, and there can be no guarantee that such increased expenditures would not be significant.

A portion of our workforce is unionized and our operations may be adversely affected by work stoppages, strikes or other collective actions.

As of June 30, 2013, approximately 570 of our 14,950 active employees were represented by unions and covered by collective bargaining agreements. In addition, certain labor unions have publicly stated that they are concentrating their organizing efforts within the long-term healthcare industry. We cannot predict the effect that continued union representation or future organizational activities will have on our business or future operations. There can be no assurance that we will not experience a material work stoppage in the future.

Disasters and similar events may seriously harm our business.

Natural and man-made disasters and similar events, including terrorist attacks and acts of nature such as hurricanes, tornados, earthquakes, floods and wildfires, may cause damage or disruption to us, our employees and our facilities, which could have an adverse impact on our patients and our business. In order to provide care for our patients, we are dependent on consistent and reliable delivery of food, pharmaceuticals, utilities and other goods to our facilities, and the availability of employees to provide services at our facilities and other locations. If the delivery of goods or the ability of employees to reach our facilities and patients were interrupted in any material respect due to a natural disaster or other reasons, it would have a significant impact on our business. For example, in connection with Hurricane Katrina in New Orleans, several nursing home operators unaffiliated with us were accused of not properly caring for their residents, which resulted in, among other things, criminal charges being filed against the proprietors of those facilities. Furthermore, the impact, or impending threat, of a natural disaster has in the past and may in the future require that we evacuate one or more facilities, which would be costly and would involve risks, including potentially fatal risks, for the patients and employees. The impact of disasters and similar events is inherently uncertain. Such events could harm our patients and employees, severely damage or destroy one or more of our facilities, harm our business, reputation and financial performance, or otherwise cause our business to suffer in ways that we currently cannot predict.

The operation of our business is dependent on effective and secure information systems.

We depend on several information technology systems for the efficient functioning of our business. The software programs supporting these systems are licensed to us by independent software developers. Our inability or the inability of these developers, to continue to maintain and upgrade these information systems and software programs could disrupt or reduce the

59

efficiency of our operations. In addition, costs and potential problems and interruptions associated with the implementation of new or upgraded systems and technology or with maintenance or adequate support of existing systems could also disrupt or reduce the efficiency of our operations. Furthermore, while we budget for the changes and upgrades to our information technology systems that we anticipate needing over time, it is possible that we may underestimate the actual costs of those changes and upgrades. Failure to make necessary changes and upgrades due to financial or other concerns could negatively impact the effectiveness of our information technology systems, as well as our operations and financial performance.

Additionally, we maintain information necessary to conduct our business, including confidential and proprietary information as well as personal information regarding our patients, employees and others with whom we do business, in digital form. Data maintained in digital form is subject to the risk of tampering, theft and unauthorized access. We develop and maintain systems to prevent this from occurring, but the development and maintenance of these systems is costly and requires ongoing monitoring and updating as technologies change and efforts to overcome security measures become more sophisticated. Moreover, despite our efforts, the possibility of tampering, theft and other unauthorized access cannot be eliminated entirely, and risks associated with each of these remain. If our information technology systems are compromised and personal or other protected information regarding patients, employees or others with whom we do business is stolen, tampered with or otherwise improperly accessed, our ability to conduct our business and our reputation may be impaired. If personal or other protected information of our patients, employees or others with whom we do business is tampered with, stolen or otherwise improperly accessed, and we may incur significant costs to remediate possible injury to the affected persons, compensate the affected persons, pay any applicable fines, or take other action with respect to judicial or regulatory actions arising out of the incident, including under HIPAA or the HITECH Act, as applicable.

Risks Related to Ownership of Our Class A Common Stock

We are controlled by Onex Corporation, whose interests may conflict with yours.

Our Class A common stock has one vote per share, while our Class B common stock has ten votes per share, on all matters voted on by our stockholders. As of June 30, 2013, Onex Corporation, its affiliates and certain of our directors and members of our senior management who are party to a voting agreement with an affiliate of Onex Corporation owned shares of common stock representing over 75.0% of the combined voting power of our outstanding common stock. Accordingly, Onex Corporation generally has the power to control the outcome of matters on which stockholders are entitled to vote. Such matters include the election and removal of directors, the adoption or amendment of our certificate of incorporation and bylaws, possible mergers, corporate control contests and significant transactions. Through its control of elections to our board of directors, Onex Corporation may also have the ability to appoint or replace our senior management and cause us to issue additional shares of our common stock or repurchase common stock, declare dividends or take other actions. Onex Corporation may make decisions regarding our company and business that are opposed to our other stockholders’ interests or with which they disagree. Onex Corporation may also delay or prevent a change of control of us, even if the change of control would benefit our other stockholders, which could deprive our other stockholders of the opportunity to receive a premium for their Class A common stock. The significant concentration of stock ownership and voting power may also adversely affect the trading price of our Class A common stock due to investors’ perception that conflicts of interest may exist or arise. To the extent that the interests of our public stockholders are harmed by the actions of Onex Corporation, the price of our Class A common stock may be harmed.

Additionally, Onex Corporation is in the business of making investments in companies and currently holds, and may from time to time in the future acquire, controlling interests in businesses engaged in the healthcare industries that complement or directly or indirectly compete with certain portions of our business. Further, if it pursues such acquisitions in the healthcare industry, those acquisition opportunities may not be available to us.

If our stock price is volatile, purchasers of our Class A common stock could incur substantial losses.

Our stock price has been and is likely to continue to be volatile. The stock market in general often experiences substantial volatility that is seemingly unrelated to the operating performance of particular companies. These broad market fluctuations may adversely affect the trading price of our Class A common stock. The price for our Class A common stock may be influenced by many factors, including:

• the depth and liquidity of the market for our Class A common stock;

• developments generally affecting the healthcare industry;

• investor perceptions of us and our business;

• actions by institutional or other large stockholders;

• strategic actions, such as acquisitions or restructurings, or the introduction of new services by us or our competitors;

• new laws or regulations or new interpretations of existing laws or regulations applicable to our business;

• litigation and governmental investigations;

60

• changes in accounting standards, policies, guidance, interpretations or principles;

• adverse conditions in the financial markets, state and federal government or general economic conditions, including those resulting from statewide, national or global financial and deficit considerations, overall market conditions, war, incidents of terrorism and responses to such events;

• sales of Class B common stock by Onex, us or members of our management team;

• additions or departures of key personnel; and

• our results of operations, financial performance and future prospects.

These and other factors may cause the market price and demand for our Class A common stock to fluctuate substantially, which may limit or prevent investors from readily selling their shares of Class A common stock and may otherwise negatively affect the liquidity of our Class A common stock. In addition, in the past, when the market price of a stock has been volatile, holders of that stock have sometimes instituted securities class action litigation against the company that issued the stock. If any of our stockholders brought a lawsuit against us, we could incur substantial costs defending or settling the lawsuit. Such a lawsuit could also divert the time and attention of our management from our business.

If securities or industry analysts do not publish research or reports about our business, if they change their recommendations regarding our stock adversely or if our operating results do not meet their expectations, our stock price and trading volume could decline.

The trading market for our Class A common stock is significantly influenced by the research and reports that industry or securities analysts publish about us or our business. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline. Moreover, if one or more of the analysts who cover us downgrade our stock or if our operating results do not meet their expectations, our stock price could decline.

We do not intend to pay dividends on our common stock.

We do not anticipate paying any cash dividends on our common stock in the foreseeable future. We currently anticipate that we will retain all of our available cash, if any, for use as working capital and for other general purposes, including to service or repay our debt and to fund the operation and expansion of our business. Any payment of future dividends will be at the discretion of our board of directors and will depend on, among other things, our earnings, financial condition, capital requirements, level of indebtedness, statutory and contractual restrictions applying to the payment of dividends and other considerations that our board of directors deems relevant.

We are a “controlled company” within the meaning of NYSE rules and, as a result, qualify for and rely on exemptions from certain corporate governance requirements.

Onex Corporation and its affiliates control a majority of the voting power of our outstanding common stock. Under the NYSE rules, a company of which more than 50% of the voting power is held by another person or group of persons acting together is a “controlled company” and may elect not to comply with certain NYSE corporate governance requirements, including the requirements that:

• a majority of the board of directors consist of independent directors;

• the nominating and corporate governance committee be entirely composed of independent directors with a written charter addressing the committee’s purpose and responsibilities;

• the compensation committee be entirely composed of independent directors with a written charter addressing the committee’s purpose and responsibilities; and

• there be an annual performance evaluation of the nominating and corporate governance and compensation committees.

We elect to be treated as a controlled company and thus utilize some of these exemptions. In addition, although we currently have a board composed of a majority of independent directors and have adopted charters for our audit, corporate governance, quality and compliance and compensation committees, and intend to conduct annual performance evaluations for these committees, none of these committees are composed entirely of independent directors, except for our audit committee. Accordingly, you may not have the same protections afforded to stockholders of companies that are subject to all of NYSE corporate governance requirements.

Our amended and restated certificate of incorporation, bylaws and Delaware law contain provisions that could discourage transactions resulting in a change in control, which may negatively affect the market price of our Class A common stock.

In addition to the effect that the concentration of ownership and voting power in our significant stockholders may have, our amended and restated certificate of incorporation and our amended and restated bylaws contain provisions that may enable our management to resist a change in control. These provisions may discourage, delay or prevent a change in the ownership of our company or a change in our management, even if doing so might be beneficial to our stockholders. In addition, these

61

provisions could limit the price that investors would be willing to pay in the future for shares of our Class A common stock. The provisions in our amended and restated certificate of incorporation or amended and restated bylaws include:

• our board of directors is authorized, without prior stockholder approval, to create and issue preferred stock, commonly referred to as “blank check” preferred stock, with rights senior to those of our Class A common stock and Class B common stock;

• advance notice requirements for stockholders to nominate individuals to serve on our board of directors or to submit proposals that can be acted upon at stockholder meetings; provided, that prior to the date that the total number of outstanding shares of our Class B common stock is less than 10% of the total number of shares of common stock outstanding, which we refer to as the "Transition Date," no such requirement is required for holders of at least 10% of our outstanding Class B common stock;

• our board of directors is classified so not all of the members of our board of directors are elected at one time, which may make it more difficult for a person who acquires control of a majority of our outstanding voting stock to replace our directors;

• following the Transition Date, stockholder action by written consent will be prohibited;

• special meetings of the stockholders are permitted to be called only by the chairman of our board of directors, our chief executive officer or by a majority of our board of directors;

• stockholders are not permitted to cumulate their votes for the election of directors;

• newly created directorships resulting from an increase in the authorized number of directors or vacancies on our board of directors will be filled only by majority vote of the remaining directors;

• our board of directors is expressly authorized to make, alter or repeal our bylaws; and

• stockholders are permitted to amend our bylaws only upon receiving at least 66 2/3% of the votes entitled to be cast by holders of all outstanding shares then entitled to vote generally in the election of directors, voting together as a single class.

After the Transition Date, we will also be subject to the provisions of Section 203 of the Delaware General Corporation Law, which may prohibit certain business combinations with stockholders owning 15% or more of our outstanding voting stock. These and other provisions in our amended and rested certificate of incorporation, amended and restated bylaws and Delaware law could discourage acquisition proposals and make it more difficult or expensive for stockholders or potential acquirers to obtain control of our board of directors or initiate actions that are opposed by our then-current board of directors, including delaying or impeding a merger, tender offer or proxy contest involving us. Any delay or prevention of a change of control transaction or changes in our board of directors could cause the market price of our Class A common stock to decline.

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

The table below sets forth information with respect to purchases of our Class A common stock made by us or on our behalf during the quarter ended June 30, 2013:

Period	Total Number of Shares Purchased (1)	Average Price Paid per Share		Total Number of Shares Purchase as Part of Publicly Announced Plans or Programs	Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
April 1 - 30, 2013	—	$	—	n/a	n/a
May 1 - 31, 2013	2,374	$	6.74	n/a	n/a
June 1 - 30, 2013	—	$	—	n/a	n/a
Total:	2,374	$	6.74	n/a	n/a

(1) Reflects shares forfeited to us upon the vesting of restricted stock granted to participants in our 2007 Incentive Award Plan, to satisfy applicable tax withholding obligations with respect to such vesting. We did not have any publicly announced plans or programs to purchase our Class A common stock in the quarter ended June 30, 2013.

Item 3.Defaults Upon Senior Securities

None.

Item 4.Mine Safety Disclosures

None.

62

Item  5.Other Information

None.

63

Item 6.Exhibits

(a) Exhibits.

Number	Description
10.1*	Employment Transition Offer Letter, dated June 28, 2013, with Matt Moore.
10.2*	Employment Transition Offer Letter, dated June 28, 2013, with Chris Felfe.
10.3	Amendment No.1, dated as of June 6, 2013, to the Fourth Amended and Restated Credit Agreement, dated as of April 12, 2012, by and among Skilled Healthcare Group, Inc., certain subsidiary guarantors, Credit Suisse AG, as administrative agent and collateral agent, Credit Suisse Securities (USA) LLC, as amendment arranger, and certain lenders and other parties thereto. (Filed as Exhibit 10.1 to our Current Report on Form 8-K filed on June 6, 2013, and incorporated herein by reference).
31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32**	Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	The following financial information from our Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 as filed with the SEC on August 5, 2013, formatted in Extensible Business Reporting Language (XBRL): (i) the condensed consolidated balance sheets at June 30, 2013 and December 31, 2012, and (ii) the condensed consolidated statements of operations for the three months ended June 30, 2013 and June 30, 2012, and (iii) the condensed consolidated statements of comprehensive income for the three ended June 30, 2013 and June 30, 2012, and (iv) the condensed consolidated statements of cash flows the six months ended June 30, 2013 and June 30, 2012, and (v) the Notes to Condensed Consolidated Financial Statements.

 *    Management contract or compensatory plan or arrangement.

** Furnished herewith and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

64

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		SKILLED HEALTHCARE GROUP, INC.
Date:	August 5, 2013	/s/ Christopher N. Felfe
		Christopher N. Felfe
		Acting Chief Financial Officer
		(Principal Financial Officer, Principal Accounting Officer, and Authorized Signatory)

65

EXHIBIT INDEX

Number	Description
10.1*	Employment Transition Offer Letter, dated June 28, 2013, with Matt Moore.
10.2*	Employment Transition Offer Letter, dated June 28, 2013, with Chris Felfe.
10.3	Amendment No.1, dated as of June 6, 2013, to the Fourth Amended and Restated Credit Agreement, dated as of April 12, 2012, by and among Skilled Healthcare Group, Inc., certain subsidiary guarantors, Credit Suisse AG, as administrative agent and collateral agent, Credit Suisse Securities (USA) LLC, as amendment arranger, and certain lenders and other parties thereto. (Filed as Exhibit 10.1 to our Current Report on Form 8-K filed on June 6, 2013, and incorporated herein by reference).
31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32**	Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	The following financial information from our Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 as filed with the SEC on August 5, 2013, formatted in Extensible Business Reporting Language (XBRL): (i) the condensed consolidated balance sheets at June 30, 2013 and December 31, 2012, and (ii) the condensed consolidated statements of operations for the three months ended June 30, 2013 and June 30, 2012, and (iii) the condensed consolidated statements of comprehensive income for the three ended June 30, 2013 and June 30, 2012, and (iv) the condensed consolidated statements of cash flows the six months ended June 30, 2013 and June 30, 2012, and (v) the Notes to Condensed Consolidated Financial Statements.

*        Management contract or compensatory plan or arrangement.

 ** Furnished herewith and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

66

EX-10.1

Exhibit 10.1

Via E-Mail (mmoore@skilledhc.com)

June 27, 2013

Matt Moore

14 Ginger Lily Court

Coto de Caza, CA 92679

RE: Employment Transition Offer Letter

Dear Matt:

I am happy to formally extend an offer to you, in conjunction with the internal restructuring efforts of our consolidated group of companies, to transition to a new role as Executive Director assigned to and employed by The Clairmont Tyler in Tyler, TX, with oversight and support responsibilities for Colonial Tyler Care Center and Clairmont Longview as well. In your new position you will also serve as the licensed Administrator for The Clairmont Tyler and will be employed directly by that facility. Your annual base salary for the new position will be $200,000, payable in accordance with the facility’s standard payroll practices and less applicable withholding taxes. You will also be eligible to participate in the company’s Performance Incentive Plan (PIP) at a level consistent with other LTC Executive Directors, which is currently at a target bonus of 17.5% of base salary. Any bonus earned for 2013 will be prorated between your participation in the PIP in your current position (from the beginning of this year until you assume your new position as an Executive Director) and your participation in the PIP in your new position (for the remainder of the year). The general terms and conditions of the respective PIP’s will not change as a result of your transition, and will continue to apply.

We will also reimburse you for up to $25,000 in out-of-pocket expenses that you may incur in connection with relocating your family from Orange County to the Tyler area. You should submit the applicable reimbursement requests through the company’s standard expense reimbursement process. We will also pay you a special bonus of $110,000. The special bonus will be payable in a lump sum with the first full payroll cycle after you assume your new position in Texas. Please note that applicable tax laws will require us to withhold certain taxes from the special bonus, and some portion of the relocation expense reimbursement could be taxable to you as well. (Please know that we are not providing any tax advice, and instead you should consult with your own tax advisor to determine the taxability of any payments you receive as contemplated by this letter.)

This offer contemplates your continuous service to affiliates of Skilled Healthcare Group, Inc., and as such your outstanding equity incentive awards will remain in place and vest in accordance with their terms for so long as your employment continues. Beginning in February 2014, you will be eligible for grants of equity incentive awards at an Executive Director level. As always, all grants of equity incentive awards are at the discretion of the Skilled Healthcare Group, Inc. Compensation Committee, and are subject to the terms and conditions set forth in the respective award agreements.

The changes with respect to your position, duties, base salary, and benefit allocations will be effective on August 1, 2013, unless we mutually agree otherwise in writing. We will work with the governing body of The Clairmont Tyler to coordinate your formal appointment as licensed administrator of that facility as of that effective date. In mutual consideration of the matters set forth in this letter, and upon its acceptance by you, your existing employment agreement, dated as of April 1, 2010, as amended to date, will terminate and neither party will have any further rights and obligations thereunder (including, by way of example, with respect to any severance matters). However, the provisions of Section 5 (Competition) of your April 1, 2010 employment agreement are incorporated herein by reference, mutatis mutando, and those provisions will apply as though they were set forth in full herein.

SKILLED HEALTHCARE, LLC ♦27442 PORTOLA PARKWAY, SUITE 200 ♦ FOOTHILL RANCH, CA 92610 ♦ 949.282.5800

June 28, 2013

Page 2    

You will continue to be eligible to participate in the company’s medical, dental, vision, life and disability insurance, 401(k) and other benefit programs consistent with other company employees in similar positions. You will continue to be expected to abide by all applicable company policies and procedures.

While we hope to continue to work together for years to come, as is currently the case, you will continue to be an at-will employee, which means that either you or the employer may terminate your employment at any time, for any reason or no reason, consistent with applicable law. However, to give you additional peace of mind, upon your acceptance of this offer, if your employment with us or The Clairmont Tyler, as applicable, is thereafter terminated by the employer without cause at any time on or before the first anniversary of your acceptance of this offer (excluding, of course as part of any mutually agreed-upon transfer of your employment to another Skilled Healthcare affiliate, including as part of this offer), then upon your execution and delivery (and non-revocation) of a mutually satisfactory separation agreement and release consistent with one attached to your above-referenced employment agreement, we will pay you (i) a lump sum separation payment of $200,000 (potentially prorated as described below), plus (ii) a lump sum amount equal to 12 months of COBRA continuation fees for you and your family based upon the benefits plans in which you are enrolled at the time of termination (potentially prorated as described below), plus (iii) an amount equal to the special bonus to the extent the special bonus had not already been paid at the time of termination (e.g., if the termination were to occur before you assume your new role in Texas). All of the foregoing payments will be net of any applicable required tax withholdings, and in the case of the payments described in the foregoing clauses (i) and (ii), the amount actually due and payable will be prorated downwards by 1/12 on each monthly anniversary that occurs between your acceptance of this offer and the effective date of the termination without cause.

On behalf of Boyd, Roland, myself and the board, we are sincerely grateful that you have decided to remain as part of the Skilled Healthcare family in this new role. Your skills and experience will be a great asset to the nursing facilities, residents and other employees that you serve, and you will continue to be a valuable member of the Skilled Healthcare family. We look forward to great success for you and the company as we move things forward.

Please do not hesitate to let me know if you have any questions or would otherwise like to discuss anything. If you are in agreement with the matters set forth in this letter, please countersign below and return a copy to me at your earliest convenience.

Sincerely,

/s/ Jose Lynch

Jose Lynch

President and Chief Operating Officer

Skilled Healthcare, LLC

ACKNOWLEDGED AND AGREED:

/s/ Matt Moore

Matt Moore

Date: 6/28/13

SKILLED HEALTHCARE, LLC ♦27442 PORTOLA PARKWAY, SUITE 200 ♦ FOOTHILL RANCH, CA 92610 ♦ 949.282.5800

EX-10.2

Exhibit 10.2

Via E-Mail (cfelfe@skilledhc.com)

June 28, 2013

Chris Felfe

1524 Sylvia Ln.

Newport Beach, CA 92660

RE: Employment Transition Offer Letter

Dear Chris:

I am happy to formally extend an offer to you, in conjunction with the internal restructuring efforts of our consolidated group of companies, to promote you to a new role as Acting Chief Financial Officer for the company and its parent, Skilled Healthcare Group, Inc. You will also continue to serve as Principal Accounting Officer. In your new role you will report to the Chief Executive Officer of Skilled Healthcare Group, Inc. and will have such duties and authority as may from time to time be assigned to you by the Chief Executive Officer.

Effective upon your assumption of the new role, your base salary will be increased to $325,000 per annum, payable in accordance with the company’s standard payroll practices and less applicable withholding taxes. You will also be eligible to participate in the company’s executive bonus plan at the Chief Financial Officer level, which is currently at a target bonus of 60.0% of base salary and presumes you will substantially assume the CFO goals previously set with the Compensation committee for the balance of the calendar year, the details of which will be finalized with you and Boyd in the next few weeks. Any bonus earned for 2013 will be prorated between your current bonus plan (from the beginning of this year until you assume your new position) and the CFO bonus plan (for the remainder of the year). The general terms and conditions of the respective bonus plans will not change as a result of your transition, and will continue to apply.

In conjunction with this change, effective upon your acceptance of this offer, the severance provisions in Section 3(d)(i) and (ii) of your current employment agreement, dated as of August 11, 2009, will be deemed to be modified to provide for nine months’ worth of severance pay and benefits premium cost coverage, as opposed to the six months of each as currently provided in the employment agreement.

The changes to your employment and compensation arrangements as described in this letter will be effective July 8, 2013, unless we mutually agree otherwise in writing.

This letter agreement constitutes an amendment of your existing employment agreement, but except as your terms and conditions of employment have been modified as set forth in this letter agreement, your existing employment agreement remains in full force and effect in accordance with its terms.

SKILLED HEALTHCARE, LLC ♦27442 PORTOLA PARKWAY, SUITE 200 ♦ FOOTHILL RANCH, CA 92610 ♦ 949.282.5800

June 28, 2013

Page 2

As you know, the company’s current Chief Executive Officer intends to retire in the foreseeable future, at which time someone else will succeed him in that position. The new Chief Executive Officer may desire to appoint a different person as acting or permanent Chief Financial Officer,

in which case your employment may be terminated or you may be asked to revert to a Senior Vice President role with the company. In the event that the new Chief Executive Officer determines to ask you to revert to a Senior Vice President role, he or she will notify you of that decision in writing and indicate the effective date of the change (which will be on or after the date of the notice). On the effective date of you reverting to a Senior Vice President role, the new compensation arrangements set out in this letter for you in the Acting Chief Financial Officer role will automatically revert back to what they were immediately prior to the effectiveness of this letter agreement, other than the severance provisions, which will stay at 9 months as described above. In effect, other than with respect to severance as discussed above and the specific job title and function of the new Senior Vice President role, you will be put back into the same position, with respect to compensation, etc., that you are in today. If and when that occurs, your current employment agreement will be deemed to have been further amended to revert back to its terms and conditions existing as of immediately prior to the effectiveness of this letter agreement other than as the severance provisions have been modified by this agreement, and with respect to the specific job title and function of the new Senior Vice President role.

Please let me know if you have any questions or would otherwise like to discuss anything. If you are in agreement with the matters set forth in this letter, please countersign below and return a copy to me at your earliest convenience. We look forward to continue to work with you in your new role.

Sincerely,

/s/ Jose Lynch

Jose Lynch

President, Skilled Healthcare, LLC

ACKNOWLEDGED AND AGREED:

/s/ Christopher N. Felfe

Christopher N. Felfe

Date: 6/28/13

SKILLED HEALTHCARE, LLC ♦27442 PORTOLA PARKWAY, SUITE 200 ♦ FOOTHILL RANCH, CA 92610 ♦ 949.282.5800

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Boyd Hendrickson, certify that:

(1) I have reviewed this quarterly report on Form 10-Q of Skilled Healthcare Group, Inc.;

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	August 5, 2013
		/s/ Boyd Hendrickson
		Boyd Hendrickson
		Chairman of the Board, Chief Executive
		Officer and Director
		(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Christopher Felfe, certify that:

(1) I have reviewed this quarterly report on Form 10-Q of Skilled Healthcare Group, Inc.;

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	August 5, 2013
		/s/ Christopher Felfe
		Christopher Felfe
		Acting Chief Financial Officer
		(Principal Financial Officer, Principal Accounting Officer, and Authorized Signatory)

EX-32.0

Exhibit 32

The following certifications are being furnished solely to accompany the Quarterly Report on Form 10-Q for the period ended June 30, 2013 (the “Report”), of Skilled Healthcare Group, Inc., a Delaware corporation (the “Company”), pursuant to 18 U.S.C. § 1350 and in accordance with SEC Release No. 33-8238. These certifications shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Certification of Principal Executive Officer

Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of the Company, hereby certifies, to his knowledge, that:

(1) the Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:	August 5, 2013	/s/ Boyd Hendrickson
		Boyd Hendrickson
		Chairman of the Board, Chief
		Executive Officer and Director
		(Principal Executive Officer)

Certification of Principal Financial Officer

Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of the Company, hereby certifies, to his knowledge, that:

(1) the Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:	August 6, 2013	/s/ Christopher Felfe
		Christopher Felfe
		Acting Chief Financial Officer
		(Principal Financial Officer, Principal Accounting Officer, and Authorized Signatory)

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Fair Value Measurements

6 Months Ended

Jun. 30, 2013

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

Fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions. The following table summarizes the valuation of the Company’s interest rate hedge transaction, marketable securities, and contingent consideration as of June 30, 2013 (dollars in thousands):

	June 30, 2013						December 31, 2012
	Level 1		Level 2		Level 3		Level 1		Level 2			Level 3
Interest rate hedges	$	—	$	—	$	—	$	—	$	(277	)	$	—
Available for sale securities	$	—	$	1,044	$	—	$	—	$	1,070		$	—
Contingent consideration – acquisitions	$	—	$	—	$	3,777	$	—	$	—		$	6,238

In June 2010, the Company entered into an interest rate cap agreement (which expired December 31, 2011) and an interest rate swap agreement in order to manage fluctuations in cash flows resulting from interest rate risk. The interest rate swap agreement was for a notional amount of $70.0 million with a LIBOR rate not to exceed 2.3% from January 2012 to June 2013. The Company continues to assess its exposure to interest rate risk on an ongoing basis.

The interest rate swap is required to be measured at fair value on a recurring basis. The fair value of the interest rate swap contract is determined by calculating the value of the discounted cash flows of the difference between the fixed interest rate of the interest rate swap and the counterparty’s forward LIBOR curve, which is the input used in the valuation. The forward LIBOR curve is readily available in public markets or can be derived from information available in publicly quoted markets. Therefore, the Company has categorized the interest rate swap as Level 2. For periods ended prior to the expiration of the swap agreement, the Company obtained the counterparty’s calculation of the valuation of the interest rate swap as well as a forward LIBOR curve from another investment bank and independently recalculated the valuation of the interest rate swap, which agreed with the counterparty’s calculation.

The Company's wholly-owned offshore captive insurance company is required by regulatory agencies to set aside assets to comply with the laws of the jurisdiction in which it operates. These assets consist of restricted cash and available for sale securities, which are included in other assets in the Company's consolidated June 30, 2013 balance sheet. The Company's available for sale securities are U.S. government securities with an amortized cost basis and aggregate fair value of $1.0 million and $1.0 million, respectively, as of June 30, 2013 and 2012. Net unrealized loss included in other comprehensive income on the Company's available for sale securities was negligible for the six months ended June 30, 2013 and 2012.

On May 1, 2010, the Company acquired substantially all of the assets of five Medicare-certified hospice companies and four Medicare-certified home health companies located in Arizona, Idaho, Montana and Nevada (which is sometimes referred to herein as the "Hospice/Home Health Acquisition"). As part of the purchase agreement, the purchase consideration included cash, promissory notes, contingent consideration, and deferred cash payments. The contingent consideration arrangement requires the Company to pay contingent payments should the acquired operations achieve certain financial targets based on EBITDA of the acquired businesses, as defined in the acquisition agreement, which was filed as Exhibit 2.1 to the Company’s Report on Form 10-Q filed with the SEC on May 4, 2010. The contingent consideration is up to $7.0 million over a period of 5 years following the closing. The fair value of the contingent consideration was estimated using a probability-weighted discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement. The contingent consideration was recorded at the date of acquisition in the amount of $4.9 million. As of December 31, 2012 and June 30, 2013, the contingent consideration had a fair value of $3.8 million and $1.6 million, respectively. The change from December 31, 2012 represents a reduction in fair value due to a decrease in projected EBITDA for the acquired business over the remainder of the earn-out period. This is included in the Company’s other long-term liabilities on the balance sheet. The change in fair value related to the contingent consideration is included in the Company's depreciation and amortization on the statements of operations. There has been no change in the valuation technique of the contingent consideration from December 31, 2012 to June 30, 2013.

On July 1, 2011, a wholly-owned subsidiary of the Company acquired Altura Homecare & Rehab ("Altura"). The acquisition includes contingent earn-out consideration which can be earned based on the acquired business's achievement of an EBITDA threshold. The contingent consideration is up to $1.5 million over a period of 3 years following the closing. The fair value of the contingent consideration was estimated using a probability-weighted discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement. The fair value of the earn-out at the acquisition date was $1.3 million and at June 30, 2013 was $1.0 million which reflects payments of $0.5 million to the seller and mark to market adjustments of $0.2 million.

On October 24, 2011, wholly-owned subsidiaries of the Company acquired substantially all of the assets of Cornerstone Hospice, Inc. ("Cornerstone"). The acquisition includes contingent earn-out consideration which can be earned based on the acquired business's achievement of an EBITDA threshold. The contingent consideration is up to $1.5 million over a period of 5 years following the closing. The fair value of the contingent consideration was estimated using a probability-weighted discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement. The fair value of the earn-out at the acquisition date was $1.2 million and at June 30, 2013 was $1.1 million which reflects a $0.3 million payments to the seller and mark to market adjustments of $0.2 million.

On May 13, 2012, a wholly-owned subsidiary of the Company acquired substantially all of the assets of A Better Care Home Health, Inc. ("ABC"). The acquisition includes contingent earn-out consideration which can be earned based on the acquired operations' achievement of an EBITDA threshold. The contingent consideration spans 3 years following the closing. The fair value of the contingent consideration was estimated using a probability-weighted discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement. The fair value of the earn-out at the acquisition date and at June 30, 2013 was $0.1 million.

As discussed above, EBITDA is the basis for calculating the contingent consideration. The unobservable inputs to the determination of the fair value of the contingent consideration include assumptions as to the ability of the acquired businesses to meet their EBITDA targets and discount rates used in the calculation. Should the actual EBITDA generated by the acquired businesses increase or decrease as compared to our assumptions, the fair value of the contingent consideration obligations would increase or decrease, up to the contracted limit, as applicable. As the timing of contingent payments go further into the future, discount rate assumptions increase due to the increased uncertainty of the EBITDA that may be generated in those periods.

The Company's assumptions range from the acquired businesses achieving none, a portion, or all of the consideration, and discount rates range from 2%- 5%.

Below is a table listing the Level 3 rollforward as of June 30, 2013 (in thousands):

Level 3 Rollforward
Value at January 1, 2013	$	6,238
Change in fair value	(2,161		)
Payout	(300		)
Value at June 30, 2013	$	3,777

Long Term Debt

At June 30, 2013 and December 31, 2012, the fair value of the Company's term loan, due in 2016 and the revolving credit facility, due in 2015, using the Level 2 inputs, was approximately $446.9 million and $447.4 million, respectively. The carrying value of the debt at June 30, 2013 and December 31, 2012 was $442.8 million and $443.6 million, respectively. Fair value was estimated based on current yield rates plus the Company's estimated credit spread available for loan products with similar terms and maturities.

XML

Condensed Consolidated Statements of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Revenue:
Net patient service revenue	$ 212,905	$ 216,607	$ 431,019	$ 435,266
Leased facility revenue	787	768	1,548	1,522
Revenues	213,692	217,375	432,567	436,788
Expenses:
Cost of services (exclusive of rent cost of revenue and depreciation and amortization shown below)	186,376	180,215	376,513	363,346
Rent cost of revenue	4,828	4,539	9,640	9,095
General and administrative	6,837	6,427	13,292	12,527
Change in fair value of contingent consideration	(2,244)	499	(2,161)	630
Depreciation and amortization	6,130	6,092	12,266	12,236
Expenses	201,927	197,772	409,550	397,834
Other (expenses) income:
Interest expense	(8,734)	(10,521)	(17,409)	(20,086)
Interest income	112	132	224	277
Other (expense) income, net	(32)	106	(62)	77
Equity in earnings of joint venture	472	490	961	961
Debt modification/retirement costs	(1,088)	(3,958)	(1,088)	(3,958)
Total other (expenses) income, net	(9,270)	(13,751)	(17,374)	(22,729)
Income before provision for income taxes	2,495	5,852	5,643	16,225
Provision for income taxes	972	2,355	1,050	6,391
Net income	$ 1,523	$ 3,497	$ 4,593	$ 9,834
Income (loss) per share, basic (usd per share)	$ 0.04	$ 0.09	$ 0.12	$ 0.26
Income (loss) per share, diluted (usd per share)	$ 0.04	$ 0.09	$ 0.12	$ 0.26
Weighted-average common shares outstanding, basic (in shares)	37,646	37,400	37,602	37,343
Weighted-average common shares outstanding, diluted (in shares)	38,186	37,497	38,139	37,489

XML

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2013

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed consolidated financial statements as of June 30, 2013 and for the three and six months ended June 30, 2013 and 2012 (collectively, the "Interim Financial Statements"), are unaudited. Certain information and footnote disclosures normally included in the Company’s annual consolidated financial statements have been condensed or omitted, as permitted under applicable rules and regulations. Readers of the Interim Financial Statements should refer to the Company's audited consolidated financial statements and notes thereto, updated for Note 3, "Summary of Significant Accounting Policies", to this filing, for the year ended December 31, 2012, which are included in the Company's 2012 Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC"). Management believes that the Interim Financial Statements reflect all adjustments that are of a normal and recurring nature necessary to fairly present the Company's financial information in all material respects as of the dates and for the periods presented. The results of operations presented in the Interim Financial Statements are not necessarily indicative of operations for the entire year or any other period.

The accompanying Interim Financial Statements include the accounts of Skilled and its consolidated wholly-owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.

Estimates and Assumptions

The interim consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP"), which require the Company to consolidate company financial information and make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The most significant estimates in the Company’s consolidated financial statements relate to revenue, allowance for doubtful accounts, self-insured liability risks, income taxes, valuation of contingent consideration and impairment of long-lived assets and goodwill. Actual results could differ materially from those estimates. There was a $3.6 million increase in insurance expense in the six months ended June 30, 2013 due to an increase in the reserves on professional liability claims from prior years.

Reclassifications

Certain items previously reported in specific financial statement captions have been reclassified to conform to the current period presentation. Such reclassifications do not impact previously reported revenue, operating loss, net loss, total assets, liabilities, or stockholders' equity.

Revenue and Accounts Receivables

Revenue and accounts receivable are recorded on an accrual basis as services are performed at their estimated net realizable value. The Company derives a majority of its revenue from funds under federal Medicare and state Medicaid assistance programs, the continuation of which are dependent upon governmental policies and are subject to audit risk and potential recoupment.

Overall payments made by Medicare for hospice services are subject to an annual cap amount on a per hospice agency basis. Total Medicare payments received for services rendered during the applicable Medicare hospice cap year by each Medicare-certified agency during this period are compared to the cap amount for the relevant period. Payments in excess of the cap are subject to recoupment by Medicare. For the three months ended June 30, 2013 and 2012, the Company recorded hospice Medicare cap reserves of $1.4 million and $1.0 million, respectively, as adjustments to revenue. Of the $1.4 million hospice cap reserves recorded in the three months ended June 30, 2013, $0.7 million was related to the 2013 cap year and $0.7 million was related to the 2012 cap year. The $1.0 million recorded in the three months ended June 30, 2012 was related to the 2012 cap year. For the six months ended June 30, 2013 and 2012, the Company recorded hospice Medicare cap adjustment of $2.9 million and $1.2 million respectively, as adjustments to revenue. Of the $2.9 million, $0.7 million was related to the 2013 cap year, $2.0 million was related to the 2012 cap year, and $0.2 million was related to the 2011 cap year. The $1.2 million recorded in the six months ended June 30, 2012 was related to the 2012 cap year.

Notes Receivable

As of June 30, 2013 and December 31, 2012, net notes receivable were approximately $3.7 million and $5.2 million, respectively, of which $2.4 million and $3.1 million was reflected as current assets as of June 30, 2013 and December 31, 2012, with the remaining balances reflected as long-term assets. Interest rates on these notes approximated market rates as of the date the notes were originated.

As of June 30, 2013, two of the Company's rehabilitation therapy services business customers were responsible for $3.7 million, or 100%, of the net notes receivable balance. These notes receivable, as well as the trade receivables from these customers, are secured by the assets of the customers as well as a personal guaranty by the principal owners of the customers. As of June 30, 2013, these two customers represented $12.7 million, or 47.7% of the net accounts receivable for the Company's rehabilitation therapy services business and approximately $22.2 million, or 41.4%, of the external revenue of the rehabilitation therapy services business for the six months ended June 30, 2013.

The Company also had a note receivable of $0.2 million which had an allowance for uncollectibility of $0.2 million and $0.1 million, as of June 30, 2013 and December 31, 2012, respectively.

Recent Accounting Pronouncements

In November 2011, the FASB issued ASU No. 2011-11, Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities, ("ASU 2011-11"). This ASU require an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. The adoption of ASU 2011-11 becomes effective for the Company's interim and annual periods beginning on or after January 1, 2013. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.

In February 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income. The amendments in this update require an entity to provide information about the amounts reclassified from accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in the notes, significant amounts reclassified from accumulated other comprehensive income by the net income line item. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.

XML

Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2013

Equity [Abstract]

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions

The fair value of the stock option grants for the six months ended June 30, 2012 was estimated on the dates of the grants using the Black-Scholes option pricing model with the following assumptions:

	Six Months Ended June 30,
	2013	2012
Risk-free interest rate	n/a	1.75		%
Expected Life	n/a	6.25 years
Dividend yield	n/a	—		%
Volatility	n/a	70.81		%
Weighted-average fair value	n/a	$	5.44

Schedule of Share-based Compensation, Stock Options, Activity

The following table summarizes stock option activity during the six months ended June 30, 2013 under the Skilled Healthcare Group, Inc. Amended and Restated 2007 Incentive Award Plan:

	Number of Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 2013	1,122,195	$	8.83
Granted	—	$	—
Exercised	—	$	—
Forfeited or cancelled	—	$	—
Outstanding at June 30, 2013	1,122,195	$	8.83	4.75	$	342
Fully vested and expected to vest at June 30, 2013	1,109,739	$	8.85	4.74	$	339
Exercisable at June 30, 2013	879,061	$	9.31	4.48	$	256

XML

Debt

6 Months Ended

Jun. 30, 2013

Debt Disclosure [Abstract]

Debt

Debt

The Company’s long-term debt is summarized as follows (dollars in thousands):

	As of June 30, 2013			As of December 31, 2012
Revolving Credit Facility due 2015, interest rate comprised of LIBOR plus 4.25%, or 4.50% at June 30, 2013	$	28,000		$	25,000
Revolving Credit Facility due 2015, interest rate comprised of the Prime rate of 3.25% plus 3.50%, or 6.75% at June 30, 2013	11,000			10,000
Term Loan, due 2016, interest rate based on LIBOR (subject to a 1.50% floor) plus 5.25%, or 6.75% at June 30, 2013; collateralized by substantially all assets of the Company	385,940			411,600
Term Loan due 2016, interest rate based comprised of base rate at prime plus 4.25% or 7.50% at June 30, 2013	20,417			—
Term Loan original issue discount	(2,538		)	(3,013		)
Note payable due December 2018, interest rate fixed at 6.50%, payable in monthly installments, collateralized by a first priority deed of trust	1,040			1,118
Hospice/Home Health Acquisition note, interest rate fixed at 6.00%, due November 1, 2014	—			1,483
Insurance premiums financed	1,049			2,119
Other	605			660
Total long-term debt	445,513			448,967
Less amounts due within one year	(12,306		)	(13,338		)
Long-term debt, net of current portion	$	433,207		$	435,629

Term Loan and Revolving Loan

On April 9, 2010, the Company entered into an up to $360.0 million senior secured term loan and a $100.0 million revolving credit facility (the "Prior Credit Agreement") that amended and restated the senior secured term loan and revolving credit facility that were set to mature in June 2012. On April 12, 2012, the Company entered into an Amendment and Restatement and Additional Term Loan Assumption Agreement (“Restated Credit Agreement”) that amended and restated the Prior Credit Agreement and pursuant to which, among other things, the size of the Company's existing senior secured term loan was increased by $100.0 million (hereinafter referred to as the incremental senior secured term loan). On June 6, 2013, the Company entered into an amendment to the Restated Credit Agreement that increased the maximum leverage ratio by 0.50 throughout the life of the Restated Credit Agreement. The amendment additionally permits the Company to make future offers to the lenders under the revolving loan facility to extend the maturity date of all or a portion of the revolving loans. The credit arrangements provided under the Restated Credit Agreement are collectively referred to herein as the Company's senior secured credit facility.

The Company expensed fees paid in connection with the refinancing of the Prior Credit Agreement in the amount of $2.0 million in conjunction with the amended senior secured credit facility. In connection with the June 6, 2013 modification, the Company paid fees totaling $2.5 million, of which $1.1 million were recorded as debt modification costs in the consolidated statement of operations, and $1.4 million were recorded as other assets in the consolidated balance sheet. Substantially all of the Company's assets are pledged as collateral under the senior secured credit facility. Amounts borrowed under the senior secured term loan may be prepaid at any time without penalty, except for LIBOR breakage costs. Commitments under the revolving credit facility terminate on April 9, 2015. The senior secured term loan matures on April 9, 2016.

The incremental senior secured term loan bears interest, at our option, at the London Interbank Offered Rate ("LIBOR") (subject to a floor of 1.50%) plus a margin of 5.25% or the prime rate (subject to a floor of 2.50%) plus a margin of 4.25%. As part of the refinancing, the interest rate on the existing senior secured term loan was amended to match the interest rate of the incremental senior secured term loan. The interest rate on the existing revolving credit facility was also amended to be, at the Company's option, LIBOR plus a margin of between 4.25% and 4.50% (based upon consolidated senior leverage) or the prime rate plus a margin of between 3.25% and 3.50% (based upon consolidated senior leverage). There is no longer a LIBOR or prime rate floor with respect to the revolving credit facility. Pursuant to the Restated Credit Agreement, the quarterly term loan amortization payments increased to $2.6 million beginning June 30, 2012 compared to $0.9 million under the Prior Credit Agreement. Additionally, the maximum portion of the annual Consolidated Excess Cash Flow (as defined in the Restated Credit Agreement) to be applied to term debt reductions increased to 75% from 50%, subject to stepdowns to 50% and 25% based on consolidated leverage. The Company also increased its ability to refinance a portion of its credit facility with U.S. Department of Housing and Urban Development ("HUD") insured debt up to $250 million, subject to certain credit facility covenants. The Company has received the formal portfolio conditional credit approval from HUD for up to an aggregate of $460 million in HUD insured loans secured by up to 78 facilities under HUD's Section 232 loan program, which provides loans for nursing homes, assisted living and related facilities. Any HUD insured borrowings beyond $250 million would necessitate either refinancing the senior secured credit facility in full or otherwise seeking a waiver or amendment from the senior secured lenders. The Company has not yet determined the amount of borrowings it will ultimately seek under the HUD insured loan program, and all loan applications will be subject to further review and approval by HUD. Furthermore, there can be no assurance that the Company will ultimately be approved for and close any HUD insured loans, what the timing of any approvals or closings would be, or what the interest rates on any HUD insured loans would be. The HUD approval process is subject to a number of contingencies, many of which are out of the Company's control. The Restated Credit Agreement requires that all of the net proceeds from any HUD insured loans be used to pay down the term portion of the Company's senior secured credit facility.

The Company has the right to increase its borrowings under the revolving credit facility up to an aggregate amount of $150 million provided that the Company is in compliance with the Restated Credit Agreement, that the additional debt would not cause any covenant violation of the Restated Credit Agreement, and that existing or new lenders within the Restated Credit Agreement agree to increase their commitments. To reduce the risk related to interest rate fluctuations, the Prior Credit Agreement required the Company to enter into, and the Restated Credit Agreement requires us to continue to maintain, an interest rate swap, cap or similar agreement to effectively fix or cap the interest rate on 40% of its funded long-term debt within three months of the April 2010 commencement of the senior secured credit facility. The Company entered into two interest rate hedge transactions, as described in Note 9 - "Fair Value Measurements," in order to comply with this requirement.

Under the senior secured credit facility, the Company must maintain compliance with specified financial covenants measured on a quarterly basis. The senior secured credit facility also includes certain additional affirmative and negative covenants, including limitations on the incurrence of additional indebtedness, liens, investments in other businesses and capital expenditures. Also under the senior secured credit facility, subject to certain exceptions and minimum thresholds, the Company is required to apply all of the proceeds from any issuance of debt, as much as half of the proceeds from any issuance of equity, as much as 75% of the Company's annual Consolidated Excess Cash Flow (as defined in the Restated Credit Agreement), and amounts received in connection with any sale of the Company's assets to repay the outstanding amounts under the Restated Credit Agreement. The Company believes that it is in compliance with its debt covenants as of June 30, 2013. As of June 30, 2013, the fixed charge coverage ratio was 2.3, which compares to a minimum requirement of 1.75 and the leverage ratio was 4.9, as compared to an allowed maximum of 5.25.

Senior Subordinated Notes

On May 12, 2012, the Company redeemed the entire $130.0 million outstanding principal amount plus all accrued but unpaid interest, of the 2014 Notes. The proceeds from the incremental senior secured term loan (as well as a draw on the revolving portion of the senior secured credit facility) were used to fund the redemption of the outstanding 2014 Notes at par plus accrued interest. In addition, the Company expensed unamortized deferred financing fees and original issue discount ("OID") in the amount of $1.9 million in conjunction with the redemption of the 2014 Notes.

The 2014 Notes were issued in December 2005 in the aggregate principal amount of $200.0 million, with an interest rate of 11.0% and a discount of $1.3 million. Interest was payable semiannually in January and July of each year. The 2014 Notes were to mature on January 15, 2014. The 2014 Notes were unsecured senior subordinated obligations and ranked junior to all of the Company's existing and future senior indebtedness, including indebtedness under the senior secured credit facility. The 2014 Notes were guaranteed on a senior subordinated basis by certain of the Company's subsidiaries.

Other Debt

The Company issued $10.0 million of promissory notes as part of the purchase consideration for the Hospice/Home Health Acquisition. The notes bear interest at 6.0% with $2.0 million of principal due annually beginning November 1, 2010. During 2012, the notes were substantially paid down leaving a remaining balance of $1.5 million at December 31, 2012. The promissory notes are payable to the selling entities, of which the Senior Vice President, of Signature Hospice & Home Health, LLC are significant shareholders. Signature Hospice & Home Health, LLC is a consolidated subsidiary of Skilled holding 100% interests in the operating companies for the Hospice/Home Health Acquisition. The promissory notes were paid in full in April 2013.

XML

Debt - Schedule of Debt Parenthetical (Details)	Jun. 30, 2013	Dec. 31, 2012
Secured Debt [Member] | Revolving Credit Facility due 2015, interest rate comprised of LIBOR plus 4.50% or 4.74% [Member]
Debt Instrument [Line Items]
Libor rate margin	4.50%	4.50%
Libor rate margin 2	4.74%	4.74%
Secured Debt [Member] | Revolving Credit Facility due 2015, interest rate comprised of the Prime rate of 3.25% plus 3.50%, or 6.75% [Member]
Debt Instrument [Line Items]
Prime rate	3.25%	3.25%
Prime rate margin	3.50%	3.50%
Debt instrument, interest rate percentage	6.75%	6.75%
Secured Debt [Member] | Term Loan, due 2016, interest rate based on LIBOR (subject to a 1.50% floor) plus 5.25% or 6.75% [Member]
Debt Instrument [Line Items]
LIBOR Floor	1.50%	1.50%
Libor rate margin	5.25%	5.25%
Debt instrument, interest rate percentage	6.75%	6.75%
Secured Debt [Member] | Term Loan due 2016, interest rate based comprised of base rate at prime plus 4.25% or 7.50% [Member]
Debt Instrument [Line Items]
Prime rate	4.25%	4.25%
Prime rate margin	7.50%	7.50%
Notes Payable, Other Payables [Member] | Notes payable due December 2018, interest rate fixed at 6.50% [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate percentage	6.50%	6.50%
Notes Payable, Other Payables [Member] | Hospice/Home Health Acquisition note, interest rate fixed at 6.00% [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate percentage	6.00%	6.00%

XML

Commitments and Contingencies Contingencies (Details) (USD $)	1 Months Ended	6 Months Ended		0 Months Ended
	Apr. 30, 2011 Humboldt County Action [Member] defendent	Jun. 30, 2013 Humboldt County Action [Member] defendent	Nov. 30, 2010 Humboldt County Action [Member]	Feb. 15, 2013 BMFEA Matter [Member]	Apr. 15, 2009 BMFEA Matter [Member] count subsidiary	Nov. 30, 2010 Governmental Claims [Member] Humboldt County Action [Member]	Nov. 30, 2010 Governmental Claims [Member] State of California and Other Districts [Member]	Nov. 30, 2010 Professional Fees [Member] Humboldt County Action [Member]	Nov. 30, 2010 Plaintiffs [Member] Humboldt County Action [Member]	Jun. 30, 2013 Affiliated Entity [Member] BMFEA Matter [Member] H	Feb. 15, 2013 Affiliated Entity [Member] BMFEA Matter [Member] facility	Aug. 02, 2013 Subsequent Event [Member] Minimum Creekside Hospice Investigation [Member]	Aug. 02, 2013 Subsequent Event [Member] Maximum Creekside Hospice Investigation [Member]
Loss Contingencies [Line Items]
Litigation Settlement Amount			$ 50,000,000			$ 5,000,000	$ 4,000,000
Legal Settlement Payments Approved from Court			3,000,000			1,000,000		24,800,000	10,000
Loss contingency, number of defendants	5	22
Injunction Costs			9,600,000
Number of Subsidiaries, Under Investigation					2
Loss contingency, fine					6,000							6,000	11,000
Number of Felony Counts					2
Loss Contingency, Fine Per Misdemeanor Count					2,000
Number of Misdemeanor Counts					9
Statutory Fine				680
Investigation Costs of Plantiff Paid by Defendent				$ 145,000
Period of Summary Probation				2 years
Number of skilled nursing facilities											20
Number of Nursing Hours Per Patient Day										3.2

XML

Description of Business (Details)	Jun. 30, 2013 facility
Facility Count [Line Items]
Number of leased facility asset	5
Long-Term Care Services
Facility Count [Line Items]
Number of skilled nursing facilities	74
Number of assisted living facility	22

XML

Debt (Tables)

6 Months Ended

Jun. 30, 2013

Debt Disclosure [Abstract]

Schedule of Debt

The Company’s long-term debt is summarized as follows (dollars in thousands):

	As of June 30, 2013			As of December 31, 2012
Revolving Credit Facility due 2015, interest rate comprised of LIBOR plus 4.25%, or 4.50% at June 30, 2013	$	28,000		$	25,000
Revolving Credit Facility due 2015, interest rate comprised of the Prime rate of 3.25% plus 3.50%, or 6.75% at June 30, 2013	11,000			10,000
Term Loan, due 2016, interest rate based on LIBOR (subject to a 1.50% floor) plus 5.25%, or 6.75% at June 30, 2013; collateralized by substantially all assets of the Company	385,940			411,600
Term Loan due 2016, interest rate based comprised of base rate at prime plus 4.25% or 7.50% at June 30, 2013	20,417			—
Term Loan original issue discount	(2,538		)	(3,013		)
Note payable due December 2018, interest rate fixed at 6.50%, payable in monthly installments, collateralized by a first priority deed of trust	1,040			1,118
Hospice/Home Health Acquisition note, interest rate fixed at 6.00%, due November 1, 2014	—			1,483
Insurance premiums financed	1,049			2,119
Other	605			660
Total long-term debt	445,513			448,967
Less amounts due within one year	(12,306		)	(13,338		)
Long-term debt, net of current portion	$	433,207		$	435,629

XML

Fair Value Measurements - Fair Value of Debt (Details) (USD $) In Millions, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Estimate of Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt instrument, fair value disclosure	$ 446.9	$ 447.4
Carrying (Reported) Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt instrument, fair value disclosure	$ 442.8	$ 443.6

XML

Business Segments Reconciliation of Assets by Segment (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Segment Reporting, Asset Reconciling Item [Line Items]
Segment total assets	$ 684,974	$ 682,636
Goodwill and intangibles included in total assets	107,480	107,644
Long-Term Care Services
Segment Reporting, Asset Reconciling Item [Line Items]
Segment total assets	463,370	471,129
Goodwill and intangibles included in total assets	1,532	1,670
Therapy Services
Segment Reporting, Asset Reconciling Item [Line Items]
Segment total assets	57,005	52,559
Goodwill and intangibles included in total assets	23,693	23,693
Hospice and Home Health Services
Segment Reporting, Asset Reconciling Item [Line Items]
Segment total assets	105,157	103,800
Goodwill and intangibles included in total assets	82,255	82,281
Other
Segment Reporting, Asset Reconciling Item [Line Items]
Segment total assets	59,442	55,148
Goodwill and intangibles included in total assets	$ 0	$ 0

XML

Commitments and Contingencies - Financial Gaurantees (Details) (Senior Subordinated Notes [Member], USD $) In Millions, unless otherwise specified	May 12, 2012
Senior Subordinated Notes [Member]
Guarantor Obligations [Line Items]
Redemption amount of senior subordinated notes	$ 130.0

XML

Debt Long Term Debt Terms and Details (Details) (USD $)	3 Months Ended	6 Months Ended					1 Months Ended	6 Months Ended				6 Months Ended			6 Months Ended							6 Months Ended
	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013 US Department of Housing and Urban Development [Member]	Jun. 30, 2013 US Department of Housing and Urban Development [Member] Minimum facility	May 12, 2012 Senior Subordinated Notes [Member]	Dec. 31, 2005 Senior Subordinated Notes [Member]	Jun. 30, 2013 Senior Subordinated Notes [Member]	May 12, 2012 Senior Subordinated Notes [Member]	Jun. 30, 2013 Secured Debt [Member]	Dec. 31, 2012 Secured Debt [Member]	Jun. 30, 2013 Secured Debt [Member] Prior Credit Agreement [Member] Senior Secured Term Loan [Member]	Apr. 09, 2010 Secured Debt [Member] Prior Credit Agreement [Member] Senior Secured Term Loan [Member]	Apr. 09, 2010 Secured Debt [Member] Prior Credit Agreement [Member] Revolving Credit Facility [Member]	Jun. 30, 2013 Secured Debt [Member] Restated Credit Agreement [Member] Senior Secured Term Loan Amended [Member]	Jun. 06, 2013 Secured Debt [Member] Restated Credit Agreement [Member] Senior Secured Term Loan Amended [Member]	Apr. 12, 2012 Secured Debt [Member] Restated Credit Agreement [Member] Senior Secured Term Loan Amended [Member]	Jun. 30, 2013 Secured Debt [Member] Restated Credit Agreement [Member] Revolving Credit Facility Amended [Member]	Jun. 30, 2013 Secured Debt [Member] Restated Credit Agreement [Member] Revolving Credit Facility Amended [Member] Minimum	Jun. 30, 2013 Secured Debt [Member] Restated Credit Agreement [Member] Revolving Credit Facility Amended [Member] Maximum	Jun. 30, 2013 Secured Debt [Member] US Department of Housing and Urban Development [Member] Maximum	Jun. 30, 2013 Notes Payable, Other Payables [Member] Note Payable - Hospice/Home Health Acquisition [Member]	Nov. 01, 2010 Notes Payable, Other Payables [Member] Note Payable - Hospice/Home Health Acquisition [Member]
Debt Instrument [Line Items]
Debt retirement costs	$ (3,958,000)		$ (3,958,000)					$ 1,900,000				$ 2,000,000
Debt modifcation fees		2,500,000
Debt modification costs		1,100,000
Debt modification fees, capitalized		1,400,000
Addition of debt issuance on senior secured term loan																	100,000,000
LIBOR Floor															1.50%
Libor rate margin															5.25%				4.25%	4.50%
Prime rate															2.50%
Prime rate margin															4.25%				3.25%	3.50%
Debt instrument, periodic payment, principal												900,000			2,600,000							2,000,000
Consolidated excess cash flow percentage												50.00%			75.00%
Stepdown percentage												25.00%			50.00%
Refinance portion of credit facility															250,000,000
Line of credit facility, maximum borrowing capacity				250,000,000										100,000,000				150,000,000			460,000,000
Number of skilled nursing facilities					78
Redemption amount of senior subordinated notes						130,000,000			130,000,000
Debt instrument, issuance date							Dec. 31, 2005
Debt instrument, face amount								200,000,000					360,000,000										10,000,000
Debt instrument, interest rate percentage									11.00%														6.00%
Term Loan original issue discount								1,300,000		2,538,000	3,013,000
Note payable balance after substantial paid down																						$ 1,500,000
Fixed charge coverage ratio		2.3
Fixed charge coverage ratio, minimum requirement		1.75
Leverage ratio		4.9
Leverage ratio, maximum allowable		5.25														0.50

XML

Business Segments Segment Information (Details)	3 Months Ended
	Jun. 30, 2013 segment
Facility Count [Line Items]
Number of reportable segments	3
Long-Term Care Services
Facility Count [Line Items]
Number of skilled nursing facilities	74
Number of assisted living facility	22

XML

Stockholders' Equity Stock Compensation Expense for Awards and Options (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated share-based compensation expense		$ 0.8
General and Administrative Expense
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated share-based compensation expense	0.1	0.8	0.9	1.5
Cost of Sales
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated share-based compensation expense	$ 0.2	$ 0.4	$ 0.8	$ 0.9

XML

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2013

Fair Value Disclosures [Abstract]

Fair Value Measurements, Recurring and Nonrecurring

The following table summarizes the valuation of the Company’s interest rate hedge transaction, marketable securities, and contingent consideration as of June 30, 2013 (dollars in thousands):

	June 30, 2013						December 31, 2012
	Level 1		Level 2		Level 3		Level 1		Level 2			Level 3
Interest rate hedges	$	—	$	—	$	—	$	—	$	(277	)	$	—
Available for sale securities	$	—	$	1,044	$	—	$	—	$	1,070		$	—
Contingent consideration – acquisitions	$	—	$	—	$	3,777	$	—	$	—		$	6,238

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

Below is a table listing the Level 3 rollforward as of June 30, 2013 (in thousands):

Level 3 Rollforward
Value at January 1, 2013	$	6,238
Change in fair value	(2,161		)
Payout	(300		)
Value at June 30, 2013	$	3,777

XML

Condensed Consolidated Statements of Comprehensive Income (Parenthetical) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Unrealized gain (loss) on interest rate swap, tax	$ 0	$ (2)	$ 0	$ (23)
Unrealized gain (loss) on Investment available for sale, tax	(9)	3	(10)	27
Interest expense on interest rate swap, tax	$ 56	$ 55	$ 107	$ 108

XML

Condensed Consolidated Statements of Cash Flows (Parentheticals) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash paid for:
Interest expense	$ 15,684	$ 23,660
Income taxes, net	181	7,211
Non-cash activities:
Conversion of accounts receivable into notes receivable	0	359
Liabilities issued as purchase consideration for purchase of business	0	261
Insurance premium financed	$ 1,187	$ 1,107

XML

Net Income Per Share of Class A Common Stock and Class B Common Stock

6 Months Ended

Jun. 30, 2013

Earnings Per Share [Abstract]

Net Income Per Share of Class A Common Stock and Class B Common Stock

Net Income Per Share of Class A Common Stock and Class B Common Stock

The Company computes net income per share of Class A common stock and Class B common stock using the two-class method. The Company's Class A common stock and Class B common stock are identical in all respects, except with respect to voting rights and except that each share of Class B common stock is convertible into one share of Class A common stock under certain circumstances. Net income is allocated on a proportionate basis to each class of common stock in the determination of income per share.

Basic net income per share was computed by dividing net income by the weighted-average number of outstanding shares for the period. Dilutive earnings per share is computed by dividing net income plus the effect of assumed conversions (if applicable) by the weighted-average number of outstanding shares after giving effect to all potential dilutive common stock, including options, warrants, common stock subject to repurchase and convertible preferred stock, if any. The following table sets forth the computation of basic and diluted net income per share of Class A common stock and Class B common stock for the three and six months ended June 30, 2013 and 2012 (amounts in thousands, except per share data):

	Three months ended June 30, 2013						Three months ended June 30, 2012
	Class A		Class B		Total		Class A		Class B		Total
Net Income per share, basic
Numerator:
Allocation of net income	$	893	$	630	$	1,523	$	1,950	$	1,547	$	3,497
Net Income per share, diluted
Numerator:
Allocation of net income	$	902	$	621	$	1,523	$	1,954	$	1,543	$	3,497
Denominator for basic and diluted net income per share:
Weighted average common shares outstanding, basic	22,070		15,576		37,646		20,852		16,548		37,400
Plus: incremental shares related to dilutive effect of stock options and restricted stock, if applicable	540		—		540		97		—		97
Adjusted weighted-average common shares outstanding, diluted	22,610		15,576		38,186		20,949		16,548		37,497
Net income per share, basic	$	0.04	$	0.04	$	0.04	$	0.09	$	0.09	$	0.09
Net income per share, diluted	$	0.04	$	0.04	$	0.04	$	0.09	$	0.09	$	0.09

	Six months ended June 30, 2013						Six months ended June 30, 2012
	Class A		Class B		Total		Class A		Class B		Total
Net Income per share, basic
Numerator:
Allocation of net income	$	2,690	$	1,903	$	4,593	$	5,425	$	4,409	$	9,834
Net Income per share, diluted
Numerator:
Allocation of net income	$	2,717	$	1,876	$	4,593	$	5,442	$	4,392	$	9,834
Denominator for basic and diluted net income per share:
Weighted average common shares outstanding, basic	22,026		15,576		37,602		20,600		16,743		37,343
Plus: incremental shares related to dilutive effect of stock options and restricted stock, if applicable	537		—		537		146		—		146
Adjusted weighted-average common shares outstanding, diluted	22,563		15,576		38,139		20,746		16,743		37,489
Net income per share, basic	$	0.12	$	0.12	$	0.12	$	0.26	$	0.26	$	0.26
Net income per share, diluted	$	0.12	$	0.12	$	0.12	$	0.26	$	0.26	$	0.26

The following were excluded from the weighted-average diluted shares computation for the three and six months ended June 30, 2013 and 2012, as their inclusion would have been anti-dilutive (shares in thousands):

	Three Months Ended June 30,		Six Months Ended June 30,
	2013	2012	2013	2012
Options to purchase common shares	585	464	585	464
Non-vested common shares	434	1,018	911	898
Total excluded	1,019	1,482	1,496	1,362

XML

Description of Business

6 Months Ended

Jun. 30, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business

Description of Business

Current Business

Skilled Healthcare Group, Inc. ("Skilled") is a holding company that owns subsidiary companies that in turn own and operate long-term care facilities and provide a wide range of post-acute care services, with a strategic emphasis on sub-acute specialty medical care. Skilled and its consolidated wholly-owned companies are collectively referred to as the "Company." As of June 30, 2013, the Company operated facilities in California, Iowa, Kansas, Missouri, Nevada, Nebraska, New Mexico and Texas, including 74 skilled nursing facilities ("SNFs"), which offer sub-acute care, rehabilitative, specialty healthcare, and skilled nursing care, and 22 assisted living facilities ("ALFs"), which provide room and board and assistance with activities of daily living. The Company leases five skilled nursing facilities in California to an unaffiliated third party operator. In addition, through its Hallmark Rehabilitation subsidiary ("Hallmark"), the Company provides a variety of rehabilitative services such as physical, occupational and speech therapy in Company-operated facilities and unaffiliated facilities. Furthermore, as of June 30, 2013, the Company provided hospice care and home health services in Arizona, California, Idaho, Montana, Nevada and New Mexico. The Company also provides private duty care services in Idaho, Montana, and Nevada. The Company has an administrative services company that provides a full complement of administrative and consultative services that allows affiliated operators and third-party operators with whom the Company contracts to better focus on delivery of healthcare services. The Company currently has one such service agreement with an unrelated skilled nursing facility operator. The Company is also a member in a joint venture located in Texas that provides institutional pharmacy services, which currently serves eight of the Company's SNFs and other facilities unaffiliated with the Company.

XML

Stockholders' Equity Stock Options (Details) (2007 Incentive Award plan, USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average fair value	$ 0.00
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, grants in period (in shares)	0	0	0	106,748
Risk-free interest rate		1.75%
Expected Life		6 years 3 months
Dividend yield		0.00%
Volatility		70.81%
Weighted-average fair value		$ 5.44
Unrecognized compensation	$ 0.7		$ 0.7
Award vesting period	1 year 5 months 4 days

XML

Summary of Significant Accounting Policies Notes Receivable (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, net	$ 3,700,000		$ 3,700,000		$ 5,200,000
Financing receivable, net, current	2,400,000		2,400,000		3,100,000
Allowance for doubtful accounts	11,764,000		11,764,000		15,646,000
Increase in insurance expense			3,600,000
Health care organization, revenue cap adjustment	1,400,000	1,000,000	2,900,000	1,200,000
Health care organization, revenue cap adjustment relating to current cap year	700,000		700,000	1,200,000
Health care organization, revenue cap adjustment relating to prior cap year	700,000		2,000,000
Health care organization, revenue cap adjustment, relating to 2011 cap year			200,000
Notes Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, net	200,000		200,000
Allowance for doubtful accounts	200,000		200,000		100,000
Therapy Services | Notes Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, net	3,700,000		3,700,000
Concentration risk, percentage			100.00%
Therapy Services | Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk, percentage			47.70%
Accounts receivable, net	12,700,000		12,700,000
Therapy Services | Sales Revenue, Services, Net
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk, percentage			41.40%
Accounts receivable, net	$ 22,200,000		$ 22,200,000

XML

Business Segments Segment Reporting (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Segment Reporting Information [Line Items]
Net patient service revenue from external customers	$ 212,905	$ 216,607	$ 431,019	$ 435,266
Leased facility revenue	787	768	1,548	1,522
Intersegment revenue	0	0	0	0
Total revenue	213,692	217,375	432,567	436,788
Operating income (loss)	11,765	19,603	23,017	38,954
Interest expense, net of interest income	(8,622)	(10,389)	(17,185)	(19,809)
Other expense (income)	(32)	106	(62)	77
Equity in earnings of joint venture	472	490	961	961
Debt retirement costs		(3,958)		(3,958)
Debt modification costs	(1,088)		(1,088)
Income before provision for income taxes	2,495	5,852	5,643	16,225
Depreciation and amortization	6,130	6,092	12,266	12,236
Segment capital expenditures	3,580	3,622	5,981	7,097
Adjusted EBITDA	17,640	26,790	35,570	52,858
Adjusted EBITDAR	22,468	31,329	45,210	61,953
Long-Term Care Services
Segment Reporting Information [Line Items]
Net patient service revenue from external customers	161,012	163,287	325,925	329,625
Leased facility revenue	787	768	1,548	1,522
Intersegment revenue	653	601	1,194	1,355
Total revenue	162,452	164,656	328,667	332,502
Operating income (loss)	12,176	18,126	24,426	36,264
Depreciation and amortization	5,656	5,630	11,267	11,301
Segment capital expenditures	3,365	2,894	5,562	5,299
Adjusted EBITDA	17,801	23,719	35,632	47,499
Adjusted EBITDAR	22,171	27,940	44,354	55,955
Therapy Services
Segment Reporting Information [Line Items]
Net patient service revenue from external customers	26,637	26,385	53,744	52,501
Leased facility revenue	0	0	0	0
Intersegment revenue	14,018	15,818	29,190	31,799
Total revenue	40,655	42,203	82,934	84,300
Operating income (loss)	2,705	3,543	5,659	6,491
Depreciation and amortization	174	164	350	332
Segment capital expenditures	70	269	93	546
Adjusted EBITDA	2,879	3,850	6,010	6,966
Adjusted EBITDAR	2,879	3,850	6,010	6,966
Hospice and Home Health Services
Segment Reporting Information [Line Items]
Net patient service revenue from external customers	25,256	26,935	51,350	53,140
Leased facility revenue	0	0	0	0
Intersegment revenue	0	0	0	0
Total revenue	25,256	26,935	51,350	53,140
Operating income (loss)	3,879	4,521	6,582	9,053
Depreciation and amortization	135	145	291	291
Segment capital expenditures	83	114	213	317
Adjusted EBITDA	1,792	5,255	4,784	10,123
Adjusted EBITDAR	2,258	5,565	5,702	10,747
Other
Segment Reporting Information [Line Items]
Net patient service revenue from external customers	0		0	0
Leased facility revenue	0	0	0	0
Intersegment revenue	0		0	0
Total revenue	0	0	0	0
Operating income (loss)	(6,995)	(6,587)	(13,650)	(12,854)
Depreciation and amortization	165	153	358	312
Segment capital expenditures	62	345	113	935
Adjusted EBITDA	(4,832)	(6,034)	(10,856)	(11,730)
Adjusted EBITDAR	(4,840)	(6,026)	(10,856)	(11,715)
Elimination
Segment Reporting Information [Line Items]
Net patient service revenue from external customers	0	0	0	0
Leased facility revenue	0	0	0	0
Intersegment revenue	(14,671)	(16,419)	(30,384)	(33,154)
Total revenue	(14,671)	(16,419)	(30,384)	(33,154)
Operating income (loss)	0		0	0
Depreciation and amortization	0	0	0	0
Segment capital expenditures	0	0	0	0
Adjusted EBITDA	0	0	0	0
Adjusted EBITDAR	$ 0	$ 0	$ 0	$ 0

XML

Income Taxes (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 972,000	$ 2,355,000	$ 1,050,000	$ 6,391,000
Effective income tax rate	39.00%
Tax settlement	$ 1,200,000

XML

Fair Value Measurements - Level 3 Rollforward (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2013	Jun. 30, 2012
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Value at January 1, 2013		$ 6,238
Change in fair value	(2,161)
Payout	(300)	2,161	(630)
Value at March 31, 2013	$ 3,777	$ 3,777

XML

Condensed Consolidated Balance Sheets (Parentheticals) (USD $) In Thousands, except Share data, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Current Assets:
Allowance for doubtful accounts	$ 11,764	$ 15,646
Noncurrent Assets:
Accumulated depreciation on property and equipment	129,990	118,141
Accumulated depreciation for leased facility assets	4,186	3,935
Accumulated amortization on intangible assets	$ 4,382	$ 4,218
Common Class A
Stockholders' Equity:
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	175,000,000	175,000,000
Common Stock, Shares, Outstanding	23,659,000	22,967,000
Common Class B
Stockholders' Equity:
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	30,000,000	30,000,000
Common Stock, Shares, Outstanding	15,576,000	15,576,000

XML

Income Taxes

6 Months Ended

Jun. 30, 2013

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

For the three months ended June 30, 2013, the Company recorded an income tax expense of $1.0 million representing an effective tax rate of 39.0% compared to an income tax expense of $2.4 million for the same period in 2012. For the six months ended June 30, 2013 and 2012 the Company recorded an income tax expense of $1.1 million and $6.4 million respectively. The effective tax rate for the six months ended June 30, 2013 was less than the statutory rate primarily due to a $1.2 million benefit from the resolution and ultimate disposition of remaining funds related to the 2010 settlement of the Humboldt County Action. See Note 7, "Commitments and Contingencies - Legal Matters," for additional detail.

On July 11, 2013, legislation was enacted in California that will limit the carryover period for unused Enterprise Zone credits to 10 years beginning in 2014.  Prior to this legislation, unused Enterprise Zone credits could be carried over indefinitely.  The Company is currently evaluating the impact of this change of law.

XML

Condensed Consolidated Statements of Comprehensive Income (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Net income	$ 1,523	$ 3,497	$ 4,593	$ 9,834
Other comprehensive income:
Unrealized (loss) on interest rate swap - net of income tax (benefit) of ($2) for the three months ended June 30, 2012; net of income tax (benefit) of ($23) for the six months ended June 30, 2012.	0	(2)	0	(23)
Unrealized (loss) gain on Investment available for sale - net of income tax (benefit) expense of ($9) and $3 for the three months ended June 30, 2013 and 2012, respectively; net of income tax (benefit) expense of ($10) and $27 for the six months ended June 30, 2013 and 2012, respectively.	(14)	4	(16)	42
Reclassification adjustments:
Interest expense on interest rate swap - net of income tax expense of $56 and $55 for the three months ended June 30, 2013 and 2012, respectively; net of income tax expense of $107 and $108 for the six months ended June 30, 2013 and 2012, respectively.	87	86	169	171
Other comprehensive income, net of tax	73	88	153	190
Comprehensive income	$ 1,596	$ 3,585	$ 4,746	$ 10,024

XML

Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 2,019	$ 2,003
Accounts receivable, less allowance for doubtful accounts of $11,764 and $15,646 at June 30, 2013 and December 31, 2012, respectively	122,280	107,245
Deferred income taxes	11,430	11,696
Prepaid expenses	3,355	7,569
Other current assets	11,169	10,312
Total current assets	150,253	138,825
Property and equipment, less accumulated depreciation of $129,990 and $118,141 at June 30, 2013 and December 31, 2012, respectively	364,877	370,745
Leased facility assets, less accumulated depreciation of $4,186 and $3,935 at June 30, 2013 and December 31, 2012, respectively	9,662	9,913
Other assets:
Notes receivable	1,276	2,055
Deferred financing costs, net	6,394	6,355
Goodwill	85,609	85,609
Intangible assets, less accumulated amortization of $4,382 and $4,218 at June 30, 2013 and December 31, 2012, respectively	21,871	22,035
Deferred income taxes	3,451	7,362
Other assets	41,581	39,737
Total other assets	160,182	163,153
Total assets	684,974	682,636
Current liabilities:
Accounts payable and accrued liabilities	50,799	48,780
Employee compensation and benefits	42,393	42,185
Current portion of long-term debt	12,306	13,338
Total current liabilities	105,498	104,303
Long-term liabilities:
Insurance liability risks	26,020	27,396
Other long-term liabilities	14,259	15,477
Long-term debt, less current portion	433,207	435,629
Total liabilities	578,984	582,805
Stockholders’ equity:
Additional paid-in-capital	377,439	376,027
Accumulated deficit	(271,515)	(276,108)
Accumulated other comprehensive income (loss)	26	(127)
Total stockholders’ equity	105,990	99,831
Total liabilities and stockholders’ equity	684,974	682,636
Common Class A
Stockholders’ equity:
Common stock	24	23
Common Class B
Stockholders’ equity:
Common stock	$ 16	$ 16

XML

Net Income Per Share of Class A Common Stock and Class B Common Stock Earnings Per Share of Class A Common Stock and Class B Common Stock(Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Net Income per share, basic
Allocation of net income, basic	$ 1,523	$ 3,497	$ 4,593	$ 9,834
Net Income per share, diluted
Allocation of net income, diluted	1,523	3,497	4,593	9,834
Denominator for basic and diluted net income per share:
Weighted-average common shares outstanding, basic (in shares)	37,646	37,400	37,602	37,343
Plus: incremental shares related to dilutive effect of stock options and restricted stock, if applicable (in shares)	540	97	537	146
Adjusted weighted-average common shares outstanding, diluted (in shares)	38,186	37,497	38,139	37,489
Income (loss) per share, basic (usd per share)	$ 0.04	$ 0.09	$ 0.12	$ 0.26
Income (loss) per share, diluted (usd per share)	$ 0.04	$ 0.09	$ 0.12	$ 0.26
Common Class A
Net Income per share, basic
Allocation of net income, basic	893	1,950	2,690	5,425
Net Income per share, diluted
Allocation of net income, diluted	902	1,954	2,717	5,442
Denominator for basic and diluted net income per share:
Weighted-average common shares outstanding, basic (in shares)	22,070	20,852	22,026	20,600
Plus: incremental shares related to dilutive effect of stock options and restricted stock, if applicable (in shares)	540	97	537	146
Adjusted weighted-average common shares outstanding, diluted (in shares)	22,610	20,949	22,563	20,746
Income (loss) per share, basic (usd per share)	$ 0.04	$ 0.09	$ 0.12	$ 0.26
Income (loss) per share, diluted (usd per share)	$ 0.04	$ 0.09	$ 0.12	$ 0.26
Common Class B
Net Income per share, basic
Allocation of net income, basic	630	1,547	1,903	4,409
Net Income per share, diluted
Allocation of net income, diluted	$ 621	$ 1,543	$ 1,876	$ 4,392
Denominator for basic and diluted net income per share:
Weighted-average common shares outstanding, basic (in shares)	15,576	16,548	15,576	16,743
Plus: incremental shares related to dilutive effect of stock options and restricted stock, if applicable (in shares)	0	0	0	0
Adjusted weighted-average common shares outstanding, diluted (in shares)	15,576	16,548	15,576	16,743
Income (loss) per share, basic (usd per share)	$ 0.04	$ 0.09	$ 0.12	$ 0.26
Income (loss) per share, diluted (usd per share)	$ 0.04	$ 0.09	$ 0.12	$ 0.26

XML

Commitments and Contingencies (Tables)

6 Months Ended

Jun. 30, 2013

Commitments and Contingencies Disclosure [Abstract]

Liabilities Related to Insurance Risks

	As of June 30, 2013:											As of December 31, 2012
	General and Professional			Employee Medical			Workers’ Compensation			Total		General and Professional			Employee Medical			Workers’ Compensation			Total
Current	$	7,153	(1)	$	2,516	(2)	$	5,492	(2)	$	15,161	$	5,622	(1)	$	2,143	(2)	$	5,328	(2)	$	13,093
Non-current	13,053			—			12,967			26,020		15,587			—			11,809			27,396
	$	20,206		$	2,516		$	18,459		$	41,181	$	21,209		$	2,143		$	17,137		$	40,489

XML

Fair Value Measurements - Fair Value, Hierarchy (Details) (USD $)	3 Months Ended	6 Months Ended																	6 Months Ended						6 Months Ended			6 Months Ended		6 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013 Fair Value, Measurements, Recurring Level 1	Dec. 31, 2012 Fair Value, Measurements, Recurring Level 1	Jun. 30, 2013 Fair Value, Measurements, Recurring Level 1 Interest Rate Swap	Dec. 31, 2012 Fair Value, Measurements, Recurring Level 1 Interest Rate Swap	Jun. 30, 2013 Fair Value, Measurements, Recurring Level 1 Available-for-sale Securities	Dec. 31, 2012 Fair Value, Measurements, Recurring Level 1 Available-for-sale Securities	Jun. 30, 2013 Fair Value, Measurements, Recurring Level 2	Dec. 31, 2012 Fair Value, Measurements, Recurring Level 2	Jun. 30, 2012 Fair Value, Measurements, Recurring Level 2	Jun. 30, 2013 Fair Value, Measurements, Recurring Level 2 Interest Rate Swap	Dec. 31, 2012 Fair Value, Measurements, Recurring Level 2 Interest Rate Swap	Jun. 30, 2013 Fair Value, Measurements, Recurring Level 2 Available-for-sale Securities	Dec. 31, 2012 Fair Value, Measurements, Recurring Level 2 Available-for-sale Securities	Jun. 30, 2013 Fair Value, Measurements, Recurring Level 3	Dec. 31, 2012 Fair Value, Measurements, Recurring Level 3	Jun. 30, 2013 Fair Value, Measurements, Recurring Level 3 Minimum	Jun. 30, 2013 Fair Value, Measurements, Recurring Level 3 Maximum	Jun. 30, 2013 Fair Value, Measurements, Recurring Level 3 Interest Rate Swap	Dec. 31, 2012 Fair Value, Measurements, Recurring Level 3 Interest Rate Swap	Jun. 30, 2013 Fair Value, Measurements, Recurring Level 3 Available-for-sale Securities	Dec. 31, 2012 Fair Value, Measurements, Recurring Level 3 Available-for-sale Securities	Jun. 30, 2013 Fair Value, Measurements, Recurring Level 3 Hospice/Home Health Acquisition	Dec. 31, 2012 Fair Value, Measurements, Recurring Level 3 Hospice/Home Health Acquisition	May 01, 2010 Fair Value, Measurements, Recurring Level 3 Hospice/Home Health Acquisition	Jun. 30, 2013 Fair Value, Measurements, Recurring Level 3 Altura Acquisition	Jul. 01, 2011 Fair Value, Measurements, Recurring Level 3 Altura Acquisition	Jun. 30, 2013 Fair Value, Measurements, Recurring Level 3 Cornerstone Acquisition	Oct. 24, 2011 Fair Value, Measurements, Recurring Level 3 Cornerstone Acquisition	Jun. 30, 2013 Fair Value, Measurements, Recurring Level 3 A Better Care Home Health	Jun. 30, 2013 Payment to Seller Fair Value, Measurements, Recurring Level 3 Altura Acquisition	Jun. 30, 2013 Payment to Seller Fair Value, Measurements, Recurring Level 3 Cornerstone Acquisition	Jun. 30, 2013 Mark to Market Adjustment	Jun. 30, 2013 Mark to Market Adjustment Fair Value, Measurements, Recurring Level 3 Cornerstone Acquisition
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate hedges						$ 0	$ 0						$ 0	$ (277,000)							$ 0	$ 0
Available for sale securities								0	0			1,000,000			1,044,000	1,070,000							0	0
Contingent consideration – acquisitions				0	0					0	0						3,777,000	6,238,000
Notional amount of interest rate derivatives													70,000,000
Derivative, Average Swaption Interest Rate													2.30%
Available-for-sale Securities, Amortized Cost Basis															1,000,000
Business Acquisition, Effective Date of Acquisition																									May 01, 2010			Jul. 01, 2011		Oct. 24, 2011		May 13, 2012
Business Acquisition, Contingent Consideration, Potential Cash Payment																									7,000,000			1,500,000		1,500,000
Contingent Consideration Period																									5 years			3 years		5 years		3 years
Business acquisition, contingent consideration, at fair value																									1,600,000	3,800,000	4,900,000	1,000,000	1,300,000	1,100,000	1,200,000	100,000
Change in fair value of contingent consideration	$ 300,000	$ (2,161,000)	$ 630,000																														$ (500,000)	$ (300,000)	$ (200,000)	$ (200,000)
Fair Value Inputs, Discount Rate																			200.00%	500.00%

XML

Commitments and Contingencies Schedule of Liabilities Related to Insurance Risks (Details) (USD $)			6 Months Ended		36 Months Ended			36 Months Ended		6 Months Ended				3 Months Ended				6 Months Ended
	Jun. 30, 2013	Dec. 31, 2012	Jun. 30, 2013 General and Professional Liability [Member]		Aug. 31, 2011 General and Professional Liability [Member]	Dec. 31, 2012 General and Professional Liability [Member]		Aug. 31, 2011 California Based Skilled Nursing Facilities [Member]	Aug. 31, 2011 Other Businesses [Member]	Jun. 30, 2013 Employee and Medical Liability [Member]		Dec. 31, 2012 Employee and Medical Liability [Member]		Jun. 30, 2013 Workers' Compensation Liability [Member]		Dec. 31, 2012 Workers' Compensation Liability [Member]		Jun. 30, 2013 Geographical Location Group Two [Member] Workers' Compensation Liability [Member]
Liabilities Related to Insurance Risks [Line Items]
Self Insurance Reserve, Current	$ 15,161,000	$ 13,093,000	$ 7,153,000	[1]		$ 5,622,000	[1]			$ 2,516,000	[2]	$ 2,143,000	[2]	$ 5,492,000	[2]	$ 5,328,000	[2]
Insurance liability risks	26,020,000	27,396,000	13,053,000			15,587,000				0		0		12,967,000		11,809,000
Self Insurance Reserve	41,181,000	40,489,000	20,206,000			21,209,000				2,516,000		2,143,000		18,459,000		17,137,000
Excess liability policies per loss			25,000,000		18,000,000
Limit per occurrence					1,000,000
Annual Limits per Claim			1,000,000		3,000,000			1,100,000	1,000,000
Self-Insured Retention			1,000,000		100,000					250,000				1,000,000
Self-Insured Per Loss Limit			$ 1,000,000		$ 14,000,000													$ 500,000

[1] Included in accounts payable and accrued liabilities.

[2] Included in employee compensation and benefits.

XML

Property and Equipment Schedule of Property and Equipment (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Property, Plant and Equipment [Abstract]
Land and land improvements	$ 64,983	$ 64,983
Buildings and leasehold improvements	335,118	331,316
Furniture and equipment	86,818	83,949
Construction in progress	7,948	8,638
Property, plant and equipment, gross	494,867	488,886
Less accumulated depreciation	(129,990)	(118,141)
Property, plant and equipment, net	$ 364,877	$ 370,745

XML

Property and Equipment Leased Facility Assets Schedule (Details) (USD $) In Thousands, unless otherwise specified	1 Months Ended	6 Months Ended
	Apr. 30, 2011	Jun. 30, 2013 option facility	Dec. 31, 2012
Property, Plant and Equipment [Abstract]
Leased facility assets		$ 13,848	$ 13,848
Less accumulated depreciation		(4,186)	(3,935)
Leased facility assets, net		$ 9,662	$ 9,913
Number of leased facility asset		5
Lease period	10 years
Number of lease extension options		2
Lease extension, lease period		10 years

XML

Property and Equipment

6 Months Ended

Jun. 30, 2013

Property, Plant and Equipment [Abstract]

Property and Equipment

Property and Equipment

Property and equipment consisted of the following as of June 30, 2013 and December 31, 2012 (in thousands):

	June 30, 2013			December 31, 2012
Land and land improvements	$	64,983		$	64,983
Buildings and leasehold improvements	335,118			331,316
Furniture and equipment	86,818			83,949
Construction in progress	7,948			8,638
	494,867			488,886
Less accumulated depreciation	(129,990		)	(118,141		)
	$	364,877		$	370,745

Leased facility assets consisted of the following as of June 30, 2013 and December 31, 2012 (in thousands):

	June 30, 2013			December 31, 2012
Leased facility assets	$	13,848		$	13,848
Less accumulated depreciation	(4,186		)	(3,935		)
	$	9,662		$	9,913

The Company began leasing five skilled nursing facilities in California to an unaffiliated third party operator in April 2011 and signed a 10-year lease with two10-year extension options exercisable by the lessee.

XML

Net Income Per Share of Class A Common Stock and Class B Common Stock Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Earnings Per Share [Abstract]
Options to purchase common shares	585	464	585	464
Non-vested common shares	434	1,018	911	898
Total excluded	1,019	1,482	1,496	1,362

XML

Stockholders' Equity Stock Option Activity (Details) (2007 Incentive Award plan, USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Jun. 30, 2013	Dec. 31, 2012
2007 Incentive Award plan
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding at January 1, 2013 (in shares)		1,122,195
Granted (in shares)	0
Exercised (in shares)	0
Forfeited or cancelled (in shares)	0
Outstanding at June 30, 2013 (in shares)	1,122,195	1,122,195
Fully vested and expected to vest at June 30, 2013 (in shares)	1,109,739
Exercisable at June 30, 2013 (in shares)	879,061
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Outstanding at January 1, 2013, Weighted-Average Exercise Price (usd per share)		$ 8.83
Granted, Weighted-Average Exercise Price (usd per share)	$ 0.00
Exercised, Weighted-Average Exercise Price (usd per share)	$ 0.00
Forfeited or cancelled, Weighted-Average Exercise Price (usd per share)	$ 0.00
Outstanding a June 30, 2013, Weighted-Average Exercise Price (usd per share)	$ 8.83	$ 8.83
Fully vested and expected to vest at June 30, 2013, Weighted-Average Exercise Price (usd per share)	$ 8.85
Exercisable at June 30, 2013, Weighted-Average Exercise Price (usd per share)	$ 9.31
Weighted average remaining contractual term in years for outstanding options	4 years 9 months
Weighted average remaining contractual term in years for vested	4 years 8 months 26 days
Weighted average remaining contractual term in years for excersiable options	4 years 5 months 23 days
Outstanding at June 30, 2013, Aggregate Intrinsic Value	$ 342
Fully vested and expected to vest at June 30, 2013, Aggregate Intrinsic Value	339
Exercisable at June 30, 2013, Aggregate Intrinsic Value	$ 256

XML

Stockholders' Equity

6 Months Ended

Jun. 30, 2013

Equity [Abstract]

Shareholders' Equity

Stockholders' Equity

Accumulated Other Comprehensive Income

Accumulated other comprehensive income refers to gains and losses that are recorded as an element of stockholders' equity but are excluded from net income. The Company's other comprehensive income consists of net deferred gains and losses on certain derivative instruments accounted for as cash flow hedges and gains and losses from investments available for sale. Details of other comprehensive income are included in the accompanying condensed consolidated Statement of Comprehensive Income.

2007 Incentive Award Plan

There were no new stock options granted in the three months ended June 30, 2013 and 2012. There were zero and 106,748 new stock options granted in the six months ended June 30, 2013 and 2012, respectively.

The fair value of the stock option grants for the six months ended June 30, 2012 was estimated on the dates of the grants using the Black-Scholes option pricing model with the following assumptions:

	Six Months Ended June 30,
	2013	2012
Risk-free interest rate	n/a	1.75		%
Expected Life	n/a	6.25 years
Dividend yield	n/a	—		%
Volatility	n/a	70.81		%
Weighted-average fair value	n/a	$	5.44

There were no options exercised during the three and six months ended June 30, 2013 or 2012. As of June 30, 2013, there was $0.7 million of unrecognized compensation cost related to outstanding stock options, net of estimated forfeitures. This amount is expected to be recognized over a weighted-average period of 1.43 years. To the extent the forfeiture rate is different than the Company has anticipated, stock-based compensation related to these awards will be different from the Company's expectations.

The following table summarizes stock option activity during the six months ended June 30, 2013 under the Skilled Healthcare Group, Inc. Amended and Restated 2007 Incentive Award Plan:

	Number of Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 2013	1,122,195	$	8.83
Granted	—	$	—
Exercised	—	$	—
Forfeited or cancelled	—	$	—
Outstanding at June 30, 2013	1,122,195	$	8.83	4.75	$	342
Fully vested and expected to vest at June 30, 2013	1,109,739	$	8.85	4.74	$	339
Exercisable at June 30, 2013	879,061	$	9.31	4.48	$	256

Aggregate intrinsic value represents the value of Skilled's closing stock price on the New York Stock Exchange on the last trading day of the fiscal period in excess of the exercise price, multiplied by the number of options outstanding or exercisable.

Compensation related to stock option grants and stock awards included in general and administrative expenses was $0.1 million for the three months ended June 30, 2013 and $0.8 million for the three months ended June 30, 2012. The amount of compensation included in general and administrative expenses was $0.9 million and $1.5 million for the six months ended June 30, 2013 and 2012 respectively. The amount of compensation included in cost of services was $0.2 million and $0.4 million for the three months ended June 30, 2013 and 2012, respectively. The amount of compensation included in the cost of services for the six months ended June 30, 2013 and 2012 was $0.8 million and $0.9 million respectively.

XML

Business Segments

6 Months Ended

Jun. 30, 2013

Segment Reporting [Abstract]

Business Segments

Business Segments

The Company has three reportable operating segments: (i) long-term care services ("LTC"), which includes the operation of SNFs and ALFs which is the most significant portion of the Company's business, the Company's administrative services provided to an unrelated SNF operator, and the facility lease revenue from a third-party operator; (ii) the Company's rehabilitation therapy services business; and (iii) the Company's hospice and home health businesses. The "other" column in the table below includes general and administrative items. The Company's reporting segments are business units that offer different services, and that are managed differently due to the nature of the services provided.

At June 30, 2013, LTC services included 74 wholly-owned SNF operating companies that offer post-acute, rehabilitative custodial and specialty skilled nursing care, as well as 22 wholly-owned ALF operating companies that provide room and board and social services. Therapy services included rehabilitative services such as physical, occupational and speech therapy provided in the Company's facilities and in unaffiliated facilities. Hospice and home health services were provided by the Company's wholly-owned subsidiaries to patients.

The Company evaluates performance and allocates capital resources to each segment based on an operating model that is designed to maximize the quality of care provided and profitability. Accordingly, earnings from operations before net interest, tax, depreciation and amortization, non-core expenses ("Adjusted EBITDA") and rent cost of revenue ("Adjusted EBITDAR") is used as the primary measure of each segment’s operating results because it does not include such costs as interest expense, income taxes, depreciation, amortization and rent cost of revenue which may vary from segment to segment depending upon various factors, including the method used to finance the original purchase of assets within a segment or the tax law of the states in which a segment operates. By excluding these items, the Company is better able to evaluate operating performance of the segment by focusing on more controllable measures. Adjusted EBITDA and Adjusted EBITDAR are non‑GAAP financial measures. For a full discussion of the definitions of these terms and the reasons why the Company utilizes such measures, see Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations, of this filing. General and administrative expenses are not allocated to any segment for purposes of determining segment profit or loss, and are included in the "other" category in the selected segment financial data that follows. Intersegment sales and transfers are recorded at cost plus standard mark-up; intersegment transactions have been eliminated in consolidation.

The following table sets forth selected financial data consolidated by business segment (dollars in thousands):

	Long-Term Care Services		Therapy Services		Hospice & Home Health Services		Other			Elimination			Total
Three months ended June 30, 2013
Net patient service revenue from external customers	$	161,012	$	26,637	$	25,256	$	—		$	—		$	212,905
Leased facility revenue	787		—		—		—			—			787
Intersegment revenue	653		14,018		—		—			(14,671		)	—
Total revenue	$	162,452	$	40,655	$	25,256	$	—		$	(14,671	)	$	213,692
Operating income (loss)	$	12,176	$	2,705	$	3,879	$	(6,995	)	$	—		$	11,765
Interest expense, net of interest income													(8,622		)
Other expense													(32		)
Equity in earnings of joint venture													472
Debt modification costs													(1,088		)
Income before provision for income taxes													$	2,495
Depreciation and amortization	$	5,656	$	174	$	135	$	165		$	—		$	6,130
Segment capital expenditures	$	3,365	$	70	$	83	$	62		$	—		$	3,580
Adjusted EBITDA	$	17,801	$	2,879	$	1,792	$	(4,832	)	$	—		$	17,640
Adjusted EBITDAR	$	22,171	$	2,879	$	2,258	$	(4,840	)	$	—		$	22,468
Three months ended June 30, 2012
Net patient service revenue from external customers	$	163,287	$	26,385	$	26,935	$	—		$	—		$	216,607
Leased facility revenue	768		—		—		—			—			768
Intersegment revenue	601		15,818		—		—			(16,419		)	—
Total revenue	$	164,656	$	42,203	$	26,935	$	—		$	(16,419	)	$	217,375
Operating (loss) income	$	18,126	$	3,543	$	4,521	$	(6,587	)	$	—		$	19,603
Interest expense, net of interest income													(10,389		)

	Long-Term Care Services		Therapy Services		Hospice & Home Health Services		Other			Elimination			Total
Other expense													106
Equity in earnings of joint venture													490
Debt retirement costs													(3,958		)
Income before provision for income taxes													$	5,852
Depreciation and amortization	$	5,630	$	164	$	145	$	153		$	—		$	6,092
Segment capital expenditures	$	2,894	$	269	$	114	$	345		$	—		$	3,622
Adjusted EBITDA	$	23,719	$	3,850	$	5,255	$	(6,034	)	$	—		$	26,790
Adjusted EBITDAR	$	27,940	$	3,850	$	5,565	$	(6,026	)	$	—		$	31,329
Six months ended June 30, 2013
Net patient service revenue from external customers	$	325,925	$	53,744	$	51,350	$	—		$	—		$	431,019
Leased facility revenue	1,548		—		—		—			—			1,548
Intersegment revenue	1,194		29,190		—		—			(30,384		)	—
Total revenue	$	328,667	$	82,934	$	51,350	$	—		$	(30,384	)	$	432,567
Operating income (loss)	$	24,426	$	5,659	$	6,582	$	(13,650	)	$	—		$	23,017
Interest expense, net of interest income													(17,185		)
Other income													(62		)
Equity in earnings of joint venture													961
Debt modification costs													(1,088		)
Income before provision for income taxes													$	5,643
Depreciation and amortization	$	11,267	$	350	$	291	$	358		$	—		$	12,266
Segment capital expenditures	$	5,562	$	93	$	213	$	113		$	—		$	5,981
Adjusted EBITDA	$	35,632	$	6,010	$	4,784	$	(10,856	)	$	—		$	35,570
Adjusted EBITDAR	$	44,354	$	6,010	$	5,702	$	(10,856	)	$	—		$	45,210
Six months ended June 30, 2012
Net patient service revenue from external customers	$	329,625	$	52,501	53,140		$	—		$	—		$	435,266
Leased facility revenue	1,522		—		—		—			—			1,522
Intersegment revenue	1,355		31,799		—		—			(33,154		)	—
Total revenue	$	332,502	$	84,300	53,140		$	—		$	(33,154	)	$	436,788
Operating (loss) income	$	36,264	$	6,491	9,053		$	(12,854	)	$	—		$	38,954
Interest expense, net of interest income													(19,809		)
Other income													77
Equity in earnings of joint venture													961
Debt retirement costs													(3,958		)
Income before provision for income taxes													$	16,225
Depreciation and amortization	$	11,301	$	332	$	291	$	312		$	—		$	12,236
Segment capital expenditures	$	5,299	$	546	$	317	$	935		$	—		$	7,097
Adjusted EBITDA	$	47,499	$	6,966	$	10,123	$	(11,730	)	$	—		$	52,858
Adjusted EBITDAR	$	55,955	$	6,966	$	10,747	$	(11,715	)	$	—		$	61,953

A reconciliation of Adjusted EBITDA and Adjusted EBITDAR to net income is as follows (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Adjusted EBITDAR	$	22,468		$	31,329		$	45,210		$	61,953
Rent cost of revenue	(4,828		)	(4,539		)	(9,640		)	(9,095		)
Adjusted EBITDA	17,640			26,790			35,570			52,858
Depreciation and amortization	(6,130		)	(6,092		)	(12,266		)	(12,236		)
Interest expense	(8,734		)	(10,521		)	(17,409		)	(20,086		)
Interest income	112			132			224			277
Change in fair value of contingent consideration	2,244			(499		)	2,161			(630		)
Organization restructure costs	(1,549		)	—			(1,549		)	—
Debt retirement costs	(1,088		)	(3,958		)	(1,088		)	(3,958		)
Provision for income taxes	(972		)	(2,355		)	(1,050		)	(6,391		)
Net income	$	1,523		$	3,497		$	4,593		$	9,834

The following table presents the segment assets as of June 30, 2013 compared to December 31, 2012 (in thousands):

	Long-Term Care  Services		Therapy Services		Hospice & Home Health Services		Other		Total
June 30, 2013:
Segment total assets	$	463,370	$	57,005	$	105,157	$	59,442	$	684,974
Goodwill and intangibles included in total assets	$	1,532	$	23,693	$	82,255	$	—	$	107,480
December 31, 2012:
Segment total assets	$	471,129	$	52,559	$	103,800	$	55,148	$	682,636
Goodwill and intangibles included in total assets	$	1,670	$	23,693	$	82,281	$	—	$	107,644

XML

Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash Flows from Operating Activities
Net income	$ 4,593	$ 9,834
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	12,266	12,236
Change in fair value of contingent consideration	(2,161)	630
Provision for doubtful accounts	6,097	3,562
Non-cash stock-based compensation	1,634	2,371
Disposal of fixed assets	0	(145)
Excess tax benefits from stock-based payment arrangements	0	242
Amortization of deferred financing costs	1,323	1,643
Debt modification/retirement costs	1,088	3,958
Deferred income taxes	4,080	(369)
Amortization of discount on debt	475	432
Changes in operating assets and liabilities:
Accounts receivable	(21,037)	(12,801)
Payments on notes receivable	1,419	1,482
Other current and non-current assets	(1,642)	(1,172)
Accounts payable and accrued liabilities	766	(5,330)
Employee compensation and benefits	(328)	(1,488)
Insurance liability risks	4,271	(3)
Other long-term liabilities	945	(962)
Net cash provided by operating activities	13,789	14,120
Cash Flows from Investing Activities
Additions to property and equipment	(5,981)	(7,097)
Acquisition of healthcare facilities and businesses, net of cash acquired	0	(1,053)
Proceeds from divestitures	0	1,050
Net cash used in investing activities	(5,981)	(7,100)
Cash Flows from Financing Activities
Borrowings under line of credit	165,000	162,500
Repayments under line of credit	(161,000)	(117,000)
Repayments of long-term debt	(9,121)	(157,494)
Excess tax benefits from stock-based payment arrangements	0	(242)
Taxes paid related to net share settlement of equity awards	(222)	(229)
Proceeds from issuance of long-term debt	0	98,000
Payment of financing costs	(2,449)	(3,000)
Net cash used in financing activities	(7,792)	(17,465)
Increase (decrease) in cash and cash equivalents	16	(10,445)
Cash and cash equivalents at beginning of period	2,003	16,017
Cash and cash equivalents at end of period	$ 2,019	$ 5,572

XML

Debt Schedule of Long Term Debt Instruments (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Debt Instrument [Line Items]
Insurance premiums financed	$ 605	$ 660
Total long-term debt	445,513	448,967
Less amounts due within one year	(12,306)	(13,338)
Long-term debt, net of current portion	433,207	435,629
Notes payable due December 2018, interest rate fixed at 6.50% [Member]
Debt Instrument [Line Items]
Notes payable due December 2018, interest rate fixed at 6.50%, payable in monthly installments, collateralized by a first priority deed of trust	1,040	1,118
Revolving Credit Facility Amended [Member] | Revolving Credit Facility due 2015, interest rate comprised of LIBOR plus 4.50% or 4.74% [Member]
Debt Instrument [Line Items]
Revolving Credit Facility due 2015, interest rate comprised of LIBOR plus 4.50% or 4.74% at June 30, 2012	28,000	25,000
Revolving Credit Facility Amended [Member] | Revolving Credit Facility due 2015, interest rate comprised of the Prime rate of 3.25% plus 3.50%, or 6.75% [Member]
Debt Instrument [Line Items]
Revolving Credit Facility due 2015, interest rate comprised of the Prime rate of 3.25% plus 3.50%, or 6.75%, at June 30, 2012	11,000	10,000
Senior Secured Term Loan Amended [Member] | Term Loan, due 2016, interest rate based on LIBOR (subject to a 1.50% floor) plus 5.25% or 6.75% [Member]
Debt Instrument [Line Items]
Term Loan, due 2016, interest rate based on LIBOR (subject to a 1.50% floor) plus 5.25% or 6.75%, at June 30, 2012; collaterized by sustantially all assets of the Company	385,940	411,600
Senior Secured Term Loan Amended [Member] | Term Loan due 2016, interest rate based comprised of base rate at prime plus 4.25% or 7.50% [Member]
Debt Instrument [Line Items]
Term Loan, due 2016, interest rate based on LIBOR (subject to a 1.50% floor) plus 5.25% or 6.75%, at June 30, 2012; collaterized by sustantially all assets of the Company	20,417	0
Secured Debt [Member]
Debt Instrument [Line Items]
Senior Subordinated Notes original issue discount	(2,538)	(3,013)
Note Payable - Hospice/Home Health Acquisition [Member] | Hospice/Home Health Acquisition note, interest rate fixed at 6.00% [Member]
Debt Instrument [Line Items]
Hospice/Home Health Acquisition note, interest rate fixed at 6.00%, payable in annual installments	0	1,483
Note Payable - Cornerstone Acquisition [Member]
Debt Instrument [Line Items]
Hospice/Home Health Acquisition note, interest rate fixed at 6.00%, payable in annual installments	$ 1,049	$ 2,119

XML

Business Segments Reconciliation of Adjusted EBITDA and Adjusted EBITDAR to Net Income (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Segment Reporting [Abstract]
Adjusted EBITDAR	$ 22,468	$ 31,329	$ 45,210	$ 61,953
Rent Cost of Revenue	(4,828)	(4,539)	(9,640)	(9,095)
Adjusted EBITDA	17,640	26,790	35,570	52,858
Depreciation and amortization	(6,130)	(6,092)	(12,266)	(12,236)
Interest expense	(8,734)	(10,521)	(17,409)	(20,086)
Interest income	112	132	224	277
Change in Fair Value of Contingent Consideration	2,244	(499)	2,161	(630)
Organization restructure costs	(1,549)	0	(1,549)	0
Debt retirement costs	(1,088)	(3,958)	(1,088)	(3,958)
Provision for income taxes	(972)	(2,355)	(1,050)	(6,391)
Net income	$ 1,523	$ 3,497	$ 4,593	$ 9,834

XML

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2013

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying condensed consolidated financial statements as of June 30, 2013 and for the three and six months ended June 30, 2013 and 2012 (collectively, the "Interim Financial Statements"), are unaudited. Certain information and footnote disclosures normally included in the Company’s annual consolidated financial statements have been condensed or omitted, as permitted under applicable rules and regulations. Readers of the Interim Financial Statements should refer to the Company's audited consolidated financial statements and notes thereto, updated for Note 3, "Summary of Significant Accounting Policies", to this filing, for the year ended December 31, 2012, which are included in the Company's 2012 Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC"). Management believes that the Interim Financial Statements reflect all adjustments that are of a normal and recurring nature necessary to fairly present the Company's financial information in all material respects as of the dates and for the periods presented. The results of operations presented in the Interim Financial Statements are not necessarily indicative of operations for the entire year or any other period.

The accompanying Interim Financial Statements include the accounts of Skilled and its consolidated wholly-owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.

Estimates and Assumptions

Estimates and Assumptions

The interim consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP"), which require the Company to consolidate company financial information and make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The most significant estimates in the Company’s consolidated financial statements relate to revenue, allowance for doubtful accounts, self-insured liability risks, income taxes, valuation of contingent consideration and impairment of long-lived assets and goodwill. Actual results could differ materially from those estimates.

Revenue and Accounts Receivable

Revenue and Accounts Receivables

Revenue and accounts receivable are recorded on an accrual basis as services are performed at their estimated net realizable value. The Company derives a majority of its revenue from funds under federal Medicare and state Medicaid assistance programs, the continuation of which are dependent upon governmental policies and are subject to audit risk and potential recoupment.

Overall payments made by Medicare for hospice services are subject to an annual cap amount on a per hospice agency basis. Total Medicare payments received for services rendered during the applicable Medicare hospice cap year by each Medicare-certified agency during this period are compared to the cap amount for the relevant period. Payments in excess of the cap are subject to recoupment by Medicare.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In November 2011, the FASB issued ASU No. 2011-11, Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities, ("ASU 2011-11"). This ASU require an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. The adoption of ASU 2011-11 becomes effective for the Company's interim and annual periods beginning on or after January 1, 2013. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.

In February 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income. The amendments in this update require an entity to provide information about the amounts reclassified from accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in the notes, significant amounts reclassified from accumulated other comprehensive income by the net income line item. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.

XML

Commitments and Contingencies

6 Months Ended

Jun. 30, 2013

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Legal Matters

General

Skilled and its subsidiaries are party to various legal actions and administrative proceedings and are subject to various claims arising in the ordinary course of business, including without limitation claims that their services have resulted in injury or death to patients who receive care from the Company's businesses and claims related to employment, staffing requirements and commercial matters. Although Skilled and its subsidiaries intend to vigorously defend themselves in these matters, there can be no assurance that the outcomes of these matters will not have a material adverse effect on the Company's results of operations and financial condition.

Skilled and its subsidiaries operate in a highly regulated industry. They are subject to ongoing regulatory oversight by state and federal regulatory authorities. Actual or alleged failure to comply with legal and regulatory requirements could subject Skilled and its subsidiaries to civil, administrative or criminal fines, penalties or restitutionary relief, and reimbursement authorities could seek the suspension or exclusion of the offending provider or individual from participation in government healthcare programs and could lead to recoupment claims on prior payments by government healthcare programs. Adverse determinations in legal and regulatory investigations, actions and proceedings, whether currently asserted or arising in the future, could have a material adverse effect on the Company's financial position, results of operations and cash flows.

See also Part II, Item 1A -- Risk Factors, included elsewhere in this report, including without limitation the sections therein entitled "Significant legal actions, which are commonplace in our professions, could subject us to increased operating costs and substantial uninsured liabilities, which would materially and adversely affect our results of operations, liquidity and financial condition," "Revenue we receive from Medicare and Medicaid is subject to potential retroactive reduction or repayment," "We are subject to extensive and complex laws and government regulations. If we are not operating in compliance with these laws and regulations or if these laws and regulations change, we could be required to make significant expenditures or change our operations in order to bring our facilities and operations into compliance" and "We face reviews, audits and investigations under federal and state government programs and contracts. These audits could have adverse findings that may negatively affect our business."

Humboldt County Litigation

In connection with the September 2010 settlement of the class action litigation against Skilled and certain of its subsidiaries related to, among other matters, alleged understaffing at certain California skilled nursing facilities operated by Skilled's subsidiaries (the "Humboldt County Action"), Skilled and its defendant subsidiaries (collectively, the "Defendants”) entered into settlement agreements with the plaintiffs and intervenor and agreed to an injunction. The settlement was approved by the Superior Court of California, Humboldt County on November 30, 2010. Under the terms of the settlement agreements, the defendant entities deposited a total of $50.0 million into escrow accounts to cover settlement payments to class members, notice and claims administration costs, reasonable attorneys' fees and costs and certain other payments, including $5.0 million to settle certain government agency claims and potential government claims that may arise. Of the $5.0 million provided for such government claims, $1.0 million was initially released by the court to the Humboldt County Treasurer-Tax Collector on behalf of the People of the State of California for their release of the Defendants. The remaining $4.0 million was available for the settlement and releases by the California Attorney General and certain other District Attorneys. However, in the event that any of these government authorities were to instead file certain actions against the Defendants by the second anniversary of the effective date of the settlement agreement, which occurred in February 2013, the entire $4.0 million would have reverted to the Defendants upon their request to the Settlement Administrator.No such actions were filed, however, resulting in an additional $1.0 million distribution to the Humboldt County District Attorney's Office and the remaining $3.0 million being distributed to the class settlement fund, as required by the settlement agreement.

In addition to the payments to the Humboldt County Treasurer-Tax Collector on behalf of the People of the State of California, the court alsoapproved payments from the escrow of up to approximately $24.8 million for attorneys' fees and costs and $10,000 to each of the three named plaintiffs.  Pursuant to the injunction, the twenty-two Defendants that operated California nursing facilities were required to provide specified nurse staffing levels, comply with specified state and federal regulations governing staffing levels and posting requirements, and provide reports and information to a court-appointed auditor. The injunction was to remain in effect for a period of twenty-four months unless extended for additional three-month periods as to those Defendants that may be found in violation. Defendants demonstrating compliance for an eighteen-month period that ended September 30, 2012 were permitted to petition for early termination of the injunction. The Defendants were required to demonstrate over the term of the injunction that the costs of the injunction met a minimum threshold level pursuant to the settlement agreement, which level, initially $9.6 million, was reduced by the portion attributable to any Defendant in the case that no longer operated a skilled nursing facility during the injunction period.

In April 2011, five of the subsidiary Defendants transferred their operations to an unaffiliated third party skilled nursing facility operator (the “Former Humboldt County Facilities”). On November 14, 2012, the Defendants filed a motion to terminate the injunction and vacate the final judgment in the Humboldt County Action. Based upon compliance with the injunction through the requisite eighteen-month period, on December 21, 2012, the Superior Court of California, Humboldt County granted the Defendants' motion for early termination of the injunction, and the injunction has now ended with respect to the 17 California nursing facilities that the subsidiary Defendants still operate. In its order, the court determined that the injunction termination did not apply to the Former Humboldt County Facilities. However, the 2010 court-approved stipulation and order establishing the injunction provides that the injunction applies to the named defendants and any successor licensees of the applicable nursing facilities, but only if those successor licensees are affiliates of the named defendants. As noted above, the Former Humboldt County Facilities have been operated by an unaffiliated third party since April 2011. Therefore, under the terms of the injunction it does not apply to the Former Humboldt County Facilities unless an affiliate of the Defendants operates them. Pursuant to the BMFEA matter discussed below the California theories in this context were released in February 2013.

In the course of ongoing communications with the California Attorney General's Bureau of Medi-Cal Fraud & Elder Abuse ("BMFEA") related to the BMFEA matter discussed below, representatives of the California Attorney General and the U.S. Department of Justice ("DOJ") indicated an interest in pursuing an action under the False Claims Act ("FCA"). The DOJ has expressed that it believes the company has FCA and other legal liabilities based upon the jury findings in the Humboldt County Action and otherwise related to staffing considerations related thereto. While the Company continues to cooperate with the government's evaluation of the matter, the Company views the government's apparent legal theories, including the False Claims Act theories, as lacking support in the established case law. The Company intends to vigorously defend any such action if brought.

BMFEA Matter

On April 15, 2009, two of Skilled's wholly-owned companies, Eureka Healthcare and Rehabilitation Center, LLC (“EHRC”), which at the time operated Eureka Healthcare and Rehabilitation Center (the "Facility"), and Skilled Healthcare, LLC (“SHC”), the administrative services provider for the Facility, were served with a search warrant that related to an investigation of the Facility by the BMFEA. The search warrant related to, among other things, records, property and information regarding certain enumerated patients of the Facility and covered the period from January 1, 2007 through the date of the search. On October 31, 2012, the BMFEA filed a criminal complaint (the “BMFEA Action”) in California Superior Court, Humboldt County against EHRC, SHC and Skilled alleging elder endangerment in nine misdemeanor counts under Penal Code Section 368(c) and two felony counts under Penal Code Section 368(b)(1) related to the care of certain patients at the Facility in 2008. No individuals were named as defendants in the complaint. The Company disputed the BMFEA's theories of alleged criminal liability and vigorously defended the action. The charges filed by the BMFEA, if proven, would have carried fines of up to $6,000 for each of the two felony counts and $2,000 for each of the nine misdemeanor counts. Convictions could also lead to exclusion from participation in federal healthcare programs under federal laws such as the Federal False Claims Act and the Civil Monetary Penalty Law, which could be materially adverse to Skilled's business. EHRC transferred its operations in April 2011 to an unaffiliated third party skilled nursing facility operator, and has not had any ongoing operations since that time.

On February 15, 2013, the parties reached a mutually satisfactory settlement of the BMFEA Action. Pursuant to the settlement: (i) Skilled and SHC were dismissed from the case with prejudice; (ii) EHRC pled no contest to a single misdemeanor count of elder endangerment under Penal Code Section 368(c) and agreed to pay a statutory fine of $680, pay $145,000 to the California Attorney General for its costs of investigation, and to serve two (2) years of summary probation; and (iii) the California Attorney General granted Skilled, SHC, and twenty-five (25) of their affiliates who currently or formerly operated skilled nursing facilities in California, a release of any potential liability to the California Attorney General under certain civil statutes based upon conduct occurring through the effective date of the settlement (including the FCA theories discussed under Humboldt County Litigation above). The court accepted EHRC's misdemeanor plea and the other relevant terms of the settlement on February 15, 2013. Notwithstanding EHRC's no contest plea to the single misdemeanor charge, the Company, SHC and EHRC continue to deny any liability for the allegations in the BMFEA Action. The release granted by the California Attorney General may not apply to the DOJ should it choose to pursue action against us.

Pursuant to the settlement, Skilled, SHC and their twenty (20) affiliated current California skilled nursing facility operators also agreed to a 2-year staffing agreement (the “2013 Staffing Agreement”) with the California Attorney General that essentially continues the requirements of the staffing-related injunction that was in effect until December 2012 as a result of the September 2010 settlement of the Humboldt County Action. Similar to the former staffing-related injunction, the 2013 Staffing Agreement requires the applicable nursing facility operators to provide a minimum of 3.2 nursing hours per patient day as required by applicable California regulation and to adhere to related regulatory requirements, as well as to submit to periodic compliance audits of the same. Unlike the former staffing-related injunction, however, the 2013 Staffing Agreement does not provide for early termination based on demonstrated compliance and does not contain a minimum spend requirement. To date the 2013 Staffing Agreement has not, and the Company does not believe it will, require the Company or its affected affiliates to incur any material staffing or other costs beyond what they would otherwise incur in the ordinary course of business.

Creekside Hospice Investigation

On August 2, 2013, the United States Attorney for the District of Nevada indicated that its Civil Division is investigating the Company, as well as its subsidiary, Creekside Hospice II, LLC, for possible violations of federal and state healthcare fraud and abuse laws and regulations. These laws could include the federal False Claims Act ("FCA") and the Nevada False Claims Act ("NFCA"). The FCA provides for civil and administrative fines and penalties, including civil fines ranging from $5,500 to $11,000 per claim plus treble damages. The NFCA provides for similar fines and penalties, including treble damages. Violations of these federal or state laws could also subject the Company and/or its subsidiaries to exclusion from participation in the Medicare and Medicaid programs. Any damages, fines, penalties, other sanctions and costs that we may incur as a result of any state or federal FCA suit could be significant and could have a material and adverse effect on our results of operations and financial condition. At this time, we cannot predict what effect, if any, the investigation or any potential claims arising under the FCA, the NFCA, or other statutes or regulations, could have on the Company.

Insurance

The Company maintains insurance for workers' compensation, general and professional liability, employee benefits liability, property, casualty, directors’ and officers’ liability, inland marine, crime, boiler and machinery, automobile, employment practices liability and earthquake and flood. The Company believes that its insurance programs are adequate and appropriate, and where there has been a direct transfer of risk to the insurance carrier, the Company does not recognize a liability in the consolidated financial statements.

Workers' Compensation. The Company has maintained workers' compensation insurance as statutorily required. Most of its commercial workers' compensation insurance purchased is loss sensitive in nature, except as noted below. As a result, the Company is responsible for adverse loss development. Additionally, the Company self-insures the first unaggregated $1.0 million per workers' compensation claim for all California, New Mexico and Nevada skilled nursing and assisted living businesses. The Company has elected not to carry workers' compensation insurance in Texas and it may be liable for negligence claims that are asserted against it by its Texas-based employees. For the policy periods up to December 31, 2011, the Company has purchased guaranteed cost policies for its Kansas, Missouri, Iowa and Nebraska skilled nursing and assisted living businesses, as well as all of its hospice and home health businesses. There are no deductibles associated with these programs. Since January 1, 2013, the Company self-insures the first $0.5 million for these businesses. The Company recognizes a liability in its interim consolidated financial statements for its estimated self-insured workers' compensation risks. Historically, estimated liabilities have been sufficient to cover actual claims.

General and Professional Liability. The Company's services subject it to certain liability risks. Malpractice and similar claims may be asserted against the Company if its services are alleged to have resulted in patient injury or other adverse effects. The Company is subject to malpractice and similar claims and other litigation in the ordinary course of business.

Effective September 1, 2008, the Company's California-based skilled nursing facility companies purchased individual general and professional liability insurance policies for claims reported through August 31, 2011, with a per occurrence and annual aggregate coverage limit of $1.0 million and $3.0 million, respectively, and an unaggregated $0.1 million per claim self-insured retention. Effective September 1, 2008, the Company also had an excess liability policy for claims reported through August 31, 2011, with a $14.0 million per loss limit and an $18.0 million annual aggregate limit for losses arising from claims in excess of $1.1 million for the California skilled nursing facilities and in excess of $1.0 million for all other businesses.

Effective September 1, 2011, the Company purchased excess liability policies with $25.0 million per loss and annual aggregate limits for claims in excess of $1.0 million per loss for all businesses. Effective September 1, 2011, the Company also self-insures professional liability claims at its California based SNF subsidiaries through its wholly-owned offshore captive insurance company, Fountain View Reinsurance, Ltd., for claims up to $1.0 million. Effective September 1, 2012, the Company self-insures professional liability claims for all of its SNF and ALF subsidiaries through its wholly-owned off shore captive company for claims up to $1.0 million.

The Company retains an unaggregated self-insured retention of $1.0 million per claim for all of its businesses other than its hospice and home health businesses, which are insured under a separate general and professional liability insurance policy with a $1.0 million per loss limit. The excess liability policy referenced above is also applicable to this policy.

Employee Medical Insurance. Medical preferred provider option programs are offered as a component of the Company's employee benefits. The Company retains a self-insured amount up to a contractual stop loss amount of $0.25 million deductible for most participants on its preferred provider organization plan. All other employee medical plans are guaranteed cost plans.

A summary of the liabilities related to insurance risks are as follows (dollars in thousands):

	As of June 30, 2013:											As of December 31, 2012
	General and Professional			Employee Medical			Workers’ Compensation			Total		General and Professional			Employee Medical			Workers’ Compensation			Total
Current	$	7,153	(1)	$	2,516	(2)	$	5,492	(2)	$	15,161	$	5,622	(1)	$	2,143	(2)	$	5,328	(2)	$	13,093
Non-current	13,053			—			12,967			26,020		15,587			—			11,809			27,396
	$	20,206		$	2,516		$	18,459		$	41,181	$	21,209		$	2,143		$	17,137		$	40,489

(1) Included in accounts payable and accrued liabilities.

(2) Included in employee compensation and benefits.

Hallmark Indemnification

Hallmark, the Company's rehabilitation services subsidiary, provides physical, occupational and speech therapy services to various unaffiliated skilled nursing facilities. These unaffiliated skilled nursing facilities are reimbursed for these services from the Medicare Program and other third-party payors. Hallmark has indemnified these unaffiliated skilled nursing facilities from a portion of certain disallowances of these services. Additionally, to the extent a Recovery Audit Contractor ("RAC") or other regulatory authority or contractor is successful in making a claim for recoupment of revenue from any of these skilled nursing facilities, Hallmark will typically be required to indemnify them against their charges associated with this loss. No material indemnification payments were required to be made in three or six months ended June 30, 2013 or 2012.

Financial Guarantees

Substantially of all Skilled's wholly-owned subsidiaries guarantee the Company's first lien senior secured credit facility. These guarantees are full and unconditional and joint and several. Other subsidiaries of Skilled that are not guarantors are considered minor. On May 12, 2012, the Company redeemed the entire $130.0 million of its then outstanding 11.0% senior subordinated notes due 2014 (the "2014 Notes"). The 2014 Notes were guaranteed by substantially all of Skilled's wholly-owned subsidiaries on terms similar to their guarantees of the Company's first lien senior secured credit facility.

XML

Property and Equipment (Tables)

6 Months Ended

Jun. 30, 2013

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

Property and equipment consisted of the following as of June 30, 2013 and December 31, 2012 (in thousands):

	June 30, 2013			December 31, 2012
Land and land improvements	$	64,983		$	64,983
Buildings and leasehold improvements	335,118			331,316
Furniture and equipment	86,818			83,949
Construction in progress	7,948			8,638
	494,867			488,886
Less accumulated depreciation	(129,990		)	(118,141		)
	$	364,877		$	370,745

Leased Facility Assets

Leased facility assets consisted of the following as of June 30, 2013 and December 31, 2012 (in thousands):

	June 30, 2013			December 31, 2012
Leased facility assets	$	13,848		$	13,848
Less accumulated depreciation	(4,186		)	(3,935		)
	$	9,662		$	9,913

XML

Net Income Per Share of Class A Common Stock and Class B Common Stock (Tables)

6 Months Ended

Jun. 30, 2013

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted net income per share of Class A common stock and Class B common stock for the three and six months ended June 30, 2013 and 2012 (amounts in thousands, except per share data):

	Three months ended June 30, 2013						Three months ended June 30, 2012
	Class A		Class B		Total		Class A		Class B		Total
Net Income per share, basic
Numerator:
Allocation of net income	$	893	$	630	$	1,523	$	1,950	$	1,547	$	3,497
Net Income per share, diluted
Numerator:
Allocation of net income	$	902	$	621	$	1,523	$	1,954	$	1,543	$	3,497
Denominator for basic and diluted net income per share:
Weighted average common shares outstanding, basic	22,070		15,576		37,646		20,852		16,548		37,400
Plus: incremental shares related to dilutive effect of stock options and restricted stock, if applicable	540		—		540		97		—		97
Adjusted weighted-average common shares outstanding, diluted	22,610		15,576		38,186		20,949		16,548		37,497
Net income per share, basic	$	0.04	$	0.04	$	0.04	$	0.09	$	0.09	$	0.09
Net income per share, diluted	$	0.04	$	0.04	$	0.04	$	0.09	$	0.09	$	0.09

	Six months ended June 30, 2013						Six months ended June 30, 2012
	Class A		Class B		Total		Class A		Class B		Total
Net Income per share, basic
Numerator:
Allocation of net income	$	2,690	$	1,903	$	4,593	$	5,425	$	4,409	$	9,834
Net Income per share, diluted
Numerator:
Allocation of net income	$	2,717	$	1,876	$	4,593	$	5,442	$	4,392	$	9,834
Denominator for basic and diluted net income per share:
Weighted average common shares outstanding, basic	22,026		15,576		37,602		20,600		16,743		37,343
Plus: incremental shares related to dilutive effect of stock options and restricted stock, if applicable	537		—		537		146		—		146
Adjusted weighted-average common shares outstanding, diluted	22,563		15,576		38,139		20,746		16,743		37,489
Net income per share, basic	$	0.12	$	0.12	$	0.12	$	0.26	$	0.26	$	0.26
Net income per share, diluted	$	0.12	$	0.12	$	0.12	$	0.26	$	0.26	$	0.26

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following were excluded from the weighted-average diluted shares computation for the three and six months ended June 30, 2013 and 2012, as their inclusion would have been anti-dilutive (shares in thousands):

	Three Months Ended June 30,		Six Months Ended June 30,
	2013	2012	2013	2012
Options to purchase common shares	585	464	585	464
Non-vested common shares	434	1,018	911	898
Total excluded	1,019	1,482	1,496	1,362

XML

Document and Entity Information Document	6 Months Ended
	Jun. 30, 2013	Aug. 02, 2013 Common Class A	Aug. 02, 2013 Common Class B
Entity Listings [Line Items]
Entity Registrant Name	Skilled Healthcare Group, Inc.
Entity Central Index Key	0001351051
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Document Type	10-Q
Document Period End Date	Jun. 30, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Common Stock, Shares Outstanding		23,659,035	15,576,096

XML

Business Segments (Tables)

6 Months Ended

Jun. 30, 2013

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The following table sets forth selected financial data consolidated by business segment (dollars in thousands):

	Long-Term Care Services		Therapy Services		Hospice & Home Health Services		Other			Elimination			Total
Three months ended June 30, 2013
Net patient service revenue from external customers	$	161,012	$	26,637	$	25,256	$	—		$	—		$	212,905
Leased facility revenue	787		—		—		—			—			787
Intersegment revenue	653		14,018		—		—			(14,671		)	—
Total revenue	$	162,452	$	40,655	$	25,256	$	—		$	(14,671	)	$	213,692
Operating income (loss)	$	12,176	$	2,705	$	3,879	$	(6,995	)	$	—		$	11,765
Interest expense, net of interest income													(8,622		)
Other expense													(32		)
Equity in earnings of joint venture													472
Debt modification costs													(1,088		)
Income before provision for income taxes													$	2,495
Depreciation and amortization	$	5,656	$	174	$	135	$	165		$	—		$	6,130
Segment capital expenditures	$	3,365	$	70	$	83	$	62		$	—		$	3,580
Adjusted EBITDA	$	17,801	$	2,879	$	1,792	$	(4,832	)	$	—		$	17,640
Adjusted EBITDAR	$	22,171	$	2,879	$	2,258	$	(4,840	)	$	—		$	22,468
Three months ended June 30, 2012
Net patient service revenue from external customers	$	163,287	$	26,385	$	26,935	$	—		$	—		$	216,607
Leased facility revenue	768		—		—		—			—			768
Intersegment revenue	601		15,818		—		—			(16,419		)	—
Total revenue	$	164,656	$	42,203	$	26,935	$	—		$	(16,419	)	$	217,375
Operating (loss) income	$	18,126	$	3,543	$	4,521	$	(6,587	)	$	—		$	19,603
Interest expense, net of interest income													(10,389		)

	Long-Term Care Services		Therapy Services		Hospice & Home Health Services		Other			Elimination			Total
Other expense													106
Equity in earnings of joint venture													490
Debt retirement costs													(3,958		)
Income before provision for income taxes													$	5,852
Depreciation and amortization	$	5,630	$	164	$	145	$	153		$	—		$	6,092
Segment capital expenditures	$	2,894	$	269	$	114	$	345		$	—		$	3,622
Adjusted EBITDA	$	23,719	$	3,850	$	5,255	$	(6,034	)	$	—		$	26,790
Adjusted EBITDAR	$	27,940	$	3,850	$	5,565	$	(6,026	)	$	—		$	31,329
Six months ended June 30, 2013
Net patient service revenue from external customers	$	325,925	$	53,744	$	51,350	$	—		$	—		$	431,019
Leased facility revenue	1,548		—		—		—			—			1,548
Intersegment revenue	1,194		29,190		—		—			(30,384		)	—
Total revenue	$	328,667	$	82,934	$	51,350	$	—		$	(30,384	)	$	432,567
Operating income (loss)	$	24,426	$	5,659	$	6,582	$	(13,650	)	$	—		$	23,017
Interest expense, net of interest income													(17,185		)
Other income													(62		)
Equity in earnings of joint venture													961
Debt modification costs													(1,088		)
Income before provision for income taxes													$	5,643
Depreciation and amortization	$	11,267	$	350	$	291	$	358		$	—		$	12,266
Segment capital expenditures	$	5,562	$	93	$	213	$	113		$	—		$	5,981
Adjusted EBITDA	$	35,632	$	6,010	$	4,784	$	(10,856	)	$	—		$	35,570
Adjusted EBITDAR	$	44,354	$	6,010	$	5,702	$	(10,856	)	$	—		$	45,210
Six months ended June 30, 2012
Net patient service revenue from external customers	$	329,625	$	52,501	53,140		$	—		$	—		$	435,266
Leased facility revenue	1,522		—		—		—			—			1,522
Intersegment revenue	1,355		31,799		—		—			(33,154		)	—
Total revenue	$	332,502	$	84,300	53,140		$	—		$	(33,154	)	$	436,788
Operating (loss) income	$	36,264	$	6,491	9,053		$	(12,854	)	$	—		$	38,954
Interest expense, net of interest income													(19,809		)
Other income													77
Equity in earnings of joint venture													961
Debt retirement costs													(3,958		)
Income before provision for income taxes													$	16,225
Depreciation and amortization	$	11,301	$	332	$	291	$	312		$	—		$	12,236
Segment capital expenditures	$	5,299	$	546	$	317	$	935		$	—		$	7,097
Adjusted EBITDA	$	47,499	$	6,966	$	10,123	$	(11,730	)	$	—		$	52,858
Adjusted EBITDAR	$	55,955	$	6,966	$	10,747	$	(11,715	)	$	—		$	61,953

Reconciliation of Adjusted EBITDA and Adjusted EBITDAR to Net Income

A reconciliation of Adjusted EBITDA and Adjusted EBITDAR to net income is as follows (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Adjusted EBITDAR	$	22,468		$	31,329		$	45,210		$	61,953
Rent cost of revenue	(4,828		)	(4,539		)	(9,640		)	(9,095		)
Adjusted EBITDA	17,640			26,790			35,570			52,858
Depreciation and amortization	(6,130		)	(6,092		)	(12,266		)	(12,236		)
Interest expense	(8,734		)	(10,521		)	(17,409		)	(20,086		)
Interest income	112			132			224			277
Change in fair value of contingent consideration	2,244			(499		)	2,161			(630		)
Organization restructure costs	(1,549		)	—			(1,549		)	—
Debt retirement costs	(1,088		)	(3,958		)	(1,088		)	(3,958		)
Provision for income taxes	(972		)	(2,355		)	(1,050		)	(6,391		)
Net income	$	1,523		$	3,497		$	4,593		$	9,834

Schedule of Total Assets, Goodwill, and Intangibles, by Segment

The following table presents the segment assets as of June 30, 2013 compared to December 31, 2012 (in thousands):

	Long-Term Care  Services		Therapy Services		Hospice & Home Health Services		Other		Total
June 30, 2013:
Segment total assets	$	463,370	$	57,005	$	105,157	$	59,442	$	684,974
Goodwill and intangibles included in total assets	$	1,532	$	23,693	$	82,255	$	—	$	107,480
December 31, 2012:
Segment total assets	$	471,129	$	52,559	$	103,800	$	55,148	$	682,636
Goodwill and intangibles included in total assets	$	1,670	$	23,693	$	82,281	$	—	$	107,644